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Introduction 
Introduction 
Multiple organ dysfunction syndrome (MODS) is widely considered to be the leading 
cause of morbidity and mortality in the surgical inteosive care unit (ICU) 1-3. Despite 
intensive investigation, the pathogenesis ofMODS remains elusive. Literally hundreds of 
biochemical and cellular abnormalities have beeo described in patients with MODS, and 
their very number has made it difficult, if not impossible, to define a single common 
underlying event or process as the pathogenic basis of the disorder 4. To date, several 
theories about the pathogenesis ofMODS have been emerged. These theories have led to 
some conceptual models ofMODS. 
Pathophysiology 
Infection and MODS 
The first description of MODS emphasized its common association with occult or poorly 
controlled infection 5-7, frequently either peritonitis 8 or pneumonia 9. However, more 
recent reports indicate that infection, although common in patients with MODS, is not 
necessarily present I 0 and frequently follows, rather than precedes, the developmeot of 
the syndrome II, 12. Microbial products such as endotoxin may also cause MODS. 
Endotoxemia is much more common in the critically ill patient than in documented 
infection 13 and correlates poorly with culture-proven infection 14, suggesting an 
important role for the absorption of endotoxin from the gastrointestinal tract 15. 
Systemic Inflammation and MODS 
Clinical evidence of systemic inflammation is manifest in almost all patients developing 
MODS 16, 17. In fact, remote organ dysfunction can be considered the functio laesa of 
systemic inflammation 18. Although it is difficult to differentiate the clinical 
manifestations of inflammation from the infections that may be their cause, it can be 
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demonstrated that the severity of the clinical inflammatory response, rather than the 
presence or absence of infection, is the more important determinant of !CU survival 19. 
Although the synthesis and release of a panoply of biochemical mediators of 
inflammation is characteristic of both experimental and clinical sepsis, the mechanisms 
through which these molecules may induce organ injury are much less clear 20. An 
alternate concept of the dysregulated inflanunatory response that accompanies MODS 
suggests that the problem is not so much excessive inflanunation as an acquired state of 
immunodeficiency or immune paralysis 21. It seems realistic to consider that MODS 
reflects the state of dynamic imbalance that exists between each of the component 
mediators of the systemic inflanunatory response. 
Ischemia and Reperfuswn Injury 
Reduced oxygen delivery or utilization would be expected to inhibit the normal 
physiologic functions of the cell; therefore, the assumption that cellular hypoxia is the 
final common pathway to organ dysfunction is interesting 22. Although adequate initial 
resuscitation usually restores oxygen delivery at the level of the whole organism. regional 
hypoxia in tissues such as the gastrointestinal tract 23, 24 is a well-documented 
phenomenon. 
Reperfusion injury, precipitated by lack of oxygen, is likely to play a major role in the 
development of MODS. Certain tissues, such as the intestinal mucosa and hepatic 
parenchyma and nonparenchyma, may be especially susceptible because of the specific 
microvascular anatomy. Structural changes include not ouly swelling of the organelles 
but also the entire cell due to the entry of water and electrolytes. Lysosomal ruptures 
precede cell death. Oxygen free radical formation in the intestines and liver may trigger 
or cause injury in other distant organs, e.g. the heart and lungs, and affect overall vascular 
function I, 25. 
Increased circulating concentrations oflactate are also suggestive of tissue hypoxia, 
either global or regional, and are associated with an adverse outcome 26-28. 
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Apopwsis 
Apoptosis describes a physiologic process through which cells activate an endogenous 
program that leads to the controlled death of the cell and its transformation to membrane-
bound vesicles that are cleared by macrophages without evoking an inflammatory 
response 29. The normal expression of apoptosis is fundamental to such processes as 
embryologic development, immune maturation~ aging, and the resolution of 
inflammation. In critical illness, the expression of apoptosis appears to be altered. 
Apoptosis oflymphocytes and gut epithelial cells is increased 30, 31, whereas that of 
neutrophils is delayed 32-34. 
Microvascular Coagulopathy 
Multiple lines of evidence point to a pivotal role for inappropriate intravascular 
coagulation as a final common pathway to organ dysfunction. Cohort studies demonstrate 
a striking association between dysregulated coagulation and the development of organ 
dysfunction 35. Alterations in levels of factors that regulate the balance between 
coagulation and fibrinolysis are common in critically ill patients and cause a shift toward 
a procoagulant state 4_ Changes in these parameters precede the development of organ 
dyfunction 36 and persist in those patients who develop organ dysfunction or die 37. 
Gut-Liver Axis and MODS 
The gut hypothesis of MODS has received considerable attention over the past several 
years 38, 39. Intestinal mucosal injury can lead to dysfunction of the barrier between the 
intestinal lumen and blood, with translocation of intestinal bacteria and toxins to the 
circulation 40, 41. Translocation is thought to play a substantial role in the pathogenesis 
of sepsis, systemic inflammatory response syndrome, and MODS, through stimulation of 
cytotoxic pathways 42. Hence, the gut has been called the "ptimus motor" of MODS 43. 
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When translocated bacteria and endotoxin reach the liver, activation of Kupffer cells 
occurs, resulting in the secretion of proinflammatory mediators that enhance the stress 
response and alter various immune functions 44. These mediators cause binding of 
neutrophils to endothelial cells, activate local and systemic coagulation mechanisms, and 
eventually cause direct end-organ injury. Therefore, it was proposed that the gut is the 
"starter" of MODS, whereas the liver is the "motor" ofMODS 45. 
SequentUd Insults and Priming the Immune Response 
There is accumulating evidence that various insults, such as uncontrolled infection, shock 
or trauma, can prime the organism such that a subsequent otherwise nonlethal bacterial or 
endotoxin challenge becomes lethall. Experimental observations have been used to 
develop hypotheses that attempt to explain the exaggerated inflammatory response and 
organ dysfunction experienced by critically ill patients. These "two-hit" hypotheses 
imply that an initial sublethal insult establishes a physiologic state, which "primes" the 
organism to develop an amplified response to subsequent injuries I, 45. The resultant 
overwhelming inflammatory response is postulated to underline the pathogenesis of 
MODS in critically ill patients 46, 47. 
Interventional Strategies and Therapeutic Options 
Infection Control Measures 
Despite the development of more powerful antibiotics, our ability to rescue patients from 
established MODS has not improved significantly since the syndrome was first described 
two decades ago 46. Meta-analyses of infection control measures in clinical studies have 
revealed that the evidence that successful treatment of persistent or nosocomiallCU-
acquired infections alters the outcome of MODS is far from compelling 48-51. The 
pathogenic role of endotoxin is equally uncertain, as none of the few clinical trials that 
14 
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have evaluated endotoxin neutralization as a therapeutic strategy have shown unequivocal 
evidence ofbenefit 52_ 
Immune Response Modulation 
Clinical trials of a variety of strategies designed to inhibit inflammation in critical illness 
have generally yielded disappointing results 19_ The relatively modest impact of such 
approaches suggests that either the multiple redundant mediators must be targeted or that 
the ultimate morbidity of sepsis and MODS results from the downstream consequences of 
cytokine activity 18. The lack of efficacy of early high-dose corticosteroids therapy 53, 
54 or ibuprofen 55 strategies, that would be expected to reduce the levels of a number of 
inflammatory mediators, suggests that the latter interpretation may be more accurate 56_ 
Oxygen Delivery Enhancement 
Despite advances in critical care, the development of better resuscitation and 
sophisticated ventilatory strategies, the mortality of multiple organ failure remains 
unchanged 57. The initial enthusiasm for resuscitation to supranormal values to correct 
occult tissue hypoxia 58 has not been supported by more recent randomized trials 59_ As 
a matter of fact, the use of transfusion 60 or large doses of dobutarnine 61 to increase 
oxygen delivery actually worsens outcome and increases the severity of organ 
dysfunction. 
Apoptosis Regulation 
Interventions that modulate the expression of apoptosis have been implicated in 
improving outcome in a variety of experimental models of inflammation 62, 63. 
However, therapies targeting the expression of apoptosis are not yet clinically available. 
Therefore, the ability of such novel therapeutic strategies to prevent organ dysfunction in 
the critically ill patient remains unproven. 
15 
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Coagulation Cascade Modulation 
A variety of strategies that target the coagulation cascade have shown to improve survival 
io experimental models 64. In human, however. the results of clinical trials are somehow 
conflicting. In human volunteers, iofusion of tumor necrosis factor (TNF) activates 
coagulation and reproduces the coagulopathic profile of critical illness 65; paradoxically, 
neutralization ofTNF may also augment coagulation 66. Early studies suggesting benefit 
of administration of antithrombio III 67, 68 were not replicated io a recent large phase III 
multi center trial 4_ The administration of recombioant activated proteio C has been 
shown to improve outcome io a small cohort of patients 69. Ongoiog multicenter trials 
should provide the evidence of clinical efficacy and safety 69. 
Prophylactic Measurements: Selective Gut Decontamination and Immunonutrition 
Meta-analyses of the effects ofiofection prophylaxis usiog techniques of selective 
digestive tract decontamination show a striking reduction in rates of such infections as 
pneumonia, wound iofection, and bacteremia, but a much more modest, albeit statistically 
significant, reduction io mortality 70, 71. 
Selective gut decontamination showed no clioical benefits io multi-trauma patients. Early 
enteral nutritio~ especially with immunomodulating ingredients "immunonutrition"~ 
decreases post-traumatic complications, but a reduction of mortality could not be 
described io severely iojured patients so far 72. Meta-analyses of the effect of 
immunonutrition in critically ill patients after trauma, sepsis~ or major surgery, show 
significant reductions io iofection rate, ventilator days, and hospital length of stay, but no 
effect on mortality 73. Although it is tempting to conclude that early enteral nutrition 
reduces bacterial translocation by maiotaioiog normal gut flora, enhanciog mucosal 
integrity~ and promoting local immune response, more appealing alternative explanations 
include that the gut is an immunologic organ that can be modulated to enhance systemic 
immune response or, through emphasis on use of early enteral nutrition, patients are not 
exposed early to the immunosuppressive effects of total parental nutrition 45. 
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Background and Objectives ofthe Thesis 
MODS is, with an iocidence of 10-25% and a mortality of 50-70%, the most severe 
complication after severe trauma 72_ MODS is a prototypical exemplar of the application 
of complexity theory to an understandiog of the pathophysiology of critical illness 56, 74_ 
It arises through the ioteractions of a network of physiologic iosults iocludiog iojury, 
tissue ischemi~ bacteremi~ endotoxemi~ the host inflammatory response, and the 
interventions used to sustain organ function during a time of otherwise lethal 
iosufficiency. Its mediators are many and ioterdependent, with the activity of one 
induciog the expression of others that amplifY, inlnbit, or otherwise modifY the 
expression of the process 19. 
The implications of an understandiog of the complex nature of organ dysfunction are 
critical to the development of rational strategies to prevent or treat the process. Strategies 
directed agaiost events late io the process may be effective but are unlikely to have a 
significant effect on a process whose expression, at least from the perspective of the 
element targeted, has become autonomous 4, 18, 75. In contrast, ischemia and 
reperfusion iojury to both the iotestine and the liver appears to be a relatively early event 
io the process ofpost-iojury development of MODS, as outlioed io figure L Therefore, a 
target-oriented approach includiog early augmentation of iotestinal and hepatic perfusion 
and oxygenation seems conceptually a more attractive therapeutic option, either as a 
preventive measure for subjects at risk or as a promising treatment modality in the whole 
treatment strategy for patients with MODS. 
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lnflammatcny Response BT /l.PS Metabolic Dysfunction 
Fig. 1. Conceptual model of the role of ischemia and subsequent reperfusion injury (IIR) of the 
intestine and liver in initiating post-injury MODS. 
BT (bacterial translocation), LPS (lipopolysaccharide), SIRS (systemic inflammatory response 
syndrome), MODS (multiple organ dysfunction syndrome). 
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Introduction 
Occurrence of intestinal ischemia after trauma has recently been recognized as a 
frequent and significant phenomenon. A clinical review of the autopsy records of 
severely burned patients revealed a 61% incidence of intestinal ischemia 14. At the time 
of death, sepsis was manifested in more than 80% of these patients. 
The relationship between gut ischemia and sepsis remains to be defined. 
Splanchnic ischemia has been reported to alter the intestinal mucosal barrier, leading to 
the escape of indigenous bacteria and their endotoxins to the systemic circulation and 
remote body organs 20)3,34, a process termed "bacterial translocation" 4_ There is 
accumulating evidence from experimental studies indicating that bacterial translocation 
and endotoxin release have a potential role in the pathogenesis of sepsis and multiple 
organ failure 9,34. Clinical evidence of disruption of the intestinal barrier is increasing. 
Infections with gut-associated bacteria with no detectable pathologic focus have been 
documented in victims of trauma 5. It has been postulated that intestinal ischemia and 
sepsis can become self-sustaining (Fig. 1), since endotoxin, either gut- or tissue-derived, 
has been documented to decrease intestinal blood flow and promote bacterial 
translocation 12,26,36. 
Several factors can contribute to the development of post-trauma or sepsis-
induced intestinal ischemia, including systemic hemodynamic status, condition of the 
m.icrocirculatio~ circulating vasoactive substances, humoral and cellular mediators, and 
the products oflocal cellular metabolism. 
Systemic hypovolemia and cardiac failure may result in splanchnic ischemia 1,16. 
The measured reduction in the mesenteric blood flow does not correlate with cardiac 
output. Post-injury splanchnic ischemia occurs in the absence of depression of cardiac 
output or systemic blood flow 23,33, indicating that the mesenteric blood flow can be 
independently regulated by certain mediators. 
The identification of these mediators will facilitate the development of 
interventions to modulate the mesenteric blood flow and prevent the manifestation of 
subsequent pathological events. 
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THERMAL INJURY 
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ISCHEMIA/REPERFUSION 
INTESTINAL BARRIER FAILURE 
BACTERIAL TRANSLOCATION 
F.ag. 1: Thermal-induced intestinal ischemia and reperfusion injury can initiate bacterial translocation and 
systemic endotoxemia. Endotoxin. either gut- or tissue-derived, acting synergistically with the first insult 
may create a self-sustaining septic state. 
Mediators of the Post-Trauma and Sepsis-Induced Intestinal Ischemia 
It has been recognized that the severity of ischemia-induced intestinal injury is 
inversely related to mesenteric blood flow. Recently, it has become apparent that 
mesenteric vasculature reacts in a very sensitive way to injury. In an ovine model~ a 40% 
body surface area (BSA) bum was demonstrated to decrease blood flow through the 
cephalic mesenteric artery by 50% during the first hour postbum 24_In a porcine model, 
a 40% BSA bum reduced the blood flow of the superior mesenteric artery (SMA) to 25% 
and 30% of baseline 2 and 4 hours after bUIIl, respectively 33. The impact of 
endotoxemia on mesenteric blood flow has been investigated. Endotoxin has also been 
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reported to selectively alter intestinal blood flow and cause a profouod mesenteric 
vasoconstriction. In a rat model, the administration of endotoxin yielded a 25% and 50% 
decrease in blood flow to the distal ileum and cecw:n, respectively 36_ 
The systemic hemodynamic changes occurring during the early phase of both 
post-injury and septic shock have been postulated to alter the splanchnic circulation. 
Schlag and associates have demonstrated gastrointestinal ischemia in a hypovolemic-
traumatic baboon modeJ27_ Although hypovolemia, cardiac failure and increased 
systemic vascular resistance may contribute to this phenomenon, the pathway by which 
they interfere with mesenteric circulation seems to be nonspecific. The data of several 
experiments using different models demonstrate that the decrease in intestinal blood flow 
does not correlate proportionally with systemic hemodynaraic failure and that thermal 
injuries and endotoxins can reduce the intestinal blood flow in hyperdynamic states or in 
situations with normal indices of perfusion, i.e. cardiac output, blood pressure, and urine 
output 24,33,36_ Thus, the mesenteric blood flow must have been altered in these 
situations by certain mediators which express specific mesenteric vasoconstrictive 
capacities. 
The systemic inflammatory response to severe injuries and/or sepsis encompasses 
several cellular interactions, leading to the generation of diverse proin:flammatory 
cytokines and vasoactive peptides. The vasoactive metabolite of arachidonic acid, 
thromboxane A2 (TxA2), appears to play a pivotal role in the process of mesenteric 
ischemia following burn or sepsis. TxA2 has been shown to produce vasoconstriction of 
many vessels, including the celiac and mesenteric arteries. Herndon and his group have 
documented a marked elevation oftromboxane (Tx) B2, the stable metabolite of the 
potent vasoconstrictor TxA2, in the serum of patients innnediately after burn and during 
septic episodes 19_ TxA2 has also heen implicated in the pathophysiology of endotoxic 
shock 30_ An intravenous bolus of endotoxin elicits a marked but transient increase in 
plasma TxB2 and 6-keto-PGF!a in a large number of species. A smaller, delayed and 
more prolonged increase in TxB2 and 6-keto-PGF!a is reported in animals with septic 
shock, i.e. those with fecal peritonitis or cecal ligation 2_ Using a bum/endotoxin ovine 
model, burn tissue endotoxin has been shown to stimulate local TxA2 production leading 
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to distant lung dysfunction without the need for circulating endotoxin. This study has 
clearly demonstrated that the source of the TxA2 is the burn, while with endotoxemia the 
source is the lung 13. 
Other arachidonic acid metabolites, such as leukotriene (L T) C4 and D4, may 
also be involved in the process of mesenteric vasoconstriction. 
These are potent smooth muscle vasoconstrictors. Both compounds have been found in 
high concentrations in severely injured patients 37_ Coho et al. 8 examined the effects of 
the intravenous infusion of graded doses ofLTC4 on the mesenteric blood flow in 
innnature swine. Infusing LTC4 significantly decreased the mesenteric blood flow and 
mesenteric oxygen uptake and significantly increased ileal intramucosal hydrogen ion 
concentration. 
Recently, two vasoconstrictor peptides have been shown to increase after trauma 
and selectively affect the splanchoic vasculature. In an anesthetized dog, vasopressin and 
angiotensin lllevels were measured by radioinnnunoassay. Vasopressin plasma levels 
were increased 4- to 6-fold 15 minutes postburn and remained elevated for 6 hours. 
Angiotensin !1 increased 4-fold in a linear manner between 15 minutes and 6 hours post-
injury 21_ In a canine model of occlusive mesenteric ischemia, the preferential 
constriction of the ischemic segments of intestine by vasopressin was demonstrated. 
Similarly, a differential vasoconstriction is observed in the response of the splanchoic 
circulation to angiotensin II. This phenomenon is likely related to the relatively great 
number of angiotensin II receptors in the splanchnic vascular smooth muscle 17. In an 
experimental model of nonocclusive mesenteric ischemia, disproportionate ischemia was 
seen secondary to splanchnic vasospasm 22_ These hemodynamic changes correlated 
closely with plasma renin levels and could be reproduced, in the absence of shock, by the 
infusion of angiotensin !1 directly into the mesenteric vessels. In addition, the histological 
intestinal damage resembled that seen with nonocclusive mesenteric ischemia 
Mesenteric Ischemia and Bacterial Translocation 
The intact intestinal mucosa acts a mechanical and innnunological barrier to 
indigenous bacteria and antigens. Factors which adversely interfere with this defense 
mechanism may lead to an increased translocation of viable bacteria or endotoxins from 
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the confines of the intestine to other body systems. Recent studies have clearly 
documented that the barrier function of the intestinal mucosa is deranged in experimental 
animals subjected to mesenteric ischemia 3. In an ovine model, just mechanical reduction 
of the blood flow with the use of pneumatic occluders caused bacterial translocation 23. 
Intestinal ischemia induces a spectrum of injury from relatively subtle changes in 
mucosal capillary permeability to gross transmural infarction, depending on severity and 
duration. Both bum and endotoxin have been shown to induce a profound mesenteric 
ischemia, mucosal damage and bacterial translocation. In a mouse model, grossly 
ulcerated ileal and cecal mucosa was found within 24 hours after 25% BSA bum II. 
Endotoxin has been reported to damage the intestinal mucosal barrier and consequently 
promote the translocation of various indigenous bacteria 10. Histological examination of 
the intestine after endotoxin administration revealed edema of the ileal and cecal lamina 
propria with separation of the epithelium from the villus tip. Although the exact 
mechanisms responsible for the intestinal injury have not yet been described, it appears 
that there are basically two events that can induce intestinal tissue injury in ischemic 
states, namely, hypoxia during the ischemic period and generation of oxygen :free radicals 
following ischemia at reperfusion 18. Granger and associates have extensively studied 
the pathophysiology ofischemia!reperfusion intestinal injury 38. The results of these 
studies suggest that superoxide radicals are involved in the pathogenesis of ischemic 
mucosal injury and that the enzyme xanthine oxidase is the source of superoxide radicals 
in the ischemic small bowel. 
Interventions to Prevent Intestinal Ischemia Following Injury and Sepsis 
The essential role of adequate resuscitation and maintenance of fluid balance in 
the care of major trauma and sepsis have been long established. Correction of 
hypovolemia and improvement of cardiac output can certainly be beneficial to mesenteric 
circulation and intestinal oxygenation. In a recent study, the effects ofhypertouic versus 
isotonic crystalloid resuscitation on intestinal microcirculation were demonstrated in a 
porcine hemorrhagic shock model 15. Resuscitation with hypertonic saline solutions 
restored the intestinal mucosal blood flow, as measured by a laser Doppler flow probe, to 
baseline levels. In contrast, isotouic fluid resuscitation failed to restore splanchuic 
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perfusion. ln a porcine bum model, a 33% decrease in mesenteric blood flow was 
demonstrated in animals resuscitated with only Ringer's lactate (RL) solution. This effect 
could be blocked by a prior administration of hypertonic saline/dextran solution (HSD) 
32. The HSD solution prevented the early increase in mesenteric resistance and the 
decrease in mesenteric 02 consumption seen after burns when RL alone was used for 
resuscitation. These results indicate that hypertonic resuscitation may be beneficial in 
improving the post-injury microcirculation. 
In an ovine model~ the effects of nonspecific vasodilators on the mesenteric 
circulation were demonstrated (Fig. 2) 25. The mesenteric blood flow was reduced after 
40% BSA bum by 40% witbin the first 6 hours. Selective infusion of nitroprusside into 
the mesenteric artery after the bum prevented the fall in the mesenteric blood flow.ln the 
same study, this treatment modality decreased the incidence of bacterial translocation to 
systemic organs from 88% to 24%. The administration of nonselective vasodilators 
maintains the splanchnic circulation after thermal injury. However, the nonspecificity of 
various vasodilators with their undesirable systemic effects makes it important to identifY 
selective pharmacological agents. 
Thromboxane appears to be one of the primary mediators in the process ofbum 
and sepsis-associated intestinal ischemia. The impact of inhibition ofthromboxane 
synthesis has been investigated. The effect of OKY -046, a specific tbromboxane 
synthetase inhibitor, was investigated in a 40% BSA bum porcine model. The drug was 
given as a bolus of 10 mglkg priorto bum and then as a continuous infusion at 10 
mglkg/min. OKY -046 was found to prevent the significant increase in the mesenteric 
vascular resistance seen during the first 8 hours after bum. The mesenteric blood flow 
was reduced to 25% and 30% of baseline at 2 and 4 hours after bum, respectively. This 
significant postbum decrease in mesenteric blood flow was not observed in burned 
animals receiving OKY-046.ln the same study, the incidence ofpostbum bacterial 
translocation was significantly decreased (31% to 7%) after the administration of the 
tbromboxane synthetase blocker OKY -046 31. 
ln an endotoxic shock rat model, tbromboxane synthetase inhibition was 
documented to improve the splanchnic circulation previously reduced by endotoxin 29. 
The effects of two structurally dissimilar inhibitors of tbromboxane synthetase were 
32 
Mediators and Intervention Modalities 
documented. An imidazole derivative, 7-IHA, and OKY-1581 were injected 
intravenously at 30 and 5 mgikg, respectively, prior to endotoxin. Both thromboxane 
synthetase inhibitors significantly improved the splanclmic blood flow, which was 55% 
reduced after endotoxin. 
In a porcine endotoxic shock model, pretreatment with LY171883, a specific (LT) 
D4/E4 receptor antagonist, was evaluated. Normal mesenteric perfusion and oxygen 
delivery (D02) were maintained in the animals receiving L Yl71883, whereas in controls 
these parameters decreased significantly 7. In another stndy, the administration of 
LY203647, a specific LT receptor antagonist, was reported to prevent the LTC4-induced 
mesenteric hypoperfusion and intestinal intramural acidosis 8. 
Recently, we have completed a stndy to determine the efficacy of blocking the 
action of angiotensin II in sepsis and thermal injuries 28_ In an attempt to mimic the 
clinical situation, which is commonly complicated by sepsis and endotoxin release 35, we 
utilized a combined bum and endotoxin porcine model. Bum caused a significant 
increase (198% vs. baseline) of the mesenteric vascular resistance. Postbum endotoxemia 
significantly reduced the blood flow in the superior mesenteric artery to 60% of baseline. 
Treatment with DuP753, a specific angiotensin II receptor antagonist, prevented the 
postbum vasoconstriction and subsequently abrogated the impact of the postburn 
endotoxemia on the superior mesenteric artery blood flow. The incidence ofbum- and 
sepsis-induced bacterial translocation was markedly reduced by Dup753 from 86% to 
29%. This stndy indicates that the angiotensin II receptor inhibitor DuP753 has the 
potential to prevent trauma- and sepsis-induced mesenteric hypoperfusion and 
consequently attenuate the occurrence of bacterial translocation. 
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Fig. 2: The impact of 40% third-degree burn and mechanical occlusion ( occl) on mesenteric blood flow 
and associated incidence of bacterial translocation. A summary of nonspecific, hypertonic saline dextran 
resuscitaton (HSD) 32 and nitroprusside (NPI) (unpublished data). and specific tbromboxane synthetase 
inhibitor OKY -046 31 and angiotensin IT receptor antagonist DuP753 (DuP) 28, interventions and their 
effects in a 40% BSA third-degree bUIIL. porcine modeL * P<O.OS vs. sham~# P<O.OS vs. burn. 
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Summary 
Major trauma, such as severe thermal injury, appears to have a profound impact 
on intestinal blood flow. The subsequent post-trauma intestinal ischemia has been 
implicated as the cause of translocation of indigenous bacteria and endotoxin to remote 
body systems, which in turn may potentiate the development of sepsis and multiple organ 
failure. Sepsis, gut-derived or from other origins, with circulating endotoxin also appears 
to adversely interact with mesenteric circulation. The subsequent sepsis-induced 
mesenteric ischemia acts synergistically with the initial injury, promoting mucosal 
damage and bacterial translocation. Although different mechanisms may be involved, the 
generation of vasoactive substances and proinflammatory mediators seems to play a 
pivotal role in these processes. It is of great importance to identifY the mediators which 
initiate ischemic insult and establish specific preventive modalities. So far, two 
vasomediators appear to be primarily responsible for these complications, TxA2 and 
angiotensin II. Blocking the actions of these mediators by specific antagonists has been 
shown to ameliorate the post-injury and sepsis mesenteric vasoconstriction and attenuate 
bacterial translocation (Fig. 3). 
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Fig. 3: Thromboxane A~ and angiotensin II appear to be the primary mediators of postburn mesenteric 
vasoconstriction. By blockade of these pathways v.rith specific inhibitors (OKY-046 and DuP753). 
postburn mesenteric ischemia is prevented and subsequent bacterial translocation is attenuated. 
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Hepatic Ischemia and Reperfosion Injury 
Despite continuous research efforts~ increasing knowledge and experience, 
advanced treatment modalities and sophisticated medical techniques, sepsis and multiple 
organ failure (MOF) remain the most challengiog clinical syndromes of this century. 
While sepsis and MOF are responsible for 50% - 80% of all surgical intensive care unit 
deaths, the complex pathophysiology of these syndromes remains to be fully elucidated 
1. In recent years, the gastrointestinal tract has been implicated in the pathogenesis of 
these life-threatening syndromes I D. It has been postulated that enteric organisms or their 
toxins escape the intestinal mucosal and act as triggers to initiate or exacerbate the septic 
status and thereby promote the development of sepsis 3. The clinical significance of 
bacterial translocation is controversiaL Whether it is solely a pathological process, the 
occurrence of which may initiate sepsis and MOF, or a biological event commonly found 
in animals, is still a subject of debate. At the present time, there is a body of evidence that 
bacterial translocation seen in different animal models is generated by an unbalanced 
ratio between gut bacterial growth, intestinal mucosal barrier and host inunune response 
5. Thermally injured patients have alterations of each during the course of their illness. 
The association between thermal injuries and dysfunction of the intestinal 
mucosal barrier has been clearly documented. A significant increase in permeability of 
rat small intestine was documented as early as 6 hours following 20% body surface area 
(BSA) scald bum 2. Similar changes in intestinal permeability were found in bum 
patients during the first 24 hours after injury 4. Using the lactulose-mannitol clearance 
assay, a 3-fold increase in intestinal permeability to lactulose was demonstrated in 
infected thermally injured patients 17. This alteration in the mucosal barrier may 
contribute to the translocation of indigenous bacteria and endotoxins into the portal 
circulation 3. As the hepatic mononuclear phagocytic system (Kupffer cells) appears to 
play a pivotal role in the clearance oftranslocating bacteria and/or endotoxin from the 
portal circulation, impairment of this hepatic clearance function may potentiate systemic 
effects of gut barrier failure by allowing indigenous bacteria or endotoxin to reach the 
systemic circulation, where they potentiate systemic inflammatory responses. 
Phagocytosis of bacteria and sequestering of endotoxin by hepatic Kupffer cells 
impose a higb metabolic demand of the mononuclear phagocytic system. Intermediary 
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metabolism and energy production have an absolute dependence on oxygen. Since 
oxygen cannot be stored intracellulary, inadequate oxygen availability rapidly leads to 
cellular dysfunction and ultimately cell deatb, with the net result being organ failure, 
hence, the importance of the hepatic perfusion for the performance ofKupffer cells. 
Burn injuries have been documented to have a negative impact on hepatic 
perfusion. The influence of severe thermal injury on hepatic blood flow was investigated 
in a 50% BSA burn rat model, using the tricarbocyanine dye indocyanine green (ICG) 11. 
Hepatic blood flow was decreased significantly by 0.5 hour postburn and remained 
approximately 20% below normal for 24 hours. The intrinsic efficiency of the liver in 
removing the I CG dye from the systemic circulation was also reduced. 
In an ovine model the effect of a 40% BSA third-degree burn on effective liver 
blood flow was determined, using the galactose infusion technique 7. The effective liver 
blood flow was decreased by 50% in the first 5 hours after burn, even when the animals 
were resuscitated to baseline cardiac output values. 
The second insult, which may influence the gut-hepatic axis, is the release of 
endotoxins into the circulation. Burn patients are often subjected to episodes of transient 
endotoxin showers~ which might be gut-derived or from other sources, such as the burn 
wound and the frequent surgical procedures 6,15. 
The effect of endotoxemia on the hepatic circulation was evaluated in chronically 
instrumented and sedated sheep receiving a continuous intravenous infusion of 
Escherichia coli endotoxin 12. The response of the hepatic artery was biphasic and 
consisted of a transient vasoconstriction followed by a transitory increase in hepatic 
artery blood flow, reaching a maximum of921% ofbaseline values after approximately 2 
hours. 
Since thermal injury inducing hepatic ischemia may prime the host for an 
exaggerated response to subsequent insults such as bacteria or endotoxin~ we investigated 
the impact of postburn endotoxemia on the gut-hepatic axis. 
Female mini-pigs were chronically instrumented with transit time ultrasonic flow probes 
and catheters in the superior mesenteric and left hepatic veins. Arterial and Swan-Ganz 
catheters were also inserted. Six animals received a 40% BSA, third-degree flame burn 
and were resuscitated according to the Parkland formula ( 4 mL/kg/%BSA burn). 
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Eighteen hours after burn, 100 !lg/kg E. coli lipopolysaccharide (LPS) (0111 :B4; Difco, 
Detroit, MI) was intravenously administered. 
Despite a moderate increase in the cardiac output, the blood flow in the common 
hepatic artery showed a transient but significant decrease (39%) shortly after burn. The 
second insult (LPS) yielded a dramatic and prolonged reduction of hepatic arterial blood 
flow during the first 4 hours after endotoxin (22%-77% of baseline, P<0.05). After 
recovery to baseline, a reperfusion episode followed, with an elevation of the hepatic 
artery blood flow to 152% ofbaseline values (P<0.05) at 8 hours post-endotoxin (Fig. 1). 
The pronounced ischemic effect of endotoxin on the hepatic arterial blood flow, 
observed in this study, whicb is not in agreement with the previous report, might be due 
to the fact that different species and administration schemes were used. However, it is 
more likely that the priming impact of the early burn injury was responsible for the 
amplification of tissue response to endotoxin. 
Under physiologic conditions, the regulation of hepatic arterial blood flow tends 
to buffer the impact of portal venous blood flow changes on total hepatic blood flow in 
order to maintain the latter constant. The ftmction of portal venous blood flow as the 
major intrinsic regulator of hepatic arterial tone is known as the hepatic arterial buffer 
response 8. This buffer ftmction appears to depend on portal blood flow washing away 
local concentrations of adenosine from the area of the arterial resistance site 9. Thus, a 
reduction in portal blood flow causes an increase in local adenosine levels, resulting in 
arterial dilation. Since the portal venous blood flow is determined by the vascular 
resistance of the intestine ancL, to a lesser extent, the spleen and pancreas, a decrease in 
the mesenteric blood flow would result in a compensatory increase in hepatic blood flow 
to maintain liver function. 
In contrast with this scenario, in our model of postburn endotoxemia, the response 
of the hepatic arterial blood flow was unrelated to changes in portal circulation. The early 
postbum transient hepatic vasoconstriction occurred prior to changes in both portal and 
mesenteric circulations, demonstrating the relative independence of hepatic arterial 
response in relation to other splanchnic blood flow. This ischemic insult may explain the 
occurrence of transient hepatic ftmction disorders, commonly seen early postburn, and 
may also adversely influence the phagocytic capacities of hepatic macrophages. It is also 
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possible that this hepatic ischemic insult may prime hepatic macrophages, leading to 
release of certain vasomediators, such as thromboxanes, which have been implicated in 
the pathophysiology of the postburn mesenteric vasoconstriction 14 
Despite the marked reduction in portal venous blood flow during the first 6 hours 
after endotoxin, the hepatic arterial blood flow showed a significant decrease for a period 
of 4 hours indicating a loss of the hepatic arterial buffer response (Fig. I) . 
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Fig. I: Impact of bum injury. followed by a second insult (endotoxin) on hepatic arterial blood flow 
(HABF) and portal venous blood flow (PVBF). The loss of the hepatic arterial buffer response is 
demonstrated. Data are presented as mean± SEM; *P<O.OS vs. baseline. Dunnett's tesL 
Although the precise mechanisms underlying this phenomenon remain to be identified, 
there are indications that hepatic Kupffer cells play a central role in this process. It has 
been established that the major controls of hepatic arterial and portal venous vascular 
resistance are presinusoidal 8. It is also known that mixing between the two inflows 
occurs at the entrance of the sinusoids. The actual connections between arterial and portal 
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blood flow occur presinusoidally both by direct arterioportal anastomoses and through 
the peribiliary capillary beds. Thus, potential mediators released by hepatic parenchymal 
cells are not able to reach the area of vasculature that regulate blood flow. The early 
postburn increase in hepatic vascular resistance, together with the observed pronounced 
vascular resistance in both hepatic arterial and portal venous circulations, implicates 
presinusoidal Kupffer cells in this process. The magnitude of the hepatic response 
following the second insult may demonstrate the priming effect of the first insult. 
The observed postburn reduction of the portal vascular resistance associated with 
increased portal venous blood flow together with the previously documented damage of 
the mucosal barrier caused by the mesenteric ischemia and reperfusion injury 4 are likely 
to be responsible for the washout of the indigenous bacteria or endotoxin to the liver. 
However, the induced hepatic ischemia and reperfusion injury might be the determining 
factor in the systemic spread of these bacteria or endotoxin. The profound action of 
endotoxin on the hepatic circulation, resulting in a long period of ischemia followed by 
reperfusion, may impair the phagocytic and bacterial clearance capacities of the hepatic 
macrophages, leading to spillover of indigenous bacteria and endotoxin to the systemic 
circulation. In the present study, postbum endotoxemia clearly promoted bacterial 
translocation (83%). The marked portal hypertension, seen in the postbum endotoxemic 
period (Fig. 2), may account for the occurrence of bacterial translocation and contribute 
to the previously reported phenomenon of endotoxin-induced bacterial translocation 16. 
Acute portal hypertension has been previously shown to promote bacterial translocation 
13. The underlying mechanisms are probably the disruption of the intestinal mucosal 
barrier, caused by acute venous congestion, edema and ischemia 
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Fig. 2: Changes in the superior mesenteric venous pressure after burn and endotoxin. Data are given as a 
percentage of baseline~ *P<0.05 vs. baseline. Dunnett's test. 
In conclusion, thermal injury appears to induce hepatic ischemia, which may alter 
the hepatic bacterial clearance function, resulting in systemic bacterial or endotoxin 
spillover. The magnitude of the hepatic response to a second insult (endotoxemia) is 
magnified and manifested as a pronounced hepatic ischemia and reperfusion injury. 
Primed hepatic Kupffer cells are possibly accountable for this response. The associated 
increased portal venous resistance and portal hypertension may contribute to the 
occurrence of intestinal mucosal damage and subsequent bacterial or endotoxin 
translocation (Fig. 3). 
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Fig. 3: Proposed mechanisms by which thermal injury interacts with the gut-hepatic axis, resulting in 
bacterial translocation and endotoxemia. The possible interplay between the profound impact of a second 
insult (bacterial translocation or endotoxcmia) and the amplified hepatic response is also delineated. 
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Gut Ischemia and Hypoxia: Role of Angiotensin II 
Abstract 
Objective: To investigate the role of angiotensin II as a mediator of burn- and sepsis-
induced gut ischemia and reperfusion injury, and the possible beneficial effects of 
angiotensin II inhibitor DuP753. 
Summary Background Data: A second insult ( endotoxemia) following burn may 
amplify intestinal ischemia and reperfusion injury. Angiotensin II, the prodnction of 
which has been reported to increase after burn, is thought to be one of the primary 
mediators of postbum mesenteric vasoconstriction. 
Methods: Eighteen female pigs were instrumented with an ultrasonic flow probe on the 
superior mesenteric artery and a catheter into the superior mesenteric vein. After 5 days, 
all animals were anesthetized, and 12 received 40% total body surface area third-degree 
burn. Eighteen hours after burn, I 00 J.Lg/kg Escherichia coli lipopolysaccharide (LPS) 
was intravenously administered. DuP753 was administered intravenously at I J.Lg/kg to 6 
pigs immediately after burn. The animals were studied for 42 hours. 
Results: Burn caused a significant decrease in mesenteric arterial blood flow (Qm), to 
approximately 58% of baseline. Postburn endotoxemia significantly reduced Qm to 53% 
of baseline. Treatment with DuP753 prevented postburn vasoconstriction and 
subsequently abrogated the impact of post burn endotoxemia on Qm (postbum: 386±21 
vs. 207±11 mL/min*, post-LPS: 372±23 vs. 202±18 mL/min*, *= P<0.05, Bonferroni t 
test). Mesenteric oxygen supply (mDO,) was significantly reduced after bum and 
endotoxin to 60% and 51% of baseline, respectively. DuP753 administration significantly 
improved mD02 after both insults (postburn: 49±14 vs. 23±03 mL/min*, post-LPS: 
40±08 vs. 19±37 mL/min*, *= P<0.05, Bonferroni t test). Burn- and LPS-induced 
mesenteric hypoxia, as indicated by decreased mesenteric oxygen consumption (m V02), 
was also ameliorated by DuP753 treatment. 
Conclusions: These results indicate that angiotensin II is one of the mediators of the 
burn- and sepsis-induced gut ischemia. Angiotensin II inhibitor DuP753 can attenuate 
these events. 
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introduction 
Despite recent advances in the care of thermally injured patients, sepsis remains 
the most common cause of the high morbidity and mortality rates following major burn 
injuries. I Although the precise mechanisms have not yet been elucidated, the 
gastrointestinal tract has been postulated to be a major contributor to postburn sepsis.2 
The intestinal mucosal barrier normally prevents the enteric bacteria and their products 
from escaping and reaching extraintestinal organs. However, under certain circumstances 
the integrity of intestinal mucosa appears to be disrupted, allowing spread of endogenous 
bacteria or endotoxins; a process called bacterial translocation,3,4 Previous experimental 
studies have shown bacterial translocation to occur in a number of conditions including 
burn and endotoxemia5 '6 Burn injury has been demonstrated to induce intestinal 
mucosal damage and bacterial translocation. This mucosal injury appears to be due to 
mesenteric ischemia) Endotoxin has been shown to increase intestinal permeability and 
promote bacterial translocation. 8,9 There is evidence that intestinal ischemia and 
reperfusion injury underlay this particular action of endotoxin. I 0,11 Patients with major 
bum injuries might be particularly susceptible to factors associated with bacterial 
translocation, since they appear to be frequently subjected to repeated episodes of 
endotoxemia_l2 In tum, endotoxin has been reported to act synergistically to promote 
mucosal damage and bacterial translocation after major bum injuries_l3 
The molecular mechanisms underlying the observed intestinal ischemia in such 
situations are not yet known. Mesenteric vasoconstriction may be the result of a plethora 
ofvasomediators, one of which is angiotensin lL The production of angiotensin ll has 
been reported to increase significantly after thermal injuries.l4 Therefore, we postulated 
that angiotensin ll may be one of the primary mediators ofpostbum mesenteric 
vasoconstriction. In order to evaluate the role of angiotensin ll in this response, we 
investigated in this study whether the administration ofDuP753, an angiotensin II 
antagonist, would attenuate bum- and endotoxemia-induced gut ischemia and reperfusion 
injury in a chronic porcine bum/sepsis model 
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Materials and Methods 
The following experimental protocols were approved by the Animal Care 
and Use Committee of the University ofTexas Medical Branch (ACUC #90-09-
103). 
Eighteen female mini-pigs (weight 20-25 kg) were prepared surgically 5 days 
before the experiment. After an overnight fast, the pigs were sedated with intramuscular 
ketamine (I 0 mglkg) and mechanically ventilated with 2% to 2.5% halothane after 
endotracheal intubation. A bilateral subcostal incision was performed. A transit rime 
ultrasonic flow probe (6-8 mm, Transonic Systems Inc., Ithaca, NY) was placed on the 
superior mesenteric attery. A 6.5F catheter was positioned in the superior mesenteric 
vein. A Witzel jejunostomy was also performed using a 12F Foley catheter. The abdomen 
was closed in layers. 
After surgery~ the animals were kept in recovery slings for 24 hours, then 
placed in runs for 5 days with free access to food and water. On the day of the 
experiment, the animals were reanesthetized. Through a neck incision, a catheter 
was placed via the right common carotid attery into the abdominal aorta and a 
Swan-Ganz thermal dilution catheter (Model 93 A-131-5F, American Edwards 
Laboratories, Anasco, PR) was positioned in the pulmonary attery via the right 
jugular vein. A 12F Foley catheter was inserted in the urinary bladder. 
The animals were kept in special slings for monitoring. Throughout the 
study, all animals received enteral feeding (Osmolite) at 25 mL/hr and nothing 
orally. Baseline data were collected after complete recovery from anesthesia. 
The pigs were randomized into 3 groups: 
1) The bum/lipopolysaccharide (LPS) group (n=6) had a 40% total body 
surface area (TBSA) third-degree flame bum under general anesthesia, as 
described above. The pigs were resuscitated according to the Parkland formula 
and received lactated Ringer's solution (4 mL/kgl% TBSA burned) starting 
inunediately after the burn; half was given in the frrst 8 hours after burn and the 
remainder in the next 16 hours. Eighteen hours after burn, 100 Jlg/kg E. coli LPS 
(0111 :B4; Difco, Detroit, Ml) was administered intravenously. During the second 
day of the experiment, burned animals received lactated Ringer's solution at 3,5 
mLim2 burned area and 2 mL/kglhr for daily maintenance. 
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2) The sham group (n=6) had a sham bum under anesthesia. Eighteen hours later, 
the animals received the diluent (0.9% NaCI) used for the endotoxin. Lactated Ringer's 
solution was administered at 2 mL!kglhr for daily maintenance. 
3) The treatment group (n=6) underwent the same procedure as the burn/LPS 
group, except for the administration of angiotensin II inhibitor Dup 753 ( DuPont Merck, 
Wilmington, DE) intravenously at I 11g!kg immediately after bum. 
Mean arterial (MAP) and central venous (CVP) pressures were measured using 
transducers (P231D, Statham Gould, Oxnard, CA) connected to an Electronic Medicine 
Honeywell Recorder (Honeywell Inc., Pleasantville, NY) for electronic calculation of 
mean pressures. Cardiac output (CO) was determined by the thermal dilution technique 
using a Swan-Ganz catheter and a cardiac output computer (Model 9520, American 
Edwards Laboratories, Irvine, CA). 
Mesenteric arterial blood flow (Qm) was measured with a transit time ultrasonic 
flow probe connected to a TIOI ultrasonic meter (Transonic Systems Inc., Ithaca, NY). 
Systemic and splanchoic hemodynamics were measured and blood samples were 
drawn for determinations of arterial, mixed venous, and portal blood gases at baseline 
and 14 consecutive time points, starting I hour after bum. 
Systemic vascular resistance index (SVRI) and mesenteric vascular resistance 
(MVR) were calculated with the following formulas: 
Cardiac index (Limin/m2) = cardiac output (L/min )/body surface area 
SVRI (dyne · sec · em -5 • m2) = ([mean arterial pressure - central venous pressure J x 
80)/cardiac index 
MVR (dyne · sec · em -5) = ([mean arterial pressure - central venous pressure] x 
80)/mesenteric arterial blood flow 
Systemic oxygen delivery (DO,), systemic oxygen consumption (VO,), 
mesenteric oxygen delivery (mDO,), and mesenteric oxygen consumption (m VO,) were 
calculated as follows: 
D02 (mL/min/m2) =cardiac index x arterial oxygen content x I 0 
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YO, (mL/min/m2) =cardiac index x (arterial oxygen content- mixed venous oxygen 
content) x 10 
rnDO, (mL/min) =mesenteric arterial blood flow x arterial oxygen content/100 
m V02 (mL/min) =mesenteric arterial blood flow x (arterial oxygen content- mesenteric 
oxygen content)/100 
Arterial oxygen content (mL/dL) equals (Hb x 1.34) Sa02 + (Pa02 x 0.0031); mixed 
venous oxygen content (mL/dL) equals (Hb x 1.34) Sv02 + (Pv02 x 0.0031); mesenteric 
oxygen content (mL/dL) equals (Hb x 1.34) Sm02 + (Pm02 x 0.0031). 
At the end of the 42 hours, the animals were anesthetized with 10 mg!kg 
intravenous ketamine and killed with 5 mL intravenous saturated KCL 
The data are presented as mean± SEM. Within-group analysis was performed by 
the analysis of variance (ANOVA) for repeated measurements with the Dunne! post hoc 
test. Between-groups analysis was performed by ANOV A for factorial analysis with the 
bonferroni post hoc test. P<0.05 was considered statistically significant. 
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Results 
Systemic Hemodynamics: 
Baseline hemodynamic measmements were similar in all groups. All animals 
survived the study period (Fig. I and Fig. 2). 
Throughout the experiment, sham anintals maintained their systemic (Fig.! and Fig. 2) 
and mesenteric (Fig. 4 and Fig. 5) hemodynamics within baseline range. 
After thermal injury, cardiac output (CO) showed a slight increase during the first 
6 hours, returning to baseline 8 hours after bum (Fig. 2). This increase was associated 
with a concomitant fall in the systemic vascular resistance, whereas the systemic vascular 
resistance index (SVRI) decreased to 78% ofbaseline (Fig. 2). No significant differences 
were observed between the 3 groups (Fig. I) in mean arterial pressure (MAP) and central 
venous pressute ( CVP). 
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Figure 1. Systemic hemodynamic parameters: mean arterial pressure (MAP) and central venous pressure 
(CVP) after40% TBSA third-degree burn (0 hour) and endotoxiD administration (18 hours after burn). The 
angiotensin II inhibitor DuP753 was administered intravenously immediately after burn. Differences were 
not statistically significant. P<0.05. * vs. baseline.# vs. sham.¥ vs. DuP753. 
After LPS administration, a typical biphasic response was observed. The 
hemodynamic alteration was more pronounced during the second phase: after a marked 
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drop in CO to 77% of baseline, a hyperdynamic period began 8 hours after endotoxin 
administration (Fig. 2). At this time point, SVRJ dropped to 69% of baseline. MAP 
showed a 14% decrease immediately after LPS infusion in both burn!LPS groups. During 
the further post-LPS course, no significant differences were noticed between groups in 
MAP and CVP. DuP753 treatment ameliorated to a certain extent the alteration in 
systemic circulation occurring after burn and LPS administration (Fig. I and Fig. 2). 
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Figure 2. Systemic hemodynamic parameters: cardiac output (CO) and systemic vascular resistance index 
(SVRI) after burn (0 hour) and endotoxin administration (18 hours). The hemodynamic alteration was 
more pronounced after LPS infusion. DuP753 had a positive impact on CO and SVRI. P<0.05. * vs. 
baseline,# vs. s~ ¥ vs. DuP753. 
Mesenteric Hemodvnamics: 
Although cardiac output did not full after thermal injury, mesenteric arterial blood 
flow (Qm) decreased significantly to approximately 58% of baseline during the first 4 
hours after burn (Fig. 3). In contrast to the previously observed postbum reduction in 
systemic vascular resistance, mesenteric vascular resistance (MVR) showed a significant 
increase (201% of baseline) during the early postbum phase (Fig. 4). During the late 
postburn phase, starting 4 hours after insult, a mesenteric reperfusion phase became 
manifested: Qm increased by 44% over baseline. 
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Compared with burned animals not receiving the angiotensin II antagonist, DuP753-
treated animals showed no reduction in Qm after burn; in fact, it increased by 33% over 
baseline during the early postbum phase (Fig. 3). Animals in the DuP753 treatment group 
maintained, unlike the nontreated burned animals, a stable MVR near baseline during this 
early mesenteric vasoconstrictive phase (Fig. 4). 
At 18 hours after burn, mesenteric hemodynamic measurements were comparable to 
baseline levels in all groups. 
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F.gure 3. Burn (0 hour) and endotoxin administration (18 hours after burn) significantly reduced 
mesenteric arterial blood flow (Qm). Trealment with DuP753 prevented the impact of bum/sepsis on Qm. 
P<0.05. * vs. baseline.# vs. sham.¥ vs. DuP753. 
Administration of LPS to burned animals resulted in a biphasic response of 
mesenteric ischentia and reperfusion. The second insult yielded a significant mesenteric 
vasoconstriction, with an increase ofMVR to 222% of baseline during the first 8 hours 
after LPS infusion. 
Similarly, Qm decreased significantly to 53% of baseline during the same time of peak 
MVR. After an initial moderate drop in Qm by 13% of baseline, burned animals treated 
with DuP753 showed no signs of mesenteric vasoconstriction after the second insult 
(LPS): no marked increase was noticed in MVR. Compared with nontreated animals, 
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DuP753 treatment resulted in a significant improvement ofQm after the second impact 
(LPS); 4 hours after LPS infusion, Qm reached 112% ofbaseline in the DuP753 group, 
whereas the flow was still significantly reduced to 57% of baseline in the bum/LPS group 
(Fig. 3 and Fig. 4 ). 
= 
F.agure 4. Changes in mesenteric vascular resistance (MVR) after burn (0 hour) and endotoxin 
administration (18 hours). P<O.OS. * vs. baseline.# vs. sham,¥ vs. DuP753. 
Systemic Oxygen Delivery and Consumption: 
After an initial reduction, systemic oxygen delivery (DO,) and oxygen 
consumption (VO,) showed a marked increase during the first 4 hours after bum (Fig. 5). 
Administration ofLPS yielded a significant drop in D02 during the first hour. 
V02 remained unchanged at this time point. Animals treated with DuP753 remained at 
baseline after LPS infusion (Fig. 5). During the post-LPS hyperdynamic phase, both DO, 
and V02 were increased. 
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FigUre 5. Effects of burn (0 hour) and endotoxin administration (18 hours) on systemic ox-ygen delivery 
(DOz) and oxygen consumption (V02). P<O.OS. * vs. baseline,# vs. sham,¥ vs. DuP753. 
Mesenteric Oxvgen Deliverv and Consumption: 
During the first 2 hours after bum, both mesenteric oxygen delivecy (mDO,) and 
mesenteric oxygen consumption (m VO,) showed a significant decrease to 60% and 53% 
of baseline, respectively. In contrast, animals treated with DuP753 showed an 
improvement in posthurn mD02 and m V02 to 128% and 112% of baseline, respectively 
(Fig. 6). 
The second insult (LPS) yielded a dramatic reduction in mDO, to 51% of 
baseline. Postburn treatment with DuP753 prevented this impact ofLPS, and mD02 
remained at baseline (Fig. 6). Similarly, after LPS infusion, reduced m V02 was improved 
in animals receiving DuP753 (58% vs. 127% ofbaseline). 
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Figure 6. Mesenteric oxygen delivery (mD02) and oxygen consumption (mV02) were significantly 
reduced after bum (0 hour) and endotoxin administration (18 hours after burn). These detrimental effects 
were ameliorated by DuP753 treatment P<0.05, * vs. baseline.# vs. sham,¥ vs. DuP753. 
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Discussion 
Recently, it has become apparent that mesenteric vasculature reacts in a very 
sensitive way to injury. A clinical review of the autopsy records of severely burned 
patients revealed a 61% incidence of intestinal ischemia.l5 At the time of death, sepsis 
was manifested in more than 80% of these patients. 
The relation between gut ischemia and sepsis remains to be defined. Splanchnic 
ischemia has been reported to alter the intestinal mucosal barrier, leading to the escape of 
indigenous bacteria and their endotoxins to the systemic circulation and remote body 
organs. 7,16,17 Recently, the role of the gut as a cytokine-generating organ in the post-
injury inflammatory response has been studiect.l8 As the causal relation of bacterial 
translocation or gut-derived cytokines to the development of sepsis and multiple organ 
dysfunction syndrome has become more apparent and more complex, the need to identify 
the mechanisms involved in the pathophysiology of post-injury gut dysfunction is 
increasing. 
On the other hand, endotoxin (gut-derived or due to other factors), has been 
reported to act synergistically to promote mucosal dsmage and bacterial translocation 
after major burn injuries.l3 Since patients with major burn injuries appear to be 
frequently subjected to repeated episodes of endotoxemia,12 the impact of the second 
insult, which is believed to have more dramatic consequences, may be responsible for the 
high morbidity and mortality rates in this group. Therefore, we postulated that a 
treatment modality abrogating mesenteric ischemia after the first injury would decrease 
the impact of the second hit (if occurred). 
Our current data confirm those of previous studies reporting the alteration of 
mesenteric hemodynamics secondary to thermal injury.19,20 Despite indicators of 
adequate resuscitation (i.e. minor changes in cardiac output, mean arterial pressure and 
central venous pressure), a significant reduction in mesenteric arterial blood flow (Qm) 
was observed in this study during the early phase after thermal injury. Thus, altered 
systemic hemodynamics could not be solely responsible for the observed postburn 
mesenteric vasoconstrictive phase. The significant increase in mesenteric vascular 
resistance (MVR) during the first 4 hours after burn, despite the marked decrease in 
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systemic vascular resistance~ suggests the involvement of certain mediators selectively 
acting on mesenteric vasculature. 
The renin-angiotensin axis appears to play a critical role in the pathophysiology 
ofthermal injury. Hilton et all4 reported a 4-fold increase in angiotensin II levels 6 hours 
after thermal injury. Angiotensin II is a potent vasoconstrictor that exhibits important 
mesenteric selectivity, thought to be caused by an increased affinity of the angiotensin II 
receptors on the splanchnic vascular smooth muscle.21 In a pig model of cardiogenic 
shock, a disproportionate mesenteric ischemia resulting from selective splanchnic 
vasospasm was observed.22 Ablation of the renin~angiotensin axis was shown to abolish 
this response. Moreover, the observed hemodynamic changes were found to correlate 
with serum angiotensin II concentrations and could be reproduced in the absence of 
shock by the infusion of angiotensin IJ.23 
The data of this study clearly show that postbum treatment with DuP753, a 
specific angiotensin II receptor antagonist, 24 can prevent postburn vasoconstriction and 
subsequently abrogate the impact of postbum endotoxemia on superior mesenteric artery 
blood flow (Qm). In contrast to an approximately 50% decrease in Qm occurring as early 
as the first hour after thermal injury, an initial increase by 11% in Qm was observed after 
DuP7 53 treatment. Postbum administration of DuP7 53 was found to prevent bum-
induced mesenteric vasoconstriction: MVR remained near baseline in treated animals, 
compared with an almost I 00% increase in nontreated animals. 
Systemic oxygen delivery (DO,) and oxygen consumption (VO,) showed a 
pattern of increase similar to tbat seen in cardiac output (CO) after thermal injury.ln 
contrast, mesenteric oxygen supply (mDO,) was significantly reduced during this early 
postburn phase. This observation also confirms the independence of the postbum altered 
mesenteric circulation and oxygenation, with respect to the systemic circulation.20,25,26 
At the same time, mesenteric oxygen Consumption (m VO:J showed a reduction that was 
dependent on the mD02• This postburn pathologic supply-dependent gut oxygen 
consumption was observed before in experimental models. 20,27 This early decreased 
mVO, indicates the inability of the gut to compensate for inadequate oxygen delivery by 
increasing oxygen extraction, resulting in tissue hypoxia. Early hypoxia in the splanchnic 
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region is suggested as a plausible mechanism behind the development of secondary organ 
failure, especially in sepsis. 28 Animals receiving DuP753 showed no decrease in mD00 
after thermal injury. Administration ofDuP753 after thermal injury resulted in a 
significant improvement in mD02 2 hours after bum; 49.14 mL/min [DuP753] vs. 23.03 
[bum], P<0.05). Postbum mesenteric hypoxia, as indicated by a decreased mV02, was 
not observed in animals in the treatment group. The action ofDuP753 appears to be 
selective. The enhancement in oxygen supply to meet the increased oxygen demand was 
noticed only in the mesenteric circnlation: no differences were found between treated and 
untreated burned animals with respect to D02 or V02• 
Although no important changes were noticed in D00 and V00 in both burn/LPS 
and DuP753 groups after endotoxin infusion, the impact of this second insnlt on the 
mesenteric oxygenation was dramatic. A typical biphasic response was observed, with a 
more pronounced flow-dependent hypoxic period. The first 8 hours after LPS 
administration to burned animals were marked by a significant decrease in mD02• 
Mesenteric oxygen consumption showed a pathologic dependence on oxygen delivery, 
leading to an oxygen debt that limits metabolism. LPS alone has been shown to cause 
such an alteration in mesenteric oxygenation. 26 These results conld be explained by a 
defect in microvascular regulation of blood flow that interfered with the optimal 
distribution of a limited supply of oxygen in accordance with tissue oxygen needs.29 Our 
data demonstrate that these negative effects of LPS on mesenteric oxygenation can be 
prevented by DuP753 treatment. After LPS challenge, burned animals in the treatment 
group showed a significant improvement in their mesenteric oxygenation status 
compared with nontreated animals (m VO,ImD02, 4 hours after LPS infusion: 
12.57/40.08 mL/min [DuP753] vs. 5.47/19.37 [bum], P<0.05). 
66 
Gut Ischemia and H.}poxia: Role of Angiotensin II 
Conclusion 
ln our combined burn and sepsis chronic-instrumente'd porcine model, both insults 
had adverse effects on mesenteric circulation and oxygenation, whereas the impact of the 
second insult was more pronounced and prolonged. Angiotensin ll appears to be involved 
in this process. Postburn treatment with DuP753, a specific angiotensin II receptor 
antagonist, can ameliorate burn- and endotoxemia-induced mesenteric ischemia by 
improving mesenteric blood flow and oxygen supply. 
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Abstract 
Objective: To investigate whether treatment with angiotensin II inhibitor DuP753 can 
attenuate mucosal injury and bacterial translocation in a burnlendotoxemia chronic 
porcine model. 
Summary Background Data: Thermal injuries and endotoxemia have been shown to 
induce ischemia and reperfusion injury to the intestine, leading to increased mucosal 
permeability and bacterial translocation. Recently, angiotensin II inhibitor DuP753 has 
been reported to ameliorate bum- and sepsis-induced gut ischemia. 
Methods: Twenty-one female pigs were anesthetized and 14 of them received 40% total 
body surface area third-degree burn. DuP753 was administered intravenously at l !Lg/kg 
to 7 pigs immediately after burn. Eighteen hours after burn, l 00 !Lg/kg Escherichia coli 
lipopolysaccharide (LPS) was administered intravenously. Plasma conjugated dienes 
(PCDs ), an index oflipid peroxidation, were measured every 6 hours. Intestinal 
permeability was assessed every 6 hours by measuring the lactulose/mannitol (LIM) 
excretion ratio. At the end of the study (42 hours), tissue samples were harvested for 
bacteriologic cultures. 
Results: PCD levels were significantly elevated 8 hours after burn (182% increase vs. 
sham, P<O.Ol). LPS caused a higher and prolonged increase in PCD levels (210% of 
baseline). Treatment with DuP753 significantly reduced PCD levels after burn and after 
LPS (P<0.01).1ntestinal permeability, as assessed by the LIM ratio, showed 6- and 12-
fold increases after thermal injury and LPS, respectively (P<0.05). In contrast, the LIM 
ratio was only doubled in DuP753-treated animals (P<O.Ol). Bacterial translocation was 
significantly increased after burn and endotoxin (6/7 vs. l/7 sham, P<O.OS). The 
incidence of bacterial translocation in the DuP753-treated animals was sintilar to that in 
the sham group (217). 
Conclusions: Angiotensin II appears to play a pivotal role in burn- and endotoxin-
induced intestinal ischemia and reperfusion injury, with subsequent increases in 
permeability and bacterial translocation. Postburn administration of angiotensin II 
receptor antagonist DuP753 significantly reduces the extent of these events. 
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Introduction 
After major thermal injuries, elevated serum endotoxin levels have been 
documented in humans,l,2 Endotoxin levels were found to increase within 24 hours after 
injury 2, peaking on days 3 and 4 after burn. 1 
Previous studies have investigated the impact ofthennal injuries or endotoxin on 
intestinal mucosal integrity. 
The association between thermal injuries and the dysfunction of the intestinal mucosal 
barrier has been clearly documented. A significant increase in intestinal permeability in 
thennally injured patients was reported within 24 hours and throughout the first 2 weeks 
after injury_3,4 This alteration in the mucosal barrier may contribute to the translocation 
of indigenous bacteria and endotoxins into the circulation. 5 In turn, endotoxin has been 
shown to impair gut barrier function in humans: a brief exposure to circulating endotoxin 
was reported to increase the permeability of the normal gut. 6 The cause and the 
clinical significance of the altered intestinal mucosal integrity under such conditions 
remain unclear. Based on experimental studies, intestinal ischemia and reperfusion injury 
appears to be the most likely mechanism underlying this phenomenon_? In a previous 
stndy, angiotensin ll was shown to be one of the mediators responsible for the 
impairment of mesenteric blood flow and oxygenation after burn and endotoxemia. 8 
Pharmacological blockade of angiotensin ll receptors by a specific agent (DuP753) was 
found to abolish these events. 
Therefore, we investigated in this study whether treatment with angiotensin II 
antagonist DuP753 can abrogate the detrimental impact of burn and endotoxin on 
mucosal barrier function in a chronic porcine burn/endotoxemia modeL 
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Methods 
The following experimental protocols were approved by the Animal Cate 
and Use Committee of the University of Texas Medical Branch (ACUC # 90-09-
103). 
Surgical preparation 
Studies were performed in 21 fentale mini-pigs (weight 20-25 kg). After 
an overnight fast, the pigs were sedated with intratnusculat ketamine (I 0 mglkg) 
and mechanically ventilated with 2% to 2.5% halothane after endotracheal 
intubation. Through a neck incision, a catheter was placed via the right common 
eatotid attery into the abdominal aorta, and a Swan-Ganz thermal dilution 
catheter (Model93 A-13!-5F, American Edwatds Laboratories, Anasco, PR) was 
positioned in the pulmonaty attery via the right jugulat vein. A Witzel 
jejunostomy was performed using a 12F Foley catheter, and a 12F Foley catheter 
was inserted in the urinaty bladder. 
Experimt!f1tal design 
The animals were kept in special slings for monitoring. Throughout the 
study, all animals received enteral feeding (Osmolite) at 25 mL!hr, and nothing 
orally. Baseline data were collected after complete recovery from anesthesia. 
The pigs were randomized into 3 groups: 
I) The burn/lipopolysaccharide (LPS) group (n=7) had a 40% total body 
surface atea (TBSA) third-degree flatne burn under general anesthesia as 
described above. The pigs were resuscitated according to the Parkland formula 
and received lactated Ringer's solution ( 4 mL!kg/% TBSA burned) starting 
immediately after the burn; half was given in the first 8 hours after burn and the 
remainder in the next 16 hours. Eighteen hours after burn, I 00 !lg/kg E. coli LPS 
(0111 :B4; Difco, Detroit, Ml) was administered intravenously. During the second 
day of the experiment, the burned animals received lactated Ringer's solution at 
3,5 mL/m2 burned atea and 2 mL!kg!hr for daily maintenance. 
2) The shatn group (n=7) had a shatn burn under anesthesia. Eighteen hours later, 
the animals received the diluent (0.9% NaCI) used for the endotoxin. Lactated Ringer's 
solution was administered at 2 mL/kg!hr for daily maintenance. 
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3) The treatment group (n=7) underwent the same procedute as the butn!LPS 
group, except for the administration of angiotensin II inhibitor DuP753 (DuPont Merck, 
Wihnington, DE) intravenously at I f!g/kg innnediately after burn. 
Mean arterial (MAP) and central venous (CVP) pressutes were measuted using 
transducers (P231D, Statham Gould, Oxnard, CA) connected to an Electronic Medicine 
Honeywell Recorder (Honeywelllnc.,Pleasantville, NY) for electronic calculation of 
mean pressutes. Cardiac output (CO) was determined by the thermal dilution technique 
using a Swan-Ganz catheter and a cardiac output computer (Model 9520, American 
Edwards Laboratories, Irvine, CA). 
Blood samples for plasma conjugated diene (PCD) assays were taken from the 
arterial line catheter at baseline and then every 6 hours, beginning I hout after burn. 
Permeability assessment 
After the animals had recovered from the surgical instrumentation, a solution of 
10 g lactulose and 5 g mannitol, diluted in 60 mL distilled water (1,160 mOsmlkg), was 
given via the jejunostomy tube, and utine was collected for a 6-hout period to obtain 
baseline measutements. Lactulose/mannitol (LIM) assessment was repeated every 6 
hours. At the completion of collection, the utine was divided into aliquots and frozen at 
20°C until assayed. Urinary lactulose and mannitol concentrations were simultaneously 
determined by the technique described by Fleming et a!, 9 using high- pressute liqnid 
chromatography coupled with pulsed amperometric detection (HPLC-P AD). Urine was 
diluted 2- to 20-fold with deionized water, depending on the collection volume. One mL 
diluted utine was mixed with internal saccharide standards, desalted, vortex-mixed, 
centrifuged, and filtered. Fifty microliters of the filtrate was injected onto a 250 x 40 mm 
anion exchange column (Dionex Carbopak, PAl, Houston, TX) and eluted with 0.15 
mol/L NaOH, l mL/min, at 20°C. Detection was by pulsed amperometric detection with 
a working gold electrode and silver/silver chloride reference electrode, with a detection 
potential of +0.05, oxidation potential of +0.06, and a reduction potential of -0.95V. 
Quantification was by peak height analysis and peak height ratios, with internal 
standardization. This method offers excellent separation of the carbohydrates and precise 
detection at low concentrations (lactulose 0.3 mg!L). The amount of each sugar excreted 
in the utine duting 6 hours was then converted to a percentage of the amount of the given 
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sugar, reflecting the excretion fraction of each sugar. By dividing the lactulose and 
mannitol excretion fractions, a permeability index- the lactulose/mannitol (LIM) ratio-
was calculated. 
Conjugated diene assay 
Plasma conjugated dienes (PCDs) were measured according to the method of Till 
et al.l 0 Conjugated dienes were extracted from the plasma by using a 2: I (vol/vol) 
mixture of chloroform and methanoL Seven mL of the chloroform/methanol mixture, 
preheated to 45°C, was added to 0.5 mL plasma. The mixture was then vigorously 
agitated for 2 minutes and centrifuged for 5 minutes at 3,000 rpm at 4°C. The lower layer 
was aspirated and pipetted into a test tube and dried under a direct flow of nitrogen gas. 
The residue was reconstituted with 1.5 mL heptane and read on a spectrophotometer at 
233 nanometers (Spectronic 1001; Milton Roy Co., Houston, TX). 
Testing (Or bacterial translocation 
At the end of the 42 hours, the animals were anesthetized with 10 mglkg 
intravenous ketamine and killed with 5 mL intravenous saturated KCL Using aseptic 
technique, through a midline laparotomy incision, peritoneal fluid and tissue samples 
from the proximal and distal mesenteric lymph nodes, spleen, liver, kidney, lung, 
jejunum, ileum, cecum, and colon were taken for bacteriologic cultures. Collected tissue 
samples were weighed, and 0.5 g of each was homogenized in a tissue grinder with 4.5 
mL nonbacteriostatic saline to create a 1:10 dilution of the original sample; 0.1 mL and 
0.01 mL (of the 1:10 dilution) were inoculated onto a MacConkey agar plate and a 
Columbia Nutrient Agar (CNA) plate for isolation of gram-negative and gram-positive 
organisms, respectively. Therefore, one colony would represent 1 x 102 and 1 x 103 
colony-forming units per gram oftissue, respectively, for each inoculum size. Limits of 
detection were 100 organisms per gram of tissue. Inoculated plates were incubated at 
37°C for 24 and 48 hours and read with a Darkfield Quebec Colony Counter (Model 
3330, American Optical Co., Buffalo, NY). Cultures were considered positive when more 
than 100 colonies per gram of tissue were found. All bacterial isolates were identified by 
biotype using a Microscan 4 bacterial analyzer (Baxter, Sacramento, CA.) 
Statistical aiUllysis 
The data are presented as mean ± SEM. Within-group analysis was performed by 
the analysis of variance (ANOVA) for repeated measurements with the Durmet post hoc 
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test. Between-groups analysis was performed by ANOV A for factorial analysis with the 
Bonferroni post hoc test. Bacteriologic tissue culture results were analyzed by the Fischer 
exact test. P <0.05 was considered statistically significant. 
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Results 
Svstemic hemodvnamics 
Baseline hemodynamic measurements were similar in all groups. All animals 
survived the study period (Fig. I). 
After thermal injury, the cardiovascular variables (CO, MAP and CVP) were stable as a 
result of adequate resuscitation (Parkland formula). After the administration of endotoxin 
there were some moderate hemodynamic changes, but of no statistical significance (Fig. 
I). 
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Figure 1. Systemic hemodynamic parameters: cardiac output (CO). mean arterial pressure (MAP). and 
central venous pressure (CVP) after 40% TBSA third-degree bum (0 hour) and endotoxin administration 
(E. coli LPS. 18 hours after bum). DuP753 was administered intravenously immediately after burn. 
Differences were not statistically significant. P<O.OS. *vs. Baseline.# vs. Sham,.¥ vs. DuP753. 
Conjugated diene assay 
Levels ofPCDs were significantly increased in the burn/LPS group at 4 and 8 
hours after bum (Fig. 2). Postbum PCDs reached 168% of baseline at 4 hours, and the 
differences compared with sham aninut!s were significant. Eight hours after thermal 
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injury, PCDs showed a !82% increase compared with control animals. DuP753 treatment 
resulted in a significant decrease of postburn PCDs at 4 hours (Fig. 2). 
LPS infusion to burn animals yielded a higber and prolonged elevation ofPCDs, 
showing an increase ofl78% of baseline at 4 hours and 210% of baseline at 8 hours after 
LPS infusion. PCD levels remained significantly elevated in the burn!LPS group until the 
end of the stndy period. In contrast, animals treated with DuP753 showed no elevation in 
their PCD levels after LPS administration (Fig. 2). 
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Figure 2. Plasma conjugated d.ienc (PCD) levels. an index of ischemia and reperfusion injury-induced lipid 
peroxidation.. were significantly elevated after burn (0 hour) and endotoxin administration (18 hours after 
burn). Postburn treatment with DuP753 yielded a significant reduction in PCD levels after burn and 
endotoxin challenges. P <0.05. * vs. baseline.# vs. sham.¥ vs. DuP753. 
Lactulose and mannitol assay 
There were no differences between groups in baseline levels of the LIM ratio (Fig. 
3). The LIM ratio for burned animals was moderately increased at 6 hours after burn. 
lntestiual permeability, as indicated by the LIM ratio, showed a 6-fold increase at 12 
hours after burn in the burn!LPS group compared with only a doubled increase in the 
treatment group. The differences between groups were significant at this time point (Fig. 
3). 
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The changes in mucosal permeability, as measured by the LIM ratio, were more 
pronounced after LPS administration to burned animals. The LIM excretion ratio was 12-
and I 0-fo!d elevated in the burn!LPS group at 12 and 18 hours after LPS, respectively. In 
contrast, treated animals showed only a 3- and 2-fold increase at these time points. 
Differences between groups were significant (Fig. 3). 
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F.agure 3. Changes in intestinal permeability. as assessed by the Iactulose/mannitol (LIM) excretion ratio. 
after 40% TBSA third-degree bum (0 hour) and endotoxin administration (E. coli LPS. 18 hours after 
burn). DuP753 was administered intravenously immediately after burn. P <0.05, * vs. baseline.# vs. sham. 
¥ vs. DuP753. 
Quantitative bacteriologic culture of tissue samples 
The rates of positive tissue cultures were significantly higher in animals receiving 
burn and LPS compared with the sham group (6/7 vs.l/7, P <0.05). Animals treated with 
DnP753 showed rates of positive tissue cultures comparable to those of the control 
animals (Fig. 4). Specific tissue isolates and their origin from animals in the three groups 
are shown in Table I. Only tissue cultures that were positive with enteric bacteria of the 
same biotype as that found in the intestine of corresponding animal were interpreted as 
evidence ofbacterial translocation. In the burn!LPS group, 86% of the animals showed 
bacterial translocation to the mesenteric lymph nodes (MLNs) and lung, 71.4% to the 
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spleen and liver, and 43% to the kidney (Fig. 4). In contrast, only 14% of the treated 
animals showed bacterial translocation to the MLNs and lung (P<0.05), 28% to the liver, 
14% to the spleen (P=0.053), and none to the kidney 
(Fig. 4). 
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Figure 4~ Burn and endotoxin resulted in a significant increase in the rates of positive tissue cultures v.rith 
enteric bacteria The incidence of bacterial translocation to remote organs was significantly reduced in 
animals treated with DuP753. Data are presented as percentages of harvested tissue samples. P <0.05, * vs. 
baseline..# vs. sham.¥ vs. DuP753. 
Table L Rates.. types, and origins of tissue isolates from the 3 study groups. Only tissue cultures that were 
positive with enteric bacteria of the same biotype as that found in the intestine of corresponding animal are 
presented. G =jejunum. i =ileum. c =cecum). 
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Table 1. Specific tissue isolates from the three study groups 
tissue samples positive/total oraanism orij;n 
Sham 
fMLN (ln) Escherichia coli ilc 
S intermedius ilc 
Enterococcus faecium j/c 
Lung (ln) S intermedius ilc 
Burn/LPS 
MLN (6n) Streptococcus bovis j/ilc 
Staphylococcus hyicus hyicus j/i/c 
Enterococcus fecalis j/ilc 
Spleen csn) Staphylococcus hyicus hyicus j/i/c 
Enterococcus fecalis j 
Liver csn) Staphylococcus hyicus hyicus jli 
Escherichia coli jlilc 
Enterococcus fecalis j/ilc 
Klebsiella pneumoniae j/ilc 
Lung (6n) Staphylococcus hyicus hyicus j/i/c 
Staphylococcus aureus j!Vc 
Enterococcus fecalis j/i/c 
Enterococcus faecium j/ilc 
Streptococcus bovis j/ilc 
Klebsiella pneumoniae j/ilc 
Kidney (3n) Staphylococcus aurcus ilc 
Escherichia coli j/ilc 
Stafuylococcus hyicus hyicus c 
Burn!DuP753/LPS 
MLN (ln) Enterococcus faecium j/ilc 
Staphylococcus haemolytic-us j 
Escherichia coli j/i/c 
Spleen (In) Staphylococcus hyicus hyicus ilc 
Liver (217) Staphylococcus hyicus hyicus ilc 
Enterococcus fecalis j/ilc 
Lung (ln) Enterococcus faecium jf!lc 
Kidney con) 
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Discussion 
There is accumulating evidence that failure of the got barrier function may play 
an important role in the initiation or progression of the hypermetabolic response and 
multiple organ dysfunction syndrome (MODS) that frequently occur after major 
trauma.ll, 12 Although the causal relation between the got as a reservoir of enteric 
bacteria and endotoxins and the development of sepsis and/or MODS remains to be 
defined, bacterial translocation has been associated by various pathological conditions, 
including thermal injury 7 and endotoxemia. 13 Intestinal ischemia with a resultant 
reperfusion injury appears the most likely mechanism in the pathophysiology of 
decreased intestinal mucosal integrity, occurring shortly after thermal injury. 7 Later in 
the postbum period, altered intestinal permeability seems to be related to the episodes of 
endotoxemia to which burned patients are frequently exposed. I )Jn such situations, 
intestinal ischemia and sepsis can become self-sustaining because endotoxin, got- or 
tissue-derived, has been documented to decrease intestinal blood flow and promote 
bacterial translocation.14-16 In addition to the elucidation of the molecular mechanisms 
underlying the injury of sepsis-induced intestinal ischemia, the identification of these 
mediators may facilitate the development of interventions to modulate the mesenteric 
blood flow and prevent subsequent pathological events. Therefore, we recently reported 
on possible mediators in this complex process. The results of our previous study 8 have 
clearly shown that angiotensin II plays a critical role in the process of mesenteric 
vasoconstriction triggered by bum and endotoxin. Postbum treatment with DuP753, a 
specific angiotensin ll receptor antagonist, was found to ameliorate burn- and endotoxin-
induced mesenteric ischemia by improving mesenteric blood flow and oxygen supply. 
We therefore hypothesized that DuP753 treatment can attenuate bum- and endotoxin-
induced got barrier failure. 
In the current study, the intestinal permeability was measured by assessment of 
the lactulose/mannitol (LIM) excretion ratio. Mannitol, a monosaccharide, has a radius of 
0.4 mn and is absorbed transcellularly through aqueous pores in the cell membrane. 
Lactulose, on the other hand, is larger (0.52 om) and its absorption occurs via the 
paracellular pathway through damaged tight junctions. When absorbed, both sugars cross 
the got to the circulation, remain unmetabolized, and are excreted by the kidney. 
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Intestinal permeability, as assessed by the LIM ratio, was 6-fold increased 12 hours after 
thermal injury. These results are in agreement with those of previous reports. Deitch 3 
documented a 3-fold increase in intestinal permeability in thermally injured patients 
during the first 24 hours after injury with use of the LIM ratio. Postburn administration of 
the angiotensin ll antagonist DuP753 resulted in a significant reduction of LIM ratios in 
burned animals. This treatment effect on postburn intestinal permeability may be 
beneficial in reducing the susceptibility to infection in patients with thermal injuries, 
because a relation between increased permeability and postburn infections has been 
reported in humans_4,17 Intestinal permeability was studied in burned patients during the 
first 2 weeks by measuring the LIM ratio.4 There was a clear correlation between the 
increased LIM ratio on postbum day 2 and the occurrence of significant clinical 
infections during the first 2 postburn weeks. Ziegler et all7 studied patients 2 weeks after 
injury by the LIM ratio and noted that ouly infected burned patients had altered 
permeability. However, their patients were studied in the late postbum period, during 
which other factors, such as endotoxernia, could have contributed to the reported altered 
permeability. Endotoxin alone has been reported to increase intestinal permeability in 
humans. 6 Thus, it appears that thermally injured patients are exposed to two episodes of 
increased permeability: first, the initial burn trauma, and second, the insult of 
endotoxernia. In our model of combined burn!LPS, the impact of endotoxin, administered 
18 hours after burn, on the intestinal permeability was dramatic. Intestinal permeability, 
as indicated by the LIM ratio, showed a significant and prolonged increase in burned 
animals receiving LPS (12- and 10-fold increase at 12 and 18 hours after LPS infusion, 
respectively). The posthurn blocking of angiotensin II significantly reduced these 
detrimental effects of postburn endotoxernia on intestinal permeability. 
Because the permeability was increased in the burn!LPS group, the incidence of 
positive tissue cultures with enteric bacteria was also significantly elevated. Eighty-six 
percent of the animals with combined bum and LPS insults showed bacterial 
translocation. The linear correlation between both the increased permeability index and 
bacterial translocation rate in these animals suggests a causal relationship. Another 
finding in our study that may confirm this relation is the observation of a significant 
decrease in bacterial translocation rates in the treatment group. The bacterial 
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translocation rates of animals receiving burn and LPS and treated witb DnP753 and tbose 
oftbe sham animals did not differ significantly (14-28% vs. 14%). The involvement of 
angiotensin in tbe occurrence of bacterial translocation after burn and bacterial challenge 
has recently been reportect.l8 Mice pretreated witb angiotensin converting enzyme 
inhibitor showed a lower incidence of bacterial translocation and a higher survival rate 
after tbermal injury and bacterial challenge compared witb control animals. In tbe current 
study, a more target-specific angiotensin-blocking agent was given, as a treatment 
modality, immediately after tbe first insult "burn". 
The exact mechanism(s) by which major tbermal injuries and endotoxemia affect 
tbe intestinal permeability and bacterial translocation remain(s) to be elucidated. 
However, as previously suggested, ischemia and reperfusion injury appears to play a 
pivotal role in this complex process. The resultant oxygen-derived free radicals have been 
implicated in tbe subsequent tissue damage tbat results in intestinal mucosal injury 
_6,19,20 Altbough oxidant-induced damage may involve many cell components, 
peroxidative decomposition of membrane lipids has been considered as tbe basis of cell 
injury.2l According to Tribble et al, 21 lipid peroxidation is important in oxidative injury 
because it increases the number of free radical chain reactions, compromises 
detoxification systems, and causes direct deleterious effects, because lipid peroxidation 
products tbemselves are considered toxic. Lipid peroxidation, initiated by hydroxyl 
radicals, results in tbe formation of lipid-derived free radicals such as conjugated dienes, 
lipid hydroperoxide radicals, and lipid hydroperoxides.l9 Measurement of conjugated 
dienes is frequently used as an index oflipid peroxidation. In tbe current study, plasma 
conjugated diene (PCD) concentrations showed a 68% increase at 4 hours after bum and 
a return to baseline at 18 hours after bum. After LPS infusion, tbe elevation of PCDs was 
augmented and prolonged, beginning as early as 2 hours after LPS infusion, peaking 
(210% ofbaseline) at 8 hours after LPS infusion, and remaining elevated until tbe end of 
tbe study period. Administration ofDnP753 directly after tbermal injury yielded a 
significant reduction in postbum reperfusion injury, as indicated by tbe PCD levels. 
Treated animals showed no significant increase in tbeir PCD levels compared witb 
baseline and sham animal levels. From tbese data, we cannot determine whetber tbe 
PCDs are solely tbe product of intestinal ischemia and reperfusion injury. These radicals 
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could have their origins from other organs, such as the liver, burned skin, and lung. 22,23 
However, the observation that systemic hemodynantic parameters (cardiac output, mean 
arterial pressure, and central venous pressure) showed no significant changes because of 
adequate resuscitation, together with the data of our previous study 8 in which mesenteric 
blood flow was significantly reduced under the same conditions, argne for the concept 
that the gnt is, at least in part, a major contributor to these lipid-derived free radicals. The 
beneficial effect ofDuP753 on mesenteric arterial blood flow and mesenteric 
oxygenation after burn and endotoxin challenges, seen in our previous study 8, may 
explain the action ofDuP753 treatment in attenuating bum and endotoxentia reperfusion 
injury, as assessed by PCD measurements in the current study. 
In conclusion, major thermal trauma appears to cause ischemia and reperfusion 
injury, with a subsequent increase in intestinal permeability and bacterial translocation, 
all of which are augmented by a second insult of endotoxemia. The data of tltis study 
indicate that angiotensin II plays a central role in tltis process. Blocking angiotensin II 
receptor by DuP753 can attenuate these detrimental effects of burn and endotoxin. 
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Abstract 
Objective: To evaluate the effect ofinterleukin-la (IL-Ia) on the mesenteric circulation, 
intestinal mucosal integrity, and bacterial translocation in a burn!endotoxemia chronic 
porcine modeL 
Summary Background Data: Major burn and sepsis are associated with a high 
mortality, ischemia!reperfusion injury to the intestine, and an increased rate of bacterial 
translocation. Pathologic alterations of IL-l synthesis, degradation, and binding to 
receptors have been reported. Manipulation of IL-l-mediated effecrs might be of 
therapeutic utility in the future. 
Methods: Twenty-one female pigs were instrumented with an ultrasonic flow probe on 
the superior mesenteric artery and a catheter into the superior mesenteric vein. After 5 
days, all animals were anesthetized, and 14 received 40% total body surface area third-
degree burn. IL-l a was administered intravenously at I 000 nglkg to 7 pigs immediately 
after burn. Eighteen hours after burn, 100 J.Lg/kg Escherichia coli lipopolysaccharide 
(LPS) was administered intravenously. Systemic and splanchnic hemodynamics were 
measured and blood samples were drawn for blood gas analysis. Intestinal permeability 
was assessed every 6 hours by measuring the lactulose/mannitol (LIM) excretion ratio. At 
the end of the study (42 hours), tissue samples were harvested for bacteriologic cultures. 
Results: Mesenteric blood flow was significantly decreased after bum and endotoxin to 
59% and 60% of baseline, respectively. Administration of IL-Ia significantely improved 
mesenteric blood flow postbum and post-LPS (140% and !52% ofbaseline, 
respectively). Mesenteric oxygen supply (mDO,) and consumption (m VO,) showed a 
significant reduction after bum to 60% and 54% of baseline, respectively. In contrast, 
animals treated with IL-Ia showed an increase in postburn mDO, and mV02 to 124% 
and 128% of baseline, respectively. LPS-induced mesenteric hypoxia was also 
ameliorated by IL-l a treatment. Intestinal permeability, as assessed by the LIM ratio, 
showed a 7- and I 0-fold elevation after thermal injury and LPS, respectively. In contrast, 
IL-Ia-treated animals showed an increase of only 3- and 4-fold in the LIM ratio, 
respectively. Bacterial translocation was significantly increased in the burn/endotoxin 
group (7/7 vs. 1/7 in the sham group). IL-Ia significantly reduced the rates of bacterial 
translocation (2/7). 
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Conclusions: IL-l a treatment attenuates mesenteric ischemia and reperfusion injury 
induced by thermal injury and endotoxemia, by improving mesenteric blood flow and 
oxygenation. Subsequently, IL-l a reduces intestinal permeability and bacterial 
translocation after burn and sepsis. 
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Introduction 
The prognosis of extensively burned patients is dependent upon the presence of 
sepsis. The importance of ischemic damage and systemic iuflammatory response 
syndrome (SIRS), initiated by mediators or cytokines in the pathogenesis of postburn 
multiple organ dysfunction syndrome (MODS), was demonstrated in serial clinical and 
experimental studies 1. Sepsis syndrome also results from bacterial translocation (BT), in 
which gnt bacteria and/or endotoxins (LPS) are thought to enter the portal bloodstream 
and/or lymph system 2, 3. Circulating LPS was suggested to be the trigger for increased 
proinflammatory cytokine production, SIRS, and septic complications in injured patients 
4. The pathophysiological mechanism of sepsis is the increased release of inflammatory 
mediators and resulting imbalances between these substances and their antagonists. In 
cases of severe sepsis, the sequelae of the imbalance between iuflammatory mediators 
and their antagonists can lead to endothelial injury, disseminated intravascular 
coagulation, and finally MODS 5. Strategies against the occurrence of sepsis include 
hospital-wide infection control measures, modifying the irmnune system function, and 
minimizing the occurrence of BT 6. 
Several mediators have been reported to be involved in the process of burn- and 
endotoxemia-induced ischemia and reperfusion injury to the intestine and BT 7. There 
are some data available to implicate interleukin-1 (IL-l) as one of these mediators. IL-l 
production by blood monocytes has been documented to be markedly decreased in 
severely burned patients 8. These changes were more evident in patients complicated 
with organ injury, multiple organ failure, and systemic infection. The administration of 
interleukin-!a (IL-Ia) was shown to improve survival in an animal model ofburn wound 
sepsis 9. This survival was associated with a decrease in positive blood cultures. IL-l 
pretreatment was also shown to decrease ischemia and reperfusion injury 10. Hence, we 
examined the abili1y of IL-Ia to counteract intestinal ischemia and reperfusion injury and 
BT in a bum/sepsis chronic porcine model. 
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Methods 
The experimental protocols were approved by the Animal Care and Use 
Committee of the University ofTexas Medical Branch (ACUC # 90-09-103). 
Surgical preparation 
Studies were performed in 21 female mini-pigs (weight 20-25 kg). After an 
overnight fast, the pigs were sedated with intramuscular ketanrine (1 0 mg!kg) and 
mechanically ventilated with 2% to 2.5% halothane after endotracheal intubation. A 
bilateral subcostal incision was performed. A transit time ultrasonic flow probe (6-8 mm, 
Transonic Systems Inc., Ithaca, NY) was placed on the superior mesenteric artery. A 6.5F 
catheter was positioned in the superior mesenteric vein. A Witzel jejunostomy was also 
performed using a 12F Foley catheter. 
After surgery, the animals were kept in recovery slings for 24 hours, then placed 
in runs for 5 days with free access to food and water. On the day of the experiment, the 
animals were reanesthetized. Through a neck incision a catheter was placed via the right 
common carotid artery into the abdominal aorta, and a Swan-Ganz thermal dilution 
catheter (Model93 A-131-5F, American Edwards Laboratories, Anasco, PRJ was 
positioned in the pulmonary artery through the rightjugnlarvein. A 12F Foly catheter 
was inserted in the urinary bladder. 
Experimental design 
The animals were kept in special slings for monitoring. Throughout the study, all 
animals received enteral feeding (Osmolite) at 25 mL/hr and nothing orally. Baseline 
data were collected after complete recovery from anesthesia. 
The pigs were randomized into three groups: 
I) The bum/lipopolysaccharide (LPS) group (n=7) had a 40% total body surface 
area third-degree flame bum under general anesthesia as described above. The pigs were 
resuscitated according to the Parkland formula and received lactated Ringer's solution ( 4 
mL/kglpercentage of total body surface area burned), starting immediately after the bum; 
half of which was given in the first 8 hours after bum and the remainder in the next 16 
hours. Eighteen hours after bum, I 00 !lg/kg Escherichia coli LPS (Oil! :B4; Difco, 
Detroit, MI) was administered intravenously. During the second day of the experiment, 
burned animals received lactated Ringer's solution at 3,5 mLfm2 burned area and 2 
mL/kglhr for daily maintenance. 
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2) The sham group (n=7) had a sham bum under anesthesia. Eighteen hours later, 
the animals received the diluent (0.9% NaCI) used for the endotoxin. Lactated Rffiger's 
solution was administered at 2 mL/kglhr for daily maintenance. 
3) The treatment group (n=7) underwent the same procedure as the bum!LPS 
group, except for the administration of!L-la (recombinant human IL-Ia [lot IL-l 1/92], 
with specific activity of8.8 x!08 units/mg, provided by Hoffmann-La Roche Inc., Nutley, 
NJ) intravenously at I 000 ng!kg, immediately after bum. 
Mean arterial (MAP) and central venous ( CVP) pressures were measured using 
transducers (P23 ID, Statham Gould, Oxnard, CA) connected to an Electronic Medicine 
Honeywell Recorder (Honeywell Inc., Pleasantville, NY) for electronic calculation of 
mean pressures. Cardiac output (CO) was determined by the thermal dilution technique 
using a Swan-Ganz catheter and a cardiac output computer (Model 9520, American 
Edwards Laboratories, Irvine, CA). 
Superior mesenteric arterial (SMA) blood flow was measured with a transit time 
ultrasonic flow probe connected to a Tl 0 I ultrasonic meter (Transonic Systems Inc., 
Ithaca, NY). 
Systemic and splanchnic hemodynamics were measured and blood samples were 
drawn for determinations of arterial, mixed venous, and portal blood gases at baseline 
and I 4 consecutive time points, starting I hour after bum. 
Systemic vascular resistance index (SVRI) and mesenteric vascular resistance 
(MVR) were calculated with the following formulas: 
Cardiac index (L/min/m2) = cardiac output (Limin)/body surface area 
SVRI (dyne· sec· cm-5 • m2) =([mean arterial pressure- central venous pressure] x 
80)/cardiac index 
MVR (dyne· sec· cm-5) =([mean arterial pressure- central venous pressure] x 
80)/mesenteric arterial blood flow 
Systemic oxygen delivery (D02), systemic oxygen consumption (VO,), 
mesenteric oxygen delivery (mD02), and mesenteric oxygen consumption (m V02) were 
calculated as follows: 
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D02 (mL/min/m2) = cardiac index x arterial oxygen content x I 0 
V02 (mL/min/m2) =cardiac index x (arterial oxygen content- mixed venous oxygen 
content) x I 0 
mD02 (mL/min) =mesenteric arterial blood flow x arterial oxygen content/100 
m V02 (mL/min) =mesenteric arterial blood flow x (arterial oxygen content- mesenteric 
oxygen content)/! 00 
Arterial oxygen content (mL/dL) equals (Hb x 1.34) Sa02 + (PaOz x 0.0031); mixed 
venous oxygen content (mL/dL) equals (Hb x 1.34) Sv02 + (Pv02 x 0.0031 ); mesenteric 
oxygen content (mL/dL) equals (Hb x 1.34) Sm02 + (Pm02 x 0.0031). 
Permeabili!v Assessment 
After tbe animals had recovered from tbe surgical instrumentation, a solution of 
10 grams lactulose and 5 grams mannitol, diluted in 60 mL distilled water (1,160 
mOsmlkg), was given via tbe jejunostomy tube and urine was collected for a 6-hour 
period to obtain baseline measurements. Lactulose/mannitol (LIM) assessment was 
repeated every 6 hours. At tbe completion of collection, tbe urine was divided into 
aliquots and frozen at 20°C until assayed. Urinary lactulose and mannitol concentrations 
were simultaneously determined by tbe tecbnique described by Fleming et a! II, using 
higb pressure liquid chromatography coupled witb pulsed arnperometric detection 
(HPLC-PAD). Urine was 2-to 20-fold diluted witb deionized water, depending on tbe 
collection volume. One milliliter of diluted urine was mixed witb internal saccharide 
standards, desalted, vortex mixed, centrifuged, and filtered. Fifty microliter oftbe filtrate 
was injected onto a 250 x 40 mm anion exchange colunm (Dionex Carbopak, P AI, 
Houston, TX) and eluted witb 0.15 moi!L NaOH, I mL/min at 20°C. Detection was by 
pulsed arnperometric detection witb a working gold electrode and silver/silver chloride 
reference electrode, witb a detection potential of +0.05, oxidation potential of +0.06 and 
reduction potential of -0.95V. Quantification was by peak heigbt analysis and peak heigbt 
ratios, witb internal standardization. This metbod offers excellent separation oftbe 
carbohydrates and precise detection at low concentrations (lactulose 0.3 mg!L ). The 
amount of each sugar excreted in tbe urine during 6 hours was tben converted to a 
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percentage of the amount of the given sugar, reflecting the excretion fraction of each 
sugar. By dividing the lactulose and mannitol excretion fractions, a permeability index-
the LIM ratio- was calculated. 
Testing for bacterial translocation 
At the end of the 42 hours, the animals were anesthetized with 10 mg/kg 
intravenous ketamine and sacrificed with 5 mL intravenous saturated KCI. Using aseptic 
technique, through a midline laparotomy incision, peritoneal fluid and tissue samples 
from the proximal and distal mesenteric lymph nodes (MLNs), spleen, liver, kidney, 
lung, jejunum, ileum, cecum and colon were taken for bacteriologic cultures. Collected 
tissue samples were weighed and 0.5 g of each was homogenized in a tissue grinder with 
4.5 mL nonbacteriostatic saline to create a 1:10 dilution of the original sample; 0.1 mL 
and 0.01 mL (of the 1:10 dilution) were inoculated onto a MacConkey agar plate and a 
Columbia Nutrient Agar (CNA) plate for isolation of gram-negative and gram-positive 
organisms, respectively. Therefore, one colony would represent lx!02 and lxJ03 colony-
forming units per gram of tissue, respectively, for each inoculum size. Limits of detection 
were 100 organisms per gram of tissue. Inoculated plates were incubated at 37°C for 24 
and 48 hours and read with a Darkfield Quebec Colony Counter (Model 3330, American 
Optical Co., Buffalo, NY). Cultures were considered positive when more than I 00 
colonies per gram of tissue were found. All bacterial isolates were identified by biotype 
using a microscan 4 bacterial analyzer (Baxter, Sacramento, CA.) 
Statistical analvsis 
The data are presented as mean± SEM. Within-group analysis was performed by 
the analysis of variance (ANOVA) for repeated measurements with the Dunnett post hoc 
test. Between-groups analysis was performed by ANOV A for factorial analysis with the 
Bonferroni post hoc test. Bacteriologic tissue culture results were analyzed by the Fischer 
exact test. P values of <0.05 were considered statistically significant. 
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Results 
Svstemic hemodvnamics: 
Baseline hemodynamic measurements were similar in all groups. All animals 
survived the study period (Fig. I and Fig. 2). 
After burn, MAP and CVP showed a slight elevation, but no significant 
differences were observed between groups. CO was elevated to 158% of baseline during 
the first 4 hours, returning to baseline 8 hours after burn. This increase was associated 
with a concomitant fall in SVRI to 65% of baseline level. 
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Figure 1. Mean arterial pressure (MAP) and central venous pressure (CVP) after bum (0 hour) and 
endotoxin (18 hours). IL-l a: treatment had a marginal effect. P <0.05, * vs. baseline,# vs. sham.¥ vs. IL-
l <X. 
The second insult (administration ofLPS) led to a typical biphasic response. 
During the early post-LPS phase, a decrease was noticed in MAP to 80% of baseline, and 
in CO to 67% ofbaseline. Four hours after LPS administration, all measurements were 
stabilized to baseline levels. A hyperdynamic period began to be manifest 8 hours after 
endotoxin infusion. Whereas CO showed a 20% increase, SVRI dropped to 64 % of 
baseline, at this time point. Throughout the study period, a slight elevation of the CVP 
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was shown in all burned animals. IL-l ex treatment had a moderate impact on the 
hemodynamic alternations, seen after bum and LPS . 
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Figure 2. IL-l ex ameliorated the changes in cardiac output (CO) and systemic vascular resistance index 
(SVRI) postburn (0 hour) and early after endotoxin (18 hours). P <0.05, * vs. baseline,# vs. sham,¥ vs. 
IL-l a. 
Mesenteric hemodynamics: 
Although thermal injury resulted in a hyperdynamic status with an increased CO, 
SMA blood flow decreased significantly to approximately 59% of baseline level during 
the first 2 hours after bum (Fig. 3). In contrast to the previously observed postbum 
reduction in systemic vascular resistance, MVR showed a significant increase (195% of 
baseline) during the early postbum phase (Fig. 4). During the late postbum phase, 
starting 4 hours after insult, a mesenteric reperfusion phase became manifested, as SMA 
blood flow increased by 45% over baseline. Compared to burned animals not receiving 
IL-l ex treatment, IL-l ex-treated animals showed no reduction in SMA blood flow 
following thermal insult. On the contrary, SMA blood flow in this group showed an 
increase of 40% of baseline (Fig. 3). Animals in the IL-l ex treatment group maintained, in 
contrast to nontreated burned animals, a stable MVR near baseline during this early 
mesenteric vasoconstrictive phase (Fig. 4). 
101 
Chapter 6 
At 18 hours postbum, mesenteric hemodynamic measurements were comparable to 
baseline levels in all groups. 
Figure 3. Superior mesenteric artery (SMA) blood flow was significantly reduced and showed a pattern of 
ischemia and reperfusion after burn (0 hour) and endotoxin (18 hours). IL-lo: administration significantly 
improved S:MA blood flow. P<0.05, * vs. baseline.# vs. sham.¥ vs. IL-l ex. 
Administration of LPS to burned animals resulted in a biphasic response of 
mesenteric ischemia and reperfusion. The second insult yielded a significant mesenteric 
vasoconstriction with an increase ofMVR to 158% of baseline during the first 8 hours 
post-LPS. 
Similarly, SMA blood flow decreased significantly to 60% of baseline during the same 
time of maximum increase ofMVR. Burned animals treated with IL-Ia showed no signs 
of mesenteric vasoconstriction after the second insult (LPS). Compared to nontreated 
animals, IL-l a treatment resulted in a significant improvement of SMA blood flow after 
the second impact (LPS). Eigbt hours post-LPS, SMA blood flow reached a value of 
152% ofbaseline in the IL-Ia group, whereas MVR was significantly reduced to 56% of 
baseline (Fig. 3 and Fig. 4). 
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Figure 4. Alterations in mesenteric vascular resistance (MVR) after burn (0 hour) and endotoxin (18 
hours). IL·l o: had a positive impact on MVR.. P <0.05, * vs. baseline, # vs. sham., ¥ vs. IL-lo: . 
Svstemic oxvgen deliverv and consumption: 
During the first 4 hours after burn, the burn/LPS group showed a significant 
increase in both D02 (150% of baseline) and V02 (204% of baseline). The IL-Ia group 
showed moderate changes in DO, and V02 after bum, with au increase to 113% and 
126% of baseline, respectively (Fig. 5). 
One hour after LPS administration, a significant drop in DO, was noticed in the 
burn group (57% ofbaseline). V02 was reduced to 68% ofbaseline during this early post-
LPS phase. During the post-LPS hyperdynamic phase, D02 and V02 showed no 
significant alterations. Animals treated with IL-Ia showed some changes post-LPS, but 
of no significance (Fig. 5). 
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Figure S. Administration ofiL-1 a. slightly affected systemic oxygen delivery (D02) and oxygen 
consumption (V02) after bum (0 hour) and endotoxin (18 hours). P <0.05, * vs. baseline,# vs. sham,¥ vs. 
IL-Ia. 
Mesenteric oxvgen delivery and consumption: 
In the early phase after burn, mD02 and m VO, showed a significant fall to 60% 
and 54% ofbaseline levels, respectively. On the contrary, animals treated with IL-Ia 
showed an increase in postbum mDO, and mV02 to 124% and 128% of baseline, 
respectively (Fig. 6). 
Administration ofLPS resulted in a significant reduction in mD02 to 50% of 
baseline. Postburn treatment with IL-l a abrogated this deleterious impact of LPS and 
mDO, showed an increase to 121% of baseline. Correspondingly, post-LPS diminished 
mV02 was attenuated in animals receiving IL-Ia (Fig. 6, 79% vs. 136% ofbaseline). 
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Figure 6. burn (0 hour) and endotoxin (18 hours) significantly reduced mesenteric oxygen supply (mD02) 
and oxygen consumption (mV02)- These detrimental effects were attenuated by IL-l a. treatment. P<0.05, 
* vs. baseline. # vs. sham, ¥ vs. IL-l a. _ 
Lactulose and mannitol assay 
No differences were found between groups in baseline measurements of the LIM 
ratio. The LIM ratio for burned animals began to increase 6 hours after burn, reaching a 
7-fold elevation 12 hours after burn in the burn!LPS group, compared with only a 3-fold 
increase in the treatment group. The differences between groups were significant at this 
time point. 
LPS administration to burned animals caused a clear deterioration in the mucosal 
permeability, as assesed by the LIM ratio. The LIM excretion ratio was 10- and 8-fold 
increased in the burn!LPS group at 12 and 18 hours after LPS administration, 
respectively. On the contrary, animals treated with IL-l a showed only a 4- and 3-fold 
increase at these time points. Differences between groups were significant (Fig. 7). 
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FigUre 7. Intestinal permeability. as assessed by the lactulose/m.annitol (LIM) excretion ratio. was 
significantly increased after burn (0 hour) and endotoxin (18 hours). IL-Ia administration significantly 
reduced intestinal permeability. P <0.05. * vs. baseline.# vs. sham.¥ vs. IL-l a. 
Quantitative bacteriolo!!ic culture of tissue samples: 
Tissue cultures were tested positive for enteric bacteria in all animals in tbe 
burn/LPS group. In contrast, ouly I out of7 animals in tbe sham group showed positive 
tissue cultures (P < 0.05). IL-Ia treatment yielded a significant reduction in tbe rates of 
positive tissue cultures, whereas ouly 2 out of 7 animals in this group tested positive 
(P < 0.05 vs. burn!LPS). 
Only tissue cultures witb enteric bacteria of tbe same biotype as tbat found in tbe 
intestine of corresponding animal were interpreted as evidence of bacterial translocation 
(Table 1). 
In tbe burn!LPS group, 100% oftbe animals showed bacterial translocation to tbe MLNs 
and liver, 86% to tbe spleen and lung, and 57% to tbe kidney (Fig. 8). On tbe contrary, 
ouly 28% oftbe treated animals showed bacterial translocation to tbe MLNs and spleen 
(P<0.05), 14% to tbe liver and lung (P<0.05), and none to tbe kidney (Fig. 8). 
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Figure 8. Incidence of bacterial translocation to remote organs was significantly increased in the burn and 
endotoxin group. IL-Ia. treatment yielded a significant reduction in the rates of positive tissue cultures with 
enteric bacteria. Data are presented as percentages of harvested tissue samples. P <0.05, # vs. sham.¥ vs. 
IL-Ia... 
Table 1. Rates, types and origins of tissue isolates from the three study groups. MLN= mesenteric lymph 
nodes, j= jejunum., i=ileum., c=cecum. 
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tissue samples positive/total o=urism oril!in 
Sham 
MLN (In) Escherichia coli ilc 
Klebsiella pneumooiae i!c 
Enterococcus faecium j/c 
liver (In) Klebsiella pneumoniae i!c 
Burn/LPS 
MLN (7/7) Streptococcus bovis j/i!c 
Staphylococcus hyicus hyicus jfi/c 
Enterococcus fecalis jlilc 
Klebsiella pneumooiae jlilc 
Spleen (6n) Staphylococcus hyicus hyicus j/ilc 
Enterococcus fecalis j/i!c 
Escherichia coli j/i!c 
Liver (717) Staphylococcus hyicus hyicus j/i 
Escherichia coli j/ilc 
Enterococcus fecalis jlilc 
Klebsiella pneumoniae jlilc 
Lung (6n) Staphylococcus hyicus hyicus jfi/c 
Enterococcus fecalis j/ilc 
Enterococcus faecium jli!c 
Streptococcus bovis j/ilc 
Klebsiella pneumooiae j/i/c 
Kidney (4n) Staphylococcus aureus i!c 
Escherichia coli jli!c 
Staihylococcus hyicus hyicus c 
IL-Ia 
MLN (217) Enterococcus fecalis i!c 
Klebsiella pneumoniae ilc 
Escherichia coli i!c 
Spleen (Zn) Escherichia coli i!c 
Liver (In) Escherichia coli ilc 
Enterococcus fecalis i!c 
Lung (In) Enterococcus fecalis i!c 
Kidney (0/7) 
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Discussion 
The immense inflammatory focus incited by tbe bum causes tbe release of 
numerous cytokines aod inflammatory mediators tbat have many systemic effects, and 
may ultimately result in multiple organ dysfunction. Recently, tbe role oftbe gut as a 
cytokine-generating organ in tbe post-injury inflammatory response has been studied 12_ 
As tbe causal relation of bacterial traoslocation or gut-derived cytokines to tbe 
development of sepsis and multiple organ dysfunction syodrome (MODS) has become 
more apparent and more complex, tbe need to identifY tbe mechanisms involved in tbe 
pathophysiology of post-injury gut dysfunction is increasing 13. Therefore, we recently 
reported on possible mediators in this complex process 7_ Among the molecular 
mediators relevant to the pathogenesis of bum injury-associated changes, cytokines have 
attracted special attention. IL-l is presumed to be a key component of the inflammatory 
mediator cascade, directing the host response to infection, injury or inflammation 14. 
Since IL-Ia has multiple effects on the elements of the immune system, we examined in 
this study the ability of IL-l a to reduce bacterial traoslocation in a porcine model ofburo 
and endotoxemia. Although the potential role of bacteria/endotoxin traoslocation aod its 
clinical relevance remains controversial, many lines of evidence support the concept that 
eatly gut hypoper:fusion sets the stage for progressive gut dysfunction, such that the gut 
becomes a reservoir for pathogens and toxins that contribute to systemic inflammatory 
response syodrome (SIRS) and MODS 15_ The consequences ofbacterial traoslocation 
for the host were not the issue addressed in this study, but rather the pathophysiology of 
this process. Our animal model is based on the two hits concept 16, 17, referring to the 
episodes of endotoxemia to which burned patients are frequently exposed 18. IL-l a was 
administered as a single dose (I 000 ng!kg) directly after the onset of a major thermal 
injury in order to evaluate the action ofiL-1 a as a treatment modality. The efficacy of 
this treatment scheme in improving survival in a bum and sepsis animal model has been 
documented in a previous study 9_ 
The results of this experiment clearly show that postburo administration of IL-l a 
significantly reduces the occurrence of bacterial translocation. In contrast to an 
occurrence rate of I 00% in animals with combined bum and LPS insults, bacterial 
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translocation was observed in only 28% of animals receiving burn and LPS and treated 
with IL-l a. These findings suggest several potential explanations. It is possible that IL-
l a has enhanced bacterial clearance capacities in treated animals. Also. IL-l a treatment 
may bave altered local or systemic factors involved in the pathophysiological pathways 
of the bacterial translocation process. There is enougb evidence in the literature to 
support the first theory. IL-Ia has been reported to decrease rates of positive blood 
cultures and increase the absolute neutrophil counts in a murine model of burn wound 
sepsis 9.ln addition, IL-Ia could have increased the animal's ability to kill translocated 
bacteria via its influence on hematopoietic growth factors known to enhance the 
proliferation and functional capacity of neutrophils and macrophages 19. 
The second hypothesis regarding the possible impact of IL-l a on potential 
initiators of bacterial translocation was the subject of our study. A direct or indirect 
action of!L-la on cellular level could have interacted with the intestinal mucosal 
integrity, leading to decrease translocation of enteric bacteria. To examine whether IL-Ia 
interferes with intestinal permeability, we measured the LIM excretion ratio. The clinical 
relevancy of this assessment method has been shown in previous studies 20, 21, in which 
an association between increased LIM ratio and the occurrence of postburn infections 
was observed in humans. Furthermore, an increased LIM ratio was found to correlate 
with oxidant-induced damage and the occurrence of bacterial translocation in our 
combined burn and sepsis modeJ22. Burn yielded in our study a 7-fold increase in 
intestinal permeability during the first 12 hours after injury, as indicated by the LIM 
ratio. This detrimental impact of thermal trauma on intestinal permeability was 
augmented after the administration of endotoxin. During this post-injury toxemic phase 
the LIM ratio was I 0-fold elevated during the first 12 hours after LPS infusion. Eigbteen 
hours post-LPS, intestinal permeability was still 8-fold increased. These results confirm 
the data of previous investigators (including ourselves) 23, 22. Our data clearly show that 
postbum administration oflL-1 a can counteract the negative effects of both challenges, 
i.e. the initial burn injury and the secondary endotoxemia. Intestinal permeability in 
animals treated with IL-Ia was significantly reduced to 3- and 4-fold after burn and 
endotoxin, respectively. The beneficial effect of!L-la on intestinal permeability migbt 
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be the result of a direct pathway by which IL-Ia protects the intestinal integrity. IL-l has 
been shown to increase intestinal crypt cell mitoses and intestinal villus height, leading to 
improviog intestinal cytoarchitecture aod reducing bacterial translocation after a 32% 
total body surface area burn in mice 24. A similar effect could explain the impact of IL-
Ia in our study, however we have not explored this possibility in the current study by 
means of histological studies of intestinal samples. The hypothesis that IL-l a indirectly 
influences the intestinal permeability by interacting with other factors or pathways, such 
as mucosal perfusion, was the subject of this study. 
Ischemia and reperfusion injury to the intestinal mucosa, caused by bum aod 
endotoxin, aod its detrimental impact on intestinal permeability and bacterial 
translocation have been profoundly illustrated in previous studies from our lab 7, 22. The 
data of the current study confirm our previous findings of the occurrence of mesenteric 
ischemia and reperfusion injury following bum aod endotoxin, despite the presence of 
adequate resuscitation status. The observation of a significant mesenteric 
vasoconstriction (decreased SMA blood flow and increased mesenteric vascular 
resistance) during the early phase after thermal injury, while the animals were showing a 
hyperdynamic status (increased cardiac output and decreased systemic vascular 
resistance)~ demonstrates the selective negative impact of thermal injuries on mesenteric 
circulation. Administration ofiL-la directly postburn led to moderate alterations in the 
systemic hemodynamic parameters. In contrast, a significant improvement of the 
mesenteric blood supply was noticed after IL-l a postburn treatment. This beneficial 
effect of!L-Ja treatment on intestinal blood supply in burned animals could be explained 
by an interaction of!L-1 a with vasodilators, such as some of the prostanoids. IL-l has 
been documented to cause an alteration in prostaglandin concentrations, increasing 
prostaglandin E (PGE2) aod prostacyclin (PG!2) l4.Jn another study IL-Ia was found to 
act directly on endothelial cells, inducing the production of vasodilators such as PG!2 25. 
A similar impact ofiL-la. on systemic and mesenteric circulations was observed during 
the postburn septic phase, i.e. after administration ofLPS. IL-Ia was found to 
significantly reduce mesenteric vascular resistance (MVR) aod improve SMA blood 
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flow. The effect on systemic hemodynamic parameters was only noticeable during the 
first 4 hours after LPS infusion. 
Although systemic oxygen delivery (D02) and consumption (V02) were increased 
following thermal injury, mesenteric oxygen supply (mD02) was significantly reduced 
early postburn. The discrepancy between the changes measured in both systemic and 
mesenteric oxygenation status after burn, demonstrates the independence of the impact of 
thermal injury on the mesenteric oxygenation status, as previously seen 22. During the 
same period, m V02 became mD02-dependent, with a significant reduction, indicating 
the inability of the gut to compensate inadequate oxygen delivery by increasing oxygen 
extraction, resulting in tissue hypoxia. Early hypoxia in the splanchnic region has been 
implicated in the process of developing secondary organ failure after major injuries or 
sepsis 26_ Postburn administration oflL-la resulted in a significant improvement in 
mDOz. Mesenteric hypoxia, as indicated by decreased m VOz, was not noticed in animals 
in the treatment group. The enhancement in oxygen supply to meet the increased oxygen 
demand was only observed in the mesenteric circulation, and no significant differences 
were found between treated and untreated burned animals with respect to DOz or VOz. 
During the postburn septic phase, a typical biphasic response was observed in mDOz and 
m VOz, with a more pronounced flow-dependent mesenteric hypoxic period lasting for 
approximately 8 hours. On the contrary, LPS had only moderate effects on D02 and 
V02. LPS alone has been shown to cause mesenteric hypoperfusion, yielding intestinal 
mucosal acidosis and increased permeability 27. After the second insult (LPS), burned 
animals receiving IL-l a showed a significant improvement in their mesenteric 
oxygenation status compared with nontreated animals. 
The data of this study clearly show that postburn administration oflL-1 a 
attenuates the mesenteric ischemia and reperfusion injury induced by thermal injury and 
postbum endotoxemia. Our data are in correspondence with other data collected from 
other studies, documenting the beneficial effects of IL-l a in other organs against 
ischemia and reperfusion injury. The results of those studies have indicated that low 
doses of IL-l a can be used as a therapeutic agent to precondition the heart against 
ischemia and reperfusion injury 28 and to decrease the onset of myocardial ischemia and 
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reperfusion injury 10. However, this particular effect ofiL-Ia seems to be of a selective 
nature and is probably organ-specific, as IL-l was found to be unlikely beneficial in the 
recovery of renal function after ischemia 29. The mechanisms by which IL-l interacts 
with other mediators and modulators in the cascade of ischemia and reperfusion injury 
induced by bum and sepsis and the consequential effects of such actions on different 
organs, have not yet been fully elucidated. Therefore, further studies on this particular 
field are warranted. 
Conclusion 
The cytokine IL-l a appears to play an important role in intestinal perfusion and 
oxygenation after burn and sepsis. Posthurn treatment with IL-l a reduces intestinal 
permeability and bacterial translocation, most likely by attenuating mesenteric ischemia 
and reperfusion injury. 
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Hepatic Blood FkJw and Oxygen Consumption 
Abstract 
Background: Alteration in the hepatic circulation after burn and in sepsis seems to be an 
essential component in the development of multiple organ failure. 
Methods: Female pigs (n=12, 20-25 kg) were instrumented with ultrasonic flow probes 
on the portal vein and the common hepatic artery. Catheters were inserted in the superior 
mesenteric and left hepatic veins. After 5 days, all animals were anesthetized and 6 of 
them received 40% total body surface area third-degree burn. A total of I 00 1-lg/kg 
Escherichia coli LPS was intravenously administered at 18 hours after burn. All animals 
were studied for 42 hours. 
Results: Thermal injury resulted in a 48% decrease in hepatic arterial blood flow despite 
maintenance of normal cardiac output, resulting in a fall in hepatic oxygen delivery rate. 
Portal venous blood flow showed a 32% increase at 4 hours after burn. Post-LPS portal 
blood flow was significantly reduced for a period of8 hours (51% of baseline, P<O.OS, 
ANOV A). The hepatic arterial blood supply was also significantly reduced (12-67% of 
baseline, P<O.OS, ANOVA) during the first 4 hours after LPS, indicating loss of the 
hepatic arterial response. The following 12 hours, a hepatic reperfusion phase was 
observed with an elevation of the hepatic arterial blood flow to 152% ofbaseline 
(P<O.OS, ANOV A). Postbum endotoxernia resulted in a significant decrease of hepatic 
oxygen delivery (88%) and hepatic oxygen consumption (79%). Although the burn injury 
did not affect the portal venous pressure, postburn endotoxernia caused a significant 
portal hypertension during a period of 8 hours (225% of baseline, P<O.OS, ANOV A). 
Conclusions: Postburn sepsis amplifies the selective vasconstrictive impact of thermal 
injury on hepatic arterial blood flow, yielding a pronounced ischemia and reperfusion 
injury, associated with a critical reduction of hepatic oxygen delivery and consumption. 
A postburn septic challenge induces portal hypertension, which may account for 
previously documented gut barrier dysfunction. 
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Introduction 
Sepsis and multiple organ dysfunction syndrome (MODS) remain to be the most 
common causes of the high morbidity and mortality rates after major bum injuries 1-3_ It 
has been postulated that the amplified reaction of the primed inflammatory response 
system of thermally injured patients to a subsequent insult, initiated by bacteria and their 
by-products ( endotoxins), is responsible for the typical pathophysiological alterations 
seen in post-injmy sepsis 2_ Although a clear defined pathophysiologic mechanism has 
not yet been defined, the gastrointestinal tract has been postulated to be a major 
contributor to postbum sepsis 4_ The intestinal mucosal barrier normally prevents the 
enteric bacteria and their by-products from escaping and reaching extraintestinal organs. 
However~ under certain circumstances~ the integrity of intestinal mucosa seems to be 
disrupted, allowing an exaggerated leaking of endogenous bacteria or endotoxins to the 
portal circulation; this is a process called bacterial translocation 5,6_ 
As the hepatic mononuclear phagocytic system (Kupffer cells) seems to play a 
pivotal role in the clearance of translocating bacteria, endotoxin, or both, from the portal 
circulation 7, impairment of this hepatic clearance function may potentiate systemic 
effects of gut barrier failure by allowing indigenous bacteria or endotoxin to reach the 
systemic circulation, where they potentiate systemic inflammatory responses. 
Phagocytosis of bacteria and sequestering of endotoxin by hepatic Kupffer cells 
impose a high metabolic demand on the mononuclear phagocytic system 8_ Intermediary 
metabolism and energy production have an absolute dependence on oxygen. Because 
oxygen can not be stored intracellularly, inadequate oxygen availability rapidly leads to 
cellular dysfunction and ultimately cell death with the net result being organ failure. 
Hence, the importance of the hepatic perfusion for the performance ofKupffer cells. 
The present study was desigued to define the hemodynamic response and the 
tissue perfusion of the liver to severe thermal injuries and postbum endotoxernia in a 
bum/endotoxin porcine modeL 
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Materials and Methods 
The following experimental protocols were approved by the Animal Care 
and Use Committee of the University of Texas Medical Branch (ACUC # 90-09-
103). 
Twelve female mini-pigs, each weighing between 20 and 25 kg, were prepared 
surgically 5 days before the experiment. After an overnight fast, the pigs were sedated 
with intramuscular ketamine (I 0 mglkg) and mechanically ventilated with 2% to 2.5% 
halothane after endotracheal intubation. A subcostal incision was performed. Transit time 
ulttasonic flow probes ( 4-10 mm, Transonic Systems Inc., Ithaca, NY) were placed on 
the common hepatic artery and the portal vein. The 6.5 F catheters were positioned in the 
superior mesenteric vein and the left hepatic vein. Witzel jejunostomy was also 
performed using a 12 F Foley catheter. The abdomen was closed in layers. 
After surgery, the animals were kept in special recovery slings for 24 hours, then 
placed in runs for 5 days with free access to food and water. On the day of the 
experiment, the animals were reanesthetized, and through a neck incision an arterial 
catheter was placed via the right common carotid artery into the abdominal aorta. A 
Swan-Ganz thermal dilution catheter (Model 93 A-131-5F, American Edwards 
Laboratories, Anasco, PR) was positioned in the puhnonary artery via the right jugular 
vein. A 12 F Foly catheter was inserted in the urinary bladder. 
The animals were kept in special slings for monitoring. All animals tolerated the 
slings well, without any signs of stress or need for sedation. Throughout the study, all 
animals received enteral feeding (Osmolite) at 25 mL/br and nothing per os. Baseline 
data were collected after complete recovery from anesthesia. 
The pigs were randomized into 2 groups: 
I) The burn/LPS group (n~6) had a 40% total body surface area (TBSA) third-
degree flame bnm under general anesthesia as described above. The pigs were 
resuscitated according to the Parkland formula and received lactated Ringer's solution, 4 
mL/kg/% TBSA bnm, starting immediately after burn. Half of the fluid was given in the 
first 8 hours after bum and the remainder in the following 16 hours. Eighteen hours after 
bum, 100 11glkg E. coli lipopolysaccharide (LPS) (OIII:B4; Difco, Detroit, MI) was 
intravenously administered. During the second day of the experiment, burned animals 
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received lactated Ringer's solution at 3,5 mLim' burned area and 2 mL/kglbr for daily 
maintenance. 
2) The sham group (n=6) had a sham bum under anesthesia. Eighteen hours later 
the animals received the diluent (0.9 % NaCI) used for the endotoxin. Lactated Ringer's 
solution was administered at 2 mL/kglbr for daily maintenance. 
Mean arterial (MAP), central venous (CVP), and portal venous (PVP) pressures 
were measured using transducers (P231D, Statham Gould, Oxnard, CA) that were 
connected to an Electronic Medicine Honeywell Recorder (Honeywell Inc., Pleasantville, 
NY) for electronic calculation of mean pressures. Cardiac output (CO) was determined 
by the thermal dilution technique using a Swan-Ganz catheter and a cardiac output 
computer (Model 9520, American Edwards Laboratories, Irvine, CA). 
Hepatic arterial blood flow (Qh) and portal venous blood flow (Qp) were 
measured with transit time ultrasonic flow probes connected to a Tl 0 I ultrasonic meter 
(Transonic Systems Inc., Ithaca, NY). 
Systemic and hepatic hemodynamics were measured and blood samples were 
drawn for determination of arterial, mixed venous, and hepatic blood gases at baseline 
and 14 consecutive time points, starting I hour afler bum. 
Systemic vascular resistance index (SVRJ), hepatic arterial vascular resistance 
(HA VR), and hepatic portal vascular resistance (HPVR) were calculated with the 
following formulas: 
SVRJ (dyne·sec·cm·'·m2)=[(MAP- CVP) x 80] I Cl 
HA VR ( dyne·sec·cm·')=[(MAP- CVP) x 80] I Qh 
HPVR (dyne·sec·cm·')=[(PVP- CVP) x 80] I Qp 
Systemic 0 2 delivery (DO,), systemic 0 2 consumption (VO,), hepatic 0 2 delivery 
(hDO,), and hepatic 0 2 consumption (h VO,) were calculated with the following 
formulas: 
DO,=Cl x Ca02 x 10 (mLimin/m2) 
V02 =CI x (Ca02 - CvO,) x 10 (mLimin/m2) 
hD02 =Qh x Ca021 100 (mLimin) 
hV02 =Qh x (Ca02 - ChO,) I 100 (mLimin) 
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Where Cl =cardiac index (Limin/m2), Ca02 (arterial oxygen content, mL/dL) = (Hb x 
1.34) SaO,+ (Pa02 x 0.0031), Cv02 (mixed venous oxygen content, mL/dL) = (Hb x 
1.34) Sv02 + (Pv02 x 0.0031), and Ch02 (hepatic oxygen content, mL/dL) = (Hb x 1.34) 
Sh02+ (PhO,x 0.0031). 
At the end of the 42 hours, the animals were anesthetized with 10 mg/kg 
intravenous ketamine and killed with 5 mL intravenous saturated KCI. 
The data are presented as mean ± SEM. Within-group analysis was performed by 
the analysis of variance (ANOVA) for repeated measurements with the Dunnet post hoc 
test. Between-groups analysis was performed by ANOV A for factorial analysis with the 
Bonferroni post hoc test. All P values of <0.05 were considered statistically significant. 
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Results 
Svstemic Hemodvnamics 
Baseline hemodynamic measurements were similar in all groups. All animals 
survived the study period. Throughout the experiment, sham aoimals maintained their 
systemic (Figs. I and 2) hemodynamics within baseline raoge. 
-----•••••••••. "bum/D'S-------
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Figure 1. Cardiac output (CO) and systemic vascular resistance index (SVRI) after 40% TBSA third-
degree bum (0 hour) and endotoxin (E. coli LPS. 18 hours after burn). P <0.05. * vs. baseline,# vs. sham. 
After thermal injury, cardiac output (CO) showed a slight increase during the first 
6 hours, returning to baseline 8 hours postbum (Fig. I). This increase was associated with 
a concomitant fall in the systemic vascular resistance, whereas the systemic vascular 
resistaoce index (SVRl) decreased to 78% of baseline level (Fig. I). There were no 
significant differences in meao arterial pressure (MAP), central venous pressure (CVP), 
serial hematocrits (Hct), or urine production (UP) between the 2 groups (Figs. 2 and 3). 
After administration of LPS, a typical biphasic response was observed. The 
hemodynamic alteration was more pronounced during the second phase, as after a marked 
drop of CO to 77% of baseline level, a hyperdynamic period began to be manifest 8 hours 
post-endotoxin (Fig. I). At this time point, SVRl dropped to 69% of baseline (Fig. I). In 
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the burn/LPS group, MAP showed a 14% decrease immediately after LPS infusion (Fig. 
2). During the further post-LPS course, no significant differences were noticed between 
groups in MAP, CVP, Ret, or UP (Figs, 2 and 3) 
" .. 
... 
' ' 
Figure 2. Mean arterial pressure (MAP) and central venous pressure (CVP) after 400/o TBSA third-degree 
burn (0 hour) and endotoxin(£. coli LPS. 18 hours after burn). P <0.05, * vs. baseline,# vs. sham. 
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Figure 3. Serial bematocrits (Hct) and urine production (UP) after 40% TBSA third-degree bum (0 hour) 
and endotoxin(£. coli LPS. 18 hours after bum). No statistically significant differences were measured 
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Hepatic Hemodynamics 
Hepatic Arterial Circulation 
In contrast to the CO, which remained within baselioe raoge, Qh decreased 
significantly to approximately 52% ofbaselioe level during the first 4 hours posthurn 
(Fig. 4). This fall in Qh was associated with a significant increase in hepatic arterial 
vascular resistance (HA VR), reachiog 462% of baseline as early as I hour postburn 
(Fig. 5). 
Hc:p:ltic Nkry Blood Flow 
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F.gure 4. Hepatic arterial blood flow (Qh) after 40% TBSA third-degree burn (0 hour) and endotoxin (E. 
coli LPS, 18 hours after burn). P <0.05. * vs. baseline.# vs. sham. 
Hepatic arterial hemodynamic measurements recovered completely in all animals to 
baseline values at 18 hours after burn (Figs. 4 and 5). 
Administration of LPS to burned animals resulted in a biphasic response of 
hepatic ischemia and reperfusion. The second insult resulted in a significant hepatic 
arterial vasoconstriction, with a 16-fold increase ofHA VR during the first hour after LPS 
(Fig. 5). HA VR remained significantly increased (550% of baseline) for a period of6 
hours after LPS administration (Fig. 5). Correspondingly, Qh decreased significantly to 
12% of baseline during the same time of maximum increase ofHA VR (Fig. 4). After an 
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initial recovery ofQh to baseline values 6 hours after LPS, a marked elevation (127-
152% of baseline) was noticed during the following 6 hours (Fig. 4). 
Hepatic Arterial Va.o;o:ular Resistance 
IIIII-
Figure 5. Hepatic arteri:J.l vascular resistance (HA VR) after 40% TBSA third-degree burn (0 hour) and 
endotoxin(£. coli LPS. 18 hours after burn). P <0.05. * vs. baseline.,# vs. sham. 
Hepatic Portal Circulation 
During the first 4 hours after bum, Qp increased to approximately 132% of 
baseline (Fig. 6). Although no important changes were observed in the pattern of 
measured PVP, HPVR showed a 34% decrease of baseline values during the same time 
period (Figs. 7 and 8). 
Similar to the hepatic hemodyuamic arterial variables, portal hemodyuamic 
measurements showed the same pattern of recovery to baseline values at 18 hours after 
bum in all animals (Figs. 6, 7 and 8). 
The second insult yielded significant alterations in the portal circulation, lasting 
for a prolonged time period. The HPVR showed a 2- to 4-fold increase during the first 8 
hours after LPS administration (Fig. 7). During this early septic phase, a significant portal 
hypertension was noticed, whereas measured PVP was elevaied to approximately 225% 
of baseline values (Fig. 8). Qp showed a biphasic response after LPS administration. 
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During the first 8 hours after LPS, Qp decreased to approximately 51% of baseline (Fig. 
6). After a transient recovery to baseline, a hyperdynamic phase with an elevation of Qp 
to 147% of baseline began at 30 hours (12 hours after LPS) and remained till the end of 
the stndy period (Fig. 6). During this late septic period, HPVR was decreased to 63% of 
baseline and PVP was slightly increased to 121% of baseline (Figs. 7 and 8). 
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Figure 6. Portal venous blood flow (Qp) after 40% TBSA third-degree bum (0 hour) and endotoxin(£. 
coli LPS. 18 hours after bum). P <0.05, * vs. baseline., # vs. sham. 
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Figure 7. Hepatic portal vascular resistance (HPVR) after 40% TBSA third-degree burn (0 hour) and 
endotoxin (E. coli LPS. 18 hours after burn). P <0.05, * vs. baseline. # vs. sham. 
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Figure 8. Portal venous pressure (PVP) after 40% TBSA third-degree burn (0 hour) and endotoxin (E. coli 
LPS, 18 hours after burn). P <0.05. * vs. baseline.# vs. sham. 
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Svstemic o;xvgen delivery and consumption 
After a transient reduction, DO, and V02 showed a marked increase during the 
first 6 hours after burn (Fig. 9). 
Administration ofLPS resulted in a significant drop in 002 during the first hour. 
V02 was moderately decreased at this time point (Fig. 9). During the post-LPS 
hyperdynamic phase, both D02 and V02 were increased. 
~~-----------------, 
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Figure 9. Systemic oxygen delivery (DOz) and oxygen consumption (VOz) after 4()0/o TBSA third-degree 
bum (0 hour) and endotoxin(£. coli LPS, 18 hours after bum). P <0.05, * vs. baseline,# vs. sham. 
Hepatic oxvgen delivery and consumption 
hD02 was significantly reduced to 63% of baseline during the first 2 hours after 
burn. In contrast, h V02 was sustained within baseline values with a slight decrease of 
16%, implicating increased hepatic oxygen extraction capacities during the postburn 
phase (Fig. l 0). 
As a result of the second insult (LPS administration), hD02 decreased 
significantly to 12% of baseline during the first hour after LPS and remained as low as 
56% of baseline at 4 hours after LPS administration (Fig. 10). h V02 showed a similar 
pattern, whereas a significant decrease of21% to 65% ofbaseline values was calculated 
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during the first 4 hours after LPS (Fig. I 0). After a transient increase in both oxygen 
delivery and consumption rates at 6 hours after LPS, a recovery to baseline range was 
reached at 36 hours (18 hours after LPS). 
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Figure 10. Hepatic oxygen delivery (hD02) and hepatic oxygen consumption (h V02) after 40% TBSA 
third-degree burn (0 hour) and endotoxin(£. coli LPS, 18 hours after burn). P <0.05. * vs. baseline,# vs. 
sham. 
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Discussion 
Bum injuries have been documented to have a negative impact on hepatic 
perfusion. The influence of severe thermal injury on hepatic blood flow was investigated 
in a 50% TBSA bum rat model, by using the tricarbocyanine dye indocyanine green 
(JCG) 9. Hepatic blood flow was decreased significantly by 0.5 hour after burn and 
remained approximately 20% below normal for 24 hours. The intrinsic efficiency of the 
liver in removing the JCG dye from the systemic circulation was also reduced. 
ln an ovine model, the effect of 40% TBSA third-degree burn on effective liver 
blood flow was determined, by using the galactose infusion technique l 0. The effective 
liver blood flow was decreased by 50% in the first 5 hours after burn, even when the 
animals were resuscitated to baseline cardiac output values. 
In our model, Qh showed a transient but significant decrease (48% of baseline) 
shortly after burn, which was associated with a 4.6-fold increase in HA VR. The 
measuring of a moderate increase in CO, at the same time period, suggests a selective 
vasoconstrictive impact of thermal trauma on the hepatic arterial circulation. 
The second insult (LPS) yielded a dramatic and prolonged increase in HA VR (!6-
fold vs. baseline), which was associated with a significant reduction of Qh during the first 
4 hours after endotoxin (12%-67% of baseline). After recovery to baseline, a reperfusion 
episode followed with an elevation ofQh to 152% ofbaseline values at 8 hours after 
endotoxin. 
The impact of endotoxin on Qh, as observed in this study, is more pronounced 
compared with the results of a previous study 11. The effect of endotoxemia on the 
hepatic circulation was evaluated in chronically instrumented and sedated sheep 
receiving a continuous intravenous infusion of E. coli endotoxin 11. The response of the 
hepatic artery was biphasic and consisted of a transient vasoconstriction followed by a 
transitory increase of Qh, reaching a maximmn of 921% of baseline values after 
approximately 2 hours. The noticed dissimilarity might be due to the fact that different 
species and administration schemes were used. However, it is more likely that the 
primiog impact of the early burn injury was responsible for the amplification of Qh 
response to endotoxin. 
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Under physiological conditions, the regulation ofQh tends to buffer the impact of 
Qp changes on total hepatic blood flow in order to maintain the latter constant. The 
function ofQp as the major intrinsic regulator ofhepatic arterial tone is !mown as the 
hepatic arterial buffer response 12. This buffer function seems to depend on portal blood 
flow washing away local concentrations of adenosine from the area of arterial resistance 
13. Thus, a reduction in portal blood flow causes an increase in local adenosine levels, 
resulting in arterial dilation 13. Since Qp is determined by the vascular resistance of the 
intestine and, to a lesser exten4 the spleen and pancreas, a decrease in the mesenteric 
blood flow would result in a compensatory increase in hepatic blood flow to maintain 
liver function. 
In contrast with this scenario, in our model ofpostbum endotoxernia, the response 
of Qh was unrelated to changes in portal circulation. An early postbum transient hepatic 
vasoconstriction was found to occur before changes in portal circulation (I hour vs. 2 
hours after burn), demonstrating the relative independence of hepatic arterial response in 
relation with other splanchnic blood flow. This ischemic insult may explain the 
occurrence of transient hepatic function disorders, commonly seen early after burn, and 
may also adversely influence the phagocytic capacities of hepatic macrophages. It is also 
possible that this hepatic ischemic insult may prime hepatic macrophages, leading to 
release of certain vasomediators, such as thromboxanes, which have been implicated in 
the pathophysiologic mechanism ofpostburn mesenteric vasoconstriction 14. Despite the 
marked reduction in Qp during the first 8 hours after endotoxin, Qh showed a significant 
decrease for a period of 4 hours, indicating a loss of the hepatic arterial buffer response. 
The magnitude of the hepatic response after the second insult may demonstrate the 
priming effect of the first insult. In an intact porcine model of endotoxernia, A yuse et a!. 
have observed a similar alteration in the hepatic arterial buffer response 15. It has been 
suggested that certain mediators, gut-derived or generated by presinusoidal Kupffer cells, 
are implicated in the pathophysiologic process of the impaired hepatic arterial buffer 
response II. Another possible mediator could be nitric oxide (NO), because it has been 
reported to be involved in the pathophysiology ofliver injury during 
ischemia/reperfusion and endotoxernia 16-18.It has been suggested that endogenous NO 
formation is sufficient to limit ischemic liver injury during reperfusion and that inhibition 
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ofNO synthesis will result in additional ischemic damage 16_ NO has been reported to 
modulate hepatic arterial but not portal venous resistances under baseline conditions, 
induce hepatic arterial vasodilation, and attenuate the increase in portal resistance during 
endotoxic shock 17_ Another experimental stndy has demonstrated that inhibition of 
eNOS (L-NAME) has a detrimental effect on liver injury during ischemia!reperfusion 
and endotoxemia, mainly because it can cause additional ischemia by reducing the 
microvascular blood flow 18_ 
The marked portal hypertension, seen in the postbum endotoxemic period, may 
account for the occurrence of bacterial translocation and contribute to the previously 
reported phenomenon of endotoxin-induced bacterial translocation 20_ Acute portal 
hypertension has been previously shown to promote bacterial translocation 21_ The 
underlying mechanisms are probably the disruption of the intestinal mucosal barrier 
caused by acute venous congestion, increasing splanchnic blood pooling, edema, and 
ischemia 15,22_ Portal hypertension initiated by endotoxin has also been shown to induce 
hepatic microcirculatory distnrbance, which may cause liver injury 23. 
It is well known that oxygen delivery and utilization is deranged in the setting of 
sepsis. Patients with septic shock require higher levels of002 to maintain aerobic 
metabolism. When 002 is inadequate, peripheral tissues switch to anaerobic metabolism 
and V02 decreases 24_ The most likely cause is an inability of the microvasculatnre to 
provide sufficient oxygen to actively metabolic tissue, probably as a result of diminished 
autoregulatory control and capillary damage 25. 
In our stndy, 002 and V02 showed a similar pattern of increasing, as seen in CO 
following thermal injury. On the contrary, hD02 was significantly reduced during this 
early postbum phase. At the same time, h V02 did not show any significant changes, as 
evidence of an increased oxygen extraction capacity of hepatic cells. It is well known that 
the liver can extract nearly 100% of the available oxygen 26_ This process seems to be 
the primary compensatory adjustment after a reduced h002• 
The impact of this second insult on the hepatic oxygenation was dramatic. A 
pathologic flow-dependent h VO, response was observed, with a pronounced and 
prolonged hypoxic period. The first 4 hours after LPS administration to burned animals 
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were marked with a significant decrease in bD02• Hepatic oxygen consumption showed a 
pathologic bD02 dependency, leading to an oxygen debt that limits metabolism. This 
early decreased h V02 indicates the inability of the liver to compensate inadeqnate oxygen 
delivery by increasing oxygen extraction, resulting in tissue hypoxia. These results could 
be explained by a defect in microvascular regulation of blood flow that interfered with 
the optimal distribution of a limited 002 in accordance with tissue oxygen needs 27. The 
development of flow-dependent liver hypoxia was shown before in a septic shock pig 
model and was reflected in a decrease in liver lactate turnover (increased liver lactate 
release) during late sepsis 28. Early hypoxia in the splanchnic region is suggested as a 
plausible mechanism behind the development of secondary organ failure, especially in 
sepsis 28. Recently, NO has been shown to be involved in hepatic oxygen transport and 
consumption during endotoxemia 19,29. The role ofNO in hepatic oxygen transport is 
unclear. In a porcine model of endotoxemia, NO was found to ameliorate deterioration of 
hepatic oxygen transport and liver function induced by endotoxin 29.Jn another study, 
selective inhibition of iN OS activity was found to restore Qh and increase h V02 in pigs 
with endotoxemia 19. 
In conclusion, thermal injury appears to induce a selective vasoconstrictive effect 
on the hepatic arterial circulation, yielding hepatic ischemia and a reduction of hepatic 
oxygen delivery. The magnitude of the hepatic response to a second insult ( endotoxemia) 
is magnified and manifested as a pronounced hepatic ischemia and reperfusion episode, 
associated with an inadequate hepatic oxygen delivery and a pathologic supply-
dependent hepatic oxygen consumption. A loss of the hepatic arterial buffer response, as 
indicated by a profound decline in both portal venous and hepatic arterial blood flow, 
seems to be one of the mechanisms responsible for this phenomenon. In addition, 
postburn endotoxemia seems to induce severe portal hypertension, which may contribute 
to gnt barrier dysfunction following thermal injuries. 
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Hepatic Ischemia & Reperfosion: Role of Angiotensin II 
Abstract 
Hypothesis: We hypothesized that angiotensin II, a potent vasoconstrictor, is involved in the 
occurrence of hepatic ischemia after bum and sepsis, and that administration of angiotensin II 
aotagonist DuP753 would ameliorate this process. 
Design: Randomized animal study. 
Materials: Female pigs (n=l8, weighing 20-25 kg). 
Interventions: All animals were prepared with ultrasonic flow probes on the portal vein and 
the common hepatic artery. Catheters were inserted in the superior mesenteric and left hepatic 
veins. After 5 days, all animals were anesthetized and 12 of them received 40% total body 
surface area third-degree bum. Escherichia coli lipopolysaccharide (LPS) was intravenously 
administered at 100 fig/kg 18 hours postbum. DuP753 was administered intravenously at I 
fig/kg to 6 pigs innnediately after the bum. All animals were studied for 42 hours. 
Main Outcome Measures: Systemic and hepatic hemodynamics were measured and blood 
samples were drawn for determinations of arterial, mixed venous, and portal blood gases at 
baseline and 14 consecutive time points, starting I hour after the bum. 
Results: Bum caused a 4.6-fold increase in hepatic arterial vascular resistance (HA VR) and a 
49% decrease in hepatic arterial blood flow (HABF). Postbum administration of angiotensin 
II receptor blocker DuP753 yielded a significant improvement in the hepatic arterial 
hemodynamics (only 12% increase in HA VR and 8% decrease in HABF, P<0.05 vs. 
nontreated group, analysis of variance [ANOVA]). Post-LPS, HABF was significantly 
reduced (12% of baseline, P<0.05, ANOVA), in contrast with DuP753-treated animals (64% 
of baseline, P<0.05 vs. nontreated group, ANOV A). Postbum blocking of angiotensin ll 
receptors yielded a significaot improvement in post-LPS portal venous blood flow (PVBF, 
85% of baseline vs. 48% of baseline in nontreated animals, P<0.05, ANOV A). Postbum 
endotoxemia resulted in a significant decrease of hepatic oxygen delivery (hDO,, 22% of 
baseline) and hepatic oxygen consmnption (hVO,, 30% of baseline), while no marked 
changes were observed in the DuP753-treated group (P<0.05 vs. nontreated group, 
ANOVA). 
Conclusions: Angiotensin II seems to play a pivotal role in bmn- and sepsis-induced 
hepatic ischemia and reperfusion injury. Blocking angiotensin II receptors by DuP753 
seems to abrogate this adverse impact of thermal injuries and sepsis on hepatic perfusion 
and oxygenation. 
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Introduction 
Although sepsis and multiple organ dysfunction syndrome (MODS) are 
responsible for 50% to 80% of all surgical intensive care unit deaths, available treatment 
regimens are mainly supportive and the underlying mechanisms of these syndromes 
remain to be defined.! ,2 
It has been postulated that the amplified reaction of the primed inflammatory 
response system of bum patients to a subsequent insult, initiated by bacteria and their by-
products ( endotoxins), is responsible for the typical pathophysiological alterations seen in 
post-injury sepsis.2 
As the liver seems to have a gate function for endogenous bacteria and their endotoxins, 
it can be argued that impairment of this hepatic clearance function may potentiate 
systemic effects of gut barrier failure by allowing indigenous bacteria or endotoxin to 
reach the systemic circulation, where they potentiate systemic inflammatory responses. 3 
The results of our previous stndies in a porcine modeJ4 indicated that thermal 
injury has a selective vasoconstrictive effect on the hepatic arterial circulation, yielding 
hepatic ischemia and a reduction of hepatic oxygen delivery. Furthermore, a second insult 
( endotoxemia) was shown to cause a pronounced hepatic ischemia and reperfusion injury, 
associated with an inadequate hepatic oxygen delivery {hD02) and a pathologic supply-
dependent hepatic oxygen consumption (h V02).4,5 In this stndy an attempt was made to 
investigate the role of angiotensin II as a possible mediator involved in this process. 
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Materials and Methods 
The following experimental protocols were approved by the Animal Care 
and Use Committee of the University of Texas Medical Branch., Galveston 
(ACUC #90-09-1 03). 
Eighteen female mini-pigs, weigbing between 20 and 25 kg, were prepared 
surgically 5 days before the experiment. After an overnight fast, the pigs were 
anesthetized with intramuscular ketamine (1 0 mg/kg) and mechanically ventilated with 
2% to 2.5% halothane after endotracheal intubation. A subcostal incision was performed. 
Transit time ultrasonic flow probes ( 4-10 mm, Transonic Systems Inc., Ithaca, NY) were 
placed on the common hepatic artery and the portal vein. Catheters (6.5F) were 
positioned in the superior mesenteric vein and the left hepatic vein. A Witzel jejunostomy 
was also performed using a 12F Foley catheter. The abdomen was closed in layers. 
After surgery, the animals were kept in recovery slings for 24 hours, then placed 
in runs for 5 days with free access to food and water. On the day of the experiment, the 
animals were reanesthetized and, through a neck incision, an arterial catheter was placed 
via the right common carotid artery into the abdominal aorta. A Swan-Ganz thermal 
dilution catheter (Model93 A-131-5F, American Edwards Laboratories, Anasco, PR) 
was positioned in the pulmonary artery via the right jugular vein. A 12F Foley catheter 
was inserted in the urinary bladder. 
The animals were kept in slings for monitoring. Throughout the study, all animals 
received enteral feeding (Osmolite) at 25 mLihr and nothing orally. Baseline data were 
collected after complete recovery from anesthesia. 
The Pigs were randomized into the following 3 groups: 
1) The bum/lipopolysaccharide (LPS) group (n=6) had a 40% total body surface 
area (TBSA) third-degree flame bum under general anesthesia, as described before. I 0 
The pigs were resuscitated according to the Parkland formula and received lactated 
Ringer's solution, 4 mL/kgl% TBSA burn, starting immediately after the burn, half of 
which was given in the first 8 hours after the hum and the remainder in the following 16 
hours. Eighteen hours after the bum, 100 11g/kg E. coli LPS (Olll:B4; Difco, Detroit, 
MI) was intravenously administered. During the second day of the experiment, burned 
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animals received lactated Ringer's solution at 3,5 mL/m2 burned area and 2 mL/kglbr for 
daily maintenance. 
2) The sham group (n=6) had a sham bum under anesthesia. Eighteen hours later 
the animals received the diluent (0.9% NaCI) used for the endotoxin. Lactated Ringer's 
solution was administered at 2 mL/kglbr for daily maintenance. 
3) The treatment group (n=6) underwent the same procedure as the bum/LPS 
group, except for the administration of angiotensin II inhibitor DuP753 (DuPont Merck, 
Wilmington, DE) intravenously at I )lg/kg, immediately after burn. 
Mean arterial (MAP), central venous (CVP) and portal venous (PVP) pressures 
were measured using transducers (P231D, Statham Gould, Oxnard, CA) that were 
connected to an Electronic Medicine Honeywell Recorder (Honeywell Inc., 
Pleasantville, NY) for electronic calculation of mean pressures. Cardiac output (CO) was 
determined by the thermal dilution technique using a Swan-Ganz catheter and a cardiac 
output computer (Model 9520, American Edwards Laboratories, Irvine, CA). 
Hepatic arterial blood flow (HABF) and hepatic portal venous blood flow 
(PVBF) were measured with transit time ultrasonic flow probes, connected to an 
ultrasonic meter (T!Ol, Transonic Systems Inc., Ithaca, NY). 
Systemic and hepatic hemodynamics were measured aod blood samples were 
drawn for determinations of arterial, mixed venous, and hepatic blood gases at baseline 
aod 14 consecutive time points, starting I hour after the bum. 
Systemic vascular resistance index (SVRJ), hepatic arterial vascular resistance 
(HA VR), aod hepatic portal vascular resistance (HPVR) were calculated with the 
following formulas: 
SVRI (Dyne·second·cm·'·m'J=[(MAP- CVP) x 80]/Cl 
HA VR (Dyne·second·cm·')=[(MAP - CVP) x 80]/Qh 
HPVR (Dyne·second·cm·')=[(PVP- CVP) x 80]/Qp 
Systemic 0 2 delivery (DO,), systemic 0 2 consumption (V02), hepatic 0 2 delivery 
(hD02) and hepatic 0 2 consumption (h V02) were calculated with the following formulas: 
D02=Cl x Ca02 x 10 (mL/min/m2) 
VO,=Cl x (Ca02 - Cv02) x 10 (mL/min/m2) 
hD02 =HABF x Ca02 /100 (mL/min) 
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h VO, ~HABF x (CaO,- ChO,) I 100 (mL/min) 
Where CI~ cardiac index (L/minlm')=CO/BSA; CaO, (arterial oxygen content, mL/dL)= 
(Hb x 1.34) SaO, [arterial oxygen saturation] + (PaO, x 0.0031 ); CvO, (mixed venous 
oxygen content, mL/dL )= (Hb x 1.34) SvO, [mixed venous oxygen saturation] + (PvO, x 
0.0031); and ChO, (hepatic oxygen content, mL/dL)= (Hb x 1.34) ShO,[hepatic blood 
oxygen saturation]+ (PhO,x 0.0031). 
At the end of the 42 hours, the animals were anesthetized with 10 mg/kg 
intravenous ketamine and killed with 5 mL intravenous saturated KCI. 
The data are presented as mean ± SEM. Within-group analysis was performed by 
the analysis of variance (ANOVA) for repeated measurements with the Dunne! post hoc 
tesL Between-groups analysis was performed by ANOV A for factorial analysis with the 
bonferroni post hoc tesL P <0.05 was considered statistically significanL 
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Results 
Systemic Hemody1llll1lics 
Baseline hemodynamic measurements were similar in all groups. All animals 
survived the study period. Throughout the experiment, sham animals maintained their 
systemic (Fig. I and Fig. 2) and hepatic (Fig. 3 and Fig. 4) hemodynamics within 
baseline range. 
After thermal injury, CO showed a slight increase during the first 6 hours, 
returning to baseline 8 hours after the burn (Fig. 1 ). This increase was associated with a 
concomitant fall in the systemic vascular resistance, whereas the systemic vascular 
resistance index (SVR1) decreased to 78% of baseline level (Fig.!). No significant 
differences were noticed in MAP and CVP between the 3 groups (Fig. 2). 
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Figure 1. Systemic hemodynamics 1: cardiac output (CO) and systemic vascular resistance index (SVRI) 
after40% TBSA third-degree bum (0 hour) and endotoxin(£. Coli LPS, 18 hours after bum). Angiotensin 
IT inhibitor DuP753 was administered intravenously immediately after bum. P <0.05, * vs. baseline., # vs. 
sham,¥ vs. treattnent group (DuP753). 
Following administration ofLPS, a typical biphasic response was observed. The 
hemodynamic alteration was more pronounced during the second phase, as after a marked 
drop of CO to 77% ofbaseline a hyperdynamic period began to be manifest 8 hours after 
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endotoxin administration (Fig. I). At this time point, SVRI dropped to 69% of baseline. 
MAP showed a 14% decrease immediately after LPS infusion in both burn/LPS groups 
(Fig. 2). During the further post-LPS course, no significant differences were noticed 
between groups in MAP and CVP. DuP753 treatment ameliorated to a certain extent the 
alteration in systemic circulation, occurring after burn and LPS administration (Fig. l and 
Fig. 2) 
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Figure 2. Systemic hemodynamics 2: mean arterial pressure (MAP) and central venous pressure (CVP). P 
<0.05. • vs. baseline.# vs. sham,¥ vs. treaonent group (DuP753). 
Hepatic Hemodvnamics 
Hepatic Arterial Circulation 
HABF decreased significantly to approximately half of baseline level during the 
first 4 hours after the burn (Fig. 3). This fall in HABF was associated with a 4.6-fold 
increase in HA VR, as early as I hour after the burn (Fig. 4). 
Compared with burned animals not receiving the angiotensin !I antagonist, DuP753-
treated animals showed a slight increase ofHA VR (12% ofbaseline value) following 
thermal insult (Fig. 4). Animals in the DuP753 treatment group maintained, in contrast to 
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nontreated burned animals, a stable HABF near baseline with an average fall of 8% of 
baseline (Fig. 3). 
Hepatic arterial hemodynamic measurements recovered completely in all animals to 
baseline values at 18 hours after the burn. 
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F'.agure 3 Burn caused a 49% decrease in hepatic arterial blood flow (HABF). Post-LPS HABF was 
significantly reduced (12% ofbaseline). Postburn administration of angiotensin II receptor blocker 
DuP753 yielded a significant improvement in the hepatic arterial hemodynamics (P<0.05 vs. nontreatcd 
group. ANOVA). P <0.05. * vs. baseline.# vs. sham,¥ vs. treatment group (DuP753). 
Administration ofLPS to burned animals resulted in a biphasic response of 
hepatic ischemia and reperfusion. The second insult resulted in a significant hepatic 
arterial vasoconstriction with a 16-fold increase of HA VR during the first hour after LPS 
administration. 
Correspondingly, HABF decreased significantly to 12% of baseline during the same time 
of maximum increase ofHA VR (Fig. 3 and Fig. 4). After an initial recovery ofHABF to 
baseline values, 6 hours after LPS administration, a marked elevation (120 -152% of 
baseline) was noticed during the following 6 hours. 
Burned animals treated with DuP753 showed a transient drop in HABF to 64% of 
baseline during the first 30 minutes after the second insult (LPS). DuP753 treatment 
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attenuated significantly the hepatic arterial vasoconstriction caused by the administration 
ofLPS to burned animals, as HA VR only increased to 178% of baseline. The post-LPS 
vasoconstrictive period was very short (30 min.), where after both HA VR and HABF 
measurements were within baseline range (Fig. 3 and Fig. 4 ). 
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Figure 4. Burn and LPS yielded a significant increase ( 4.6- and 16-fold, respectively) in hepatic arterial 
vascular resistance (HA VR). DuP753 treatment ameliorated these effects. P <0.05, * vs. baseline,# vs. 
sham. ¥ vs. treatment group (DuP753). 
Hepatic Portal Circulation 
After an initial decrease (86.5% of baseline) in PVBF during the first hour after 
the bum, PVBF began to increase, reaching 135% of baseline at 4 hours after the bum 
(Fig. 5). The increased PVBF was associated with a moderate decrease in HPVR (65-83 
%of baseline) during the same period (Fig. 6). PVP showed a 40% increase I hour after 
the bum and declined thereafter to 120% of baseline at 4 hours after the bum (Fig. 7). In 
contrast, animals treated with DuP753 did not show any marked increase in their 
postburn PVBF (Fig. 5). HPVR in the treatment group decreased to 63% of baseline 
during the first 4 hours after the bum (Fig. 6). A 20% decrease in PVP was observed in 
DuP753-treated animals during the early postbum phase (Fig 7). 
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Similar to the hepatic hemodynamic arterial variables, portal hemodynamic 
measurements showed the same pattern of recovery to baseline values at 18 hours after 
the burn in all animals (Figs. 5-7). 
The second insult yielded significant alterations in the portal circulation, lasting 
for a prolonged period. HPVR showed a 2- to 4-fold increase during the first 8 hours 
following LPS administration (Fig. 6). During this early septic phase, a significant portal 
hypertension was noticed, whereas measured PVP was elevated to approximately 225% 
of baseline (Fig. 7). PVBF showed a biphasic response after LPS administration. During 
the first 8 hours after LPS administration, PVBF decreased to approximately 51% of 
baseline (Fig. 5). After a transit recovery to baseline, a hyperdynamic phase with an 
elevation ofPVBF to 147% of baseline began at 30 hours (12 hours after LPS 
administration) and remained till the end of the study period (Fig. 5). During this late 
septic period, HPVR was decreased to 63% of baseline and PVP was slightly increased to 
121% of baseline (Fig. 6 and Fig. 7). DuP753 treatment significantly attenuated the 
impact of the second insult (LPS) on portal hemodynamics in burned animals. In contrast 
with nontreated animals, HPVR in the treated group showed a transient increase of 14% 
at 2 hours after LPS administration, followed by a gradual decrease, reaching 41% of 
baseline 18 hours after LPS administration (Fig. 6). DuP753 treatment ameliorated the 
LPS-induced portal ischemia and reperfusion insult in burned animals, as PVBF showed 
after a moderate decrease of 15% at 2 hours after LPS administration, a steady increase 
with an average of20% during the rest of the study period (Fig. 5). Portal hypertension 
did not occur after LPS administration to burned animals treated with DuP753. PVP 
remained within baseline range and a slight increase of 18% was noticed during the first 
4 hours after LPS administration (Fig. 7). 
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portal venous blood flow (PVBF. 85% of baseline vs. 48% ofbaseline in nontreated animals, P<0.05, 
ANOVA ). P <0.05. * vs. baseline.# vs. sham.¥ vs. treatment group (DuP753). 
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Figure 6. Hepatic portal vascular resistance (HPVR) in the 3 experimental groups. P <0.05, * vs. baseline, 
# vs. sham.¥ vs. treatment group (DuP753). 
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Figure 7. Portal venous pressure (PVP) was significantly elevated after burn and endotoxin. but not in the 
treatment group. P <0.05. * vs. baseline, # vs. sham., ¥ vs. treatment group (DuP753). 
Svstemic Oxvgen Delivery and Consumption 
After an initial reduction, D02 and V02 showed a marked increase during the first 
4 hours after the burn (Fig. 8). 
Administration of LPS yielded a significant drop in DO, during the first hour. 
V02 was unchanged at this time point. Animals treated with DuP753 remained at baseline 
after LPS administration (Fig. 8). During the post-LPS hyperdynamic phase, both DO, 
and V02 were increased. 
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Figure 8. Effects ofbu.rn,. endotoxin and postburn administration of angiotensin II inhibitor DuP753 on 
systemic oxygen delivery (D02) and oxygen consumption (VO:i). P <0.05, * vs. baseline, # vs. sham, ¥ vs. 
treatment group (DuP753). 
Heoatic Oxvgen Delivery and Consumption 
During the first 2 hours after the bum, bD02 showed a significant drop to 53% of 
baseline, while hVO, decreased to 15% ofbaseline levels (Fig. 9).1n contrast, DuP753-
treated animals did not show any marked alterations in hD02 and h V02 after thermal 
injury (Fig. 9). 
The second insnlt (LPS) yielded a dramatic reduction in hD02 to a level of 22% 
of baseline during the first hour after LPS administration and remained as low as 52% of 
baseline at 4 hours after LPS administration (Fig. 9). Postburn treatment with DuP753 
prevented this impact ofLPS, as bD02 showed a transient 16% increase at I hour after 
LPS adroinistration and then remained at baseline. h V02 showed a similar pattern, 
whereas a significant decrease of30% to 63% ofbaseline was calcnlated during the first 
4 hours after LPS administration, followed by a 50% increase at 8 hours after LPS 
administration (Fig. 9). Animals receiving DuP753 did not show any significant changes 
in their h VO, after LPS administration (Fig. 9). 
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Figure 9. Hepatic oxygen delivery (hDOz) and hepatic oxygen consumption (hVOz) showed a significant 
drop after bum and endotoxin. DuP753 treatment significantly attenuated the impact of both insults. P 
<0.05. * vs. baseline.# vs. sham.¥ vs. treatment group (DuP753). 
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Comment 
The renin-angiotensin axis seems to play an important role in the pathophysiology 
of thermal injury. Hilton et al7 have reported a linear increase in plasma angiotensin II 
levels from 15 minutes to 6 hours after bum. Angiotensin II is a potent vasoconstrictor 
that exhibits important splanchnic selectivity, which is thought to be caused by an 
increased affinity of the angiotensin II receptors on the splanchnic vascular smooth 
muscle.8 
Our current data confirm our previous study reporting the alteration of hepatic 
hemodynamics secondary to thermal injury. 4 Despite indicators of adequate resuscitation 
(i.e. minor changes in CO, MAP, and CVP), a significant reduction in HABF was 
observed in this study during the early phase after thermal injury. Thus, alteration in 
systemic hemodynamics could not be solely accounted for the postbum hepatic arterial 
vasoconstrictive phase that was noticed. The finding that no noticeable changes were 
seen in either HABF or HA VR after thermal injury in the group treated with angiotensin 
II receptor blocker DuP753, implicates angiotensin II in the process of postbum hepatic 
ischemia. The significant improvement of postburn HABF following DuP753 treatment, 
despite no marked DuP753 systemic effects, suggests a selective action on splanchnic 
vasculature. 
The response of the hepatic arterial blood flow to the initial thermal trauma was 
unrelated to changes in portal circulation. The early postburn transient hepatic 
vasoconstriction occurred simultaneously with a decrease in the portal circulation, 
indicating an early loss of the hepatic arterial buffer response. Under physiological 
conditions, the regulation ofHABF tends to buffer the impact ofPVBF changes on total 
hepatic blood flow in order to maintain the latter constant. The function ofPVBF as the 
major intrinsic regulator of hepatic arterial tone is known as the hepatic arterial buffer 
response.9 This buffer function seems to depend on portal blood flow washing away local 
concentrations of adenosine from the area of the arterial resistance site .I 0 The selective 
improvement in hepatic arterial circulation in the treatment group suggests that 
angiotensin II is one of the mediators responsible for the postburn hepatic ischemia. 
The second insult (LPS) resulted in a siguificant hepatic arterial vasoconstriction, 
with a 16-fold increase in HA VR, which was associated with a significant reduction of 
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HABF during the first 4 hours after endotoxin (12% of baseline). During this early septic 
phase, HPVR showed a 4-fold increase with a subsequent 50% decrease in PVBF. 
Postburn administration of angiotensin II inhibitor DuP753 was found to ameliorate the 
impact of the second septic insult on both hepatic arterial and portal venous circulations. 
The noticed decrease in both arterial and portal hepatic blood flow after LPS 
administration cannot be the result of alterations in the systemic circulation, as post-
endotoxin CO and SVRJ did not show any significant changes at these time points. The 
drop in PVBF could be explained as the result of the post-injury sepsis-induced selective 
mesenteric ischemia, previously documented in the same model. 6 The previously 
documented positive action of angiotensin II receptor blocking on mesenteric blood 
flow6 could account for the observed improvement in post-LPS portal circulation after 
DuP753 treatment. However, the independent hepatic arterial vasoconstriction seen after 
the second insult, together with the finding that treatment with angiotensin II receptor 
blocker DuP7 53 ameliorated this process, indicates that angiotensin II is one of the 
mediators responsible for the adverse impact ofpostbwn sepsis on hepatic arterial 
circulation. The adverse action of angiotensin II on postbum and sepsis hepatic arterial 
circulation seems to exhibit an important splanchnic selectivity as a result of an increased 
affinity to angiotensin II receptors on splanchnic vascular smooth muscle.ll In humans, 
inhibition of angiotensin has been documented to decrease splanchnic vascular resistance 
under normotensive conditions.l2 
LPS-induced reduction in hepatic blood flow could be argued to be not primarily caused 
by a direct action of angiotensin II, but secondary to the generation or inhibition of 
another mediator. Nitric oxide (NO) has recently been implicated in the pathophysiology 
ofliver injury during ischemia!reperfusion and endotoxemia.l3-16rn vitro study 
demonstrated that angiotensin II can decrease LPS-stimulated NO production, which is 
considered to be an endogenous nitrovasodilator, 17 by inhibiting induction of the 
inducible form of NO synthase expression. 18m another in vitro study, the effect ofLPS 
on the angiotensin II receptor was found to be dose-, time- and protein synthesis-
dependent and associated with an increased expression of the receptor gene 6)9 The 
ability of LPS to increase angiotensin II binding in cultured vascular smooth muscle cell 
was independent of the endotoxin induction ofNO synthase. These results suggest that 
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endotoxin may enhance the expression of cell surface receptors, which seems to be 
caused by nonspecific LPS-related induction of genes. 
Another beneficial effect of angiotensin ll receptor blocking treatment was the 
prevention of the sepsis-induced portal hypertension. Postburn endotoxemia-induced 
portal hypertension may account for the previously reported phenomenon of endotoxin-
induced bacterial translocation. 20 Acute portal hypertension has been previously shown 
to promote bacterial translocation.21 The underlying mechanisms are probably the 
disruption of the intestinal mucosal barrier {caused by acute venous congestion), 
increasing splanchnic blood pooling, edema, and ischemia.22,23 Portal hypertension, 
initiated by endotoxin, has also been shown to induce hepatic microcirculatory 
disturbance, which may cause liver injury.24 Thus, postburn administration ofDuP753 
may decrease the incidence of hepatic injuries and bacterial translocation in the septic 
phase. 
Early hypoxia in the splanchnic region is suggested as a plausible mechanism 
behind the development of secondary organ failure, especially in sepsis.25 In this current 
study, hD02 was significantly reduced during this early posthurn phase. DuP753 
treatment significantly improved hD02 after thermal injury. 
The second insult yielded a significant fall in hD02rate. A pathologic flow-
dependent hD02 response was observed with a pronounced and prolonged hypoxic 
period. The development of flow-dependent liver hypoxia was shown before in a septic 
shock pig model and was reflected in a decrease in liver lactate turnover {increased liver 
lactate release) during late sepsis.25 hV02 showed a pathologic hD02 dependency, 
leading to oxygen debt that limits metabolism. This early decreased h V02 indicates the 
inability of the liver to compensate inadequate oxygen delivery by increasing oxygen 
extraction, resulting in tissue hypoxia. These results could be explained by a defect in 
microvascular regulation of blood flow that interfered with the optimal distribution of a 
limited D02 in accordance with tissue oxygen needs. 26 Interaction with other mediators, 
such as NO, is also a possible pathway. Recently, NO has been shown to be involved in 
hepatic oxygen transport and consumption during endotoxemia.l6,27 Our data 
demonstrate that these negative effects of LPS on hepatic oxygenation can be prevented 
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by DuP753 treatment. Following LPS challenge, burned animals in the treatment group 
showed a significant improvement in their mesenteric oxygenation status compared with 
nontreated animals. The action ofDuP753 seems to be selective. The enhancement in 
oxygen supply to meet the increased oxygen demand was only noticed in the hepatic 
circnlation and no significant differences were found between treated and untreated 
aniroals, with respect to D02 and V02• 
Conclusions 
The resnlts of this stody clearly show that angiotensin II plays a pivotal role in the 
process of hepatic ischemia and reperfusion injury induced by thermal trauma and 
endotoxemia Postbum treatment with DuP753, a specific angiotensin II receptor 
antagonist, seems to ameliorate these adverse effects of bum and endotoxin on hepatic 
perfusion and oxygenation by enhancing hepatic blood flow and oxygen supply. 
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Abstract 
Objective: to examine the hypothesis that postburn treatment with the vasodilator 
prostacyclin would be beneficial for hepatic perfusion and oxygenation in a 
burn/endotoxemia chronic porcine model. 
Summary Background Data: Burn and sepsis are associated with hepatic ischemia and 
reperfusion injury. Prostacyclin, the production of which has been reported to decrease 
after bum, seems to play a pivotal role in maintaining splanchnic perfusion. 
Methods: Female pigs (n~18, 20-25 kg) underwent laparotomy during which ultrasonic 
flow probes were placed on the portal vein and the common hepatic artery. Catheters 
were inserted in the superior meseoteric and left hepatic veins. After 5 days, all animals 
were anesthetized and 12 of them received 40% total body surface area third-degree burn. 
100 )lg/kgEscherichia coli lipopolysaccharide (LPS) was intravenously administered 18 
hours postburn. Burned animals were randomized to receive a constant infusion of 
iloprost (20 nglkglmin) or an equivalent amouot of carrier solution (normal saline). All 
animals were studied for 42 hours. 
Results: Burn caused a 2.5-fold increase in hepatic arterial vascular resistance (HA VR) 
and a 39% decrease in hepatic arterial blood flow (flAB F). Postburn administration of 
iloprost did not improve the hepatic arterial hemodynamics (1.8-fold increase in HA VR 
and 38% decrease in HABF). Post-LPS, HABF was significantly reduced to 22% of 
baseline and HA VR was 15-fold increased (P<0.05 vs. baseline, ANOVA). lo contrast, 
iloprost-treated animals did not show hepatic arterial vasoconstriction, as both HABF and 
HA VR remained baseline values during the endotoxic phase, (P<0.05 vs. nontreated 
group, ANOV A). Postbum iloprost treatment yielded a significant improvement in post-
LPS portal venous blood flow (PVBF, 79% ofbaseline vs. 45% of baseline in nontreated 
animals, P<0.05, ANOV A). Portal venous pressure (PVP) showed 16% and 56% 
increases after burn and endotoxin, respectively. Portal hypertension did not occur in 
iloprost-treated animals, as PVP remained within baseline range (P<0.05 vs. nontreated 
group, ANOV A). Burn and endotoxemia resulted in a significant decrease of hepatic 
oxygen delivery (hD02, 63% and 12% of baseline, respectively) and hepatic oxygen 
consumption (b VOz, 61% and 21% of baseline, respectively). Only during the postburn 
endotoxic phase, iloprost improved hD02 and hVOz (140% and 79%, respectively. 
P<0.05 vs. nontreated group, ANOV A). 
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Conclusions: Postburn prostacyclio treatment appears to have no beneficial effects on 
hepatic perfusion early postburn. However, during the late postburn endotoxic phase 
prostacyclio seems to significantly improve hepatic total blood flow and oxygenation. 
In addition, prostacyclin treatment attenuated bum- and endotoxio- ioduced portal 
hypertension. 
164 
Hepatic Blood Flow and Oxygen Consumption: Effects of Prostacy/in 
Introduction 
The prognosis of extensively burned patients is dependent upon the presence of 
sepsis and/or multiple organ failure. The splanchnic organs are considered to be one of 
the key components in the pathogenesis of such complications l, 2. Disturbances in organ 
blood flow are suggested to play a pivotal role in the development of progressive organ 
dysfunction 3. While restoration of optimal perfusion is essential in reducing both initial 
ischemia-induced injury and subsequent progressive metabolic and structural 
derangement, further cell deterioration might occur following reperfusion 4. 
The data of our previous studies in a porcine model showed that thermal injury 
has a selective vasoconstrictive effect on the hepatic arterial circulation. Moreover, a 
subsequent insult ( endotoxemia) was found to induce a significant hepatic ischemia and 
reperfusion injury, associated with an inadequate hepatic oxygen delivery and a 
pathologic supply-dependent hepatic oxygen consumption 5, 6. 
Endogenous prostacyclin is known to be a local mediator of microcirculatory 
tissue perfusion and metabolism and is of major importance in maintaining splanchnic 
perfusion after different endogenous vasoconstrictive stimuli, both in animals and in 
humans 7, s.ln both septic animals 9 and patients after mesenteric traction during major 
abdominal surgery I 0, the endogenous release of prostacyclin proved to play a crucial 
role in maintaining splanchnic perfusion. 
In this study we examined the hypothesis that the stable prostacyclin analogne 
iloprost may beneficially influence the hepatic hemodynamics and thereby improve tissue 
perfusion and oxygenation in a burn/endotoxin porcine model. 
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Materials and Methods 
The following experimental protocols were approved by the Animal Care 
and Use Committee of the University of Texas Medical Braoch (ACUC # 90-09-
103). 
Eighteen female mini-pigs, weighing between 20 and 25 kg, were prepared 
surgically 5 days before the experiment. After an overnight fast, the pigs were 
anesthetized with intramuscular ketarnine (1 0 mglkg) and mechanically ventilated with 
2% to 2.5% halothane after endotracheal intubation. A subcostal incision was performed. 
T raosit time ultrasonic flow probes ( 4-10 mm, Transonic Systems Inc., Ithaca, NY) were 
placed on the common hepatic artery and the portal vein. 6.5 F catheters were positioned 
in the superior mesenteric vein and the left hepatic vein. A Witzel jejunostomy was also 
performed using a 12 F Foley catheter. The abdomen was closed in layers. 
After surgery, the animals were kept in recovery slings for 24 hours, then placed 
in runs for 5 days with free access to food and water. On the day of the experiment, the 
animals were reanesthetized and through a neck incision an arterial catheter was placed 
via the right common carotid artery into the abdominal aorta. A Swan-Ganz thermal 
dilution catheter (Model93 A-131-5F, American Edwards Laboratories, Anasco, PR) 
was positioned in the puhnonary artery via the right jugular vein. A 12 F Foley catheter 
was inserted in the urinary bladder. 
The animals were kept in slings for monitoring. Throughout the stndy, all animals 
received enteral feeding (Osmolite) at 25 mL/hr and nothing per os. Baseline data were 
collected after complete recovery from anesthesia. 
The pigs were randomized into 3 groups: 
1) The burnllipopolysaccharide (LPS) group (n=6) had a 40% total body surface 
area (TBSA) third-degree flame burn under general anesthesia, as described before 11. 
The pigs were resuscitated according to the Parkland formula and received laCtated 
Ringer's solution, 4 mL!kgi%TBSA burn, starting immediately after the burn, half of 
which was given in the first 8 hours postburn and the remainder in the following 16 
hours. Eighteen hours after burn, 100 !-lg/kg E. coli LPS (0111 :B4; Difco, Detroit, M1) 
was intravenously administered. During the second day of the experiment, the burned 
animals received lactated Ringer's solution at 3,5 mL/m2 burned area and 2 mL/kglhr for 
daily maintenance. 
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2) The sham group (n~6) had a sham burn under anesthesia. Eighteen hours later 
the animals received the diluent (0.9% NaCl) used for the endotoxin. Lactated Ringer's 
solution was administered at 2 mL/kglhr for daily maintenance. 
3) The treatment group (n~) underwent the same procedure as the burn/LPS 
group, except for the administration of prostacylin analogne iloprost (llomedin, Schering, 
AG, Germany) intravenously at 20 nglkg/min, immediately after burn. 
Mean arterial (MAP), central venous (CVP) and portal venous (PVP) pressures 
were measured using transducers (P231D, Statham Gould, Oxnard, CA) that were 
connected to an Electronic Medicine Honeywell Recorder (Honeywell Inc., 
Plaeasantville, NY) for electronic calculation of mean pressures. Cardiac output (CO) 
was determined by the thermal dilution technique, using a Swan-Ganz catheter and a 
cardiac output computer (Model 9520, American Edwards Laboratories, Irvine, CA). 
Hepatic arterial blood flow (HABF) and hepatic portal venous blood flow 
(PVBF) were measured with transit time ultrasonic flow probes, connected to a T!Ol 
ultrasonic meter (Transonic Systems Inc., Ithaca, NY). 
Systemic and hepatic hemodynamics were measured and blood samples were 
drawn for determinations of arterial, mixed venous, and hepatic blood gases at baseline 
and 14 consecutive time points, starting 1 hour after burn. 
Systemic vascular resistance index (SVRI), hepatic arterial vascular resistance 
(HA VR), and hepatic portal vascular resistance (HPVR) were calculated with the 
following formulas: 
SVR! (dyne·sec·cm·'·m'}o[(MAP- CVP) x 80]/ Cl 
HA VR (dyne·sec·cm·'F[(MAP- CVP) x 80]/ Qh 
HPVR (dyne·sec·cm·'F[(PVP- CVP) x 80]/ Qp 
Systemic oxygen delivery (D02), systemic oxygen consumption (V02), hepatic 
oxygen delivery (hDO,) and hepatic oxygen consumption (h VO,) were calculated with 
the following formulas: 
DO,~CI x Ca02 x I 0 (mL/min/m2) 
VO,~Cl x (Ca02 - CvO,) x 10 (mL/min/m') 
hD02 ~HABF x Ca02 /IOO (mL/min) 
hV02 ~HABF x (Ca02 - ChO,) /100 (mL/min) 
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Where Cl= cardiac index (L/min/m2)=CO/BSA, Ca02 (arterial oxygen content, mL/dL)= 
(Hb x 1.34) Sa02 + (Pa02 x 0.0031), Cv02 (mixed venous oxygen content, mL/dL)= (Hb 
x 1.34) Sv02 + (Pv02 x 0.0031), and Ch02 (hepatic oxygen content, mL/dL)= (Hb x 1.34) 
ShO,+ (PhO,x 0.0031). 
At the end of the 42 hours, the animals were anesthetized with 10 mg!kg 
intravenous ketantine and killed with 5 mL intravenous saturated KCL 
The data are presented as mean ± SEM. Within-group analysis was performed by 
the analysis of variance (ANOVA) for repeated measurements with the Dunne! post hoc 
test. Between-groups analysis was performed by ANOV A for factorial analysis with the 
bonferroni post hoc test. P values of <0.05 were considered statistically significant. 
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Results 
Svstemic Hemodvnamics: 
Baseline hemodynamic measurements were similar in all groups. All animals 
survived the study period. Throughout the experiment, sham animals maintained their 
systemic (Figs. I and 2) and hepatic (Figs. 3 and 5) hemodynamics within baseline range. 
Thermal injury reduced CO to 72% of baseline level during the first hour (Fig. 1). 
By the second hour postburn, a hyperdynamic phase began with an increase in CO to 
139% of baseline. This increase was associated with a concomitant fall in the systemic 
vascular resistance, whereas SVRI decreased to 81% of baseline (Fig. 1). There were no 
significant differences in MAP and CVP between the 3 groups (Fig. 2). 
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Fig 1. Systemic hemodynamics 1: cardiac output (CO) and systemic vascular resistance index (SVRI) after 
40% TBSA third-degree burn (0 hour) and endotoxin(£. coli LPS, 18 hours postburn). Prostacyclin (PGI::) 
analogue iloprost was administered intravenously immediately after burn. P <0.05, * vs. baseline, # vs. 
sham, ¥ vs. treatment group (PGI2). 
Following administration ofLPS, a typical biphasic response was observed. After 
a marked drop of CO to 64% of baseline level, a hyperdynamic period began to be 
manifest 8 hours post-endotoxin (Fig. 1). At this time point, SVRI dropped to 76% of 
baseline. MAP showed a 27% decrease immediately after LPS infusion in both bum!LPS 
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groups (Fig. 2). During the further post-LPS course, no significant differences were 
noticed between groups in MAP and CVP.Iloprost treatment attenuated to a certain 
extent the alteration in systemic circulation occurring after burn and LPS administration 
(Figs. 1 and 2). 
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Fig 2. Systemic hemodynamics 2: mean arterial pressure (MAP) and central venous pressure (CVP). P 
<0.05, * vs. baseline, # vs. sham. ¥ vs. treatment group (PGI2). 
Hepatic Hemodvnomics: 
Hepatic arterial circulation: 
During the first 4 hours postburn, HABF was significantly reduced to 
approximately 61% of baseline level (Fig. 3). This fall in HABF was associated with a 
2.5-fold increase in HA VR as early as 1 hour postburo (Fig. 4). 
Iloprost-treated animals showed a 1.8-fold increase in HA VR following thermal insult 
(Fig. 4). HABF showed a significant reduction of approximately 38% of baseline level in 
iloprost-treated animals. The alteration in hepatic arterial hemodynamic parameters lasted 
for the whole postburn phase in the iloprost-treated group. Hepatic arterial hemodynamic 
measurements recovered completely in all nontreated animals to baseline values at 18 
hours postburn. 
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Administration of LPS to burned animals resulted in a biphasic response of 
hepatic ischemia and reperfusion. The second insult resulted in a significant hepatic 
arterial vasoconstriction with a 15-fold increase ofHA VR during the first hour post-LPS. 
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Fig 3. Hepatic arterial blood flow (HABF) was significantly decreased in both burn!LPS and iloprost 
groups. Postburn administration of iloprost yielded a significant improvement in HABF following 
endotoxin (P<O.OS vs. nontreated group. ANOVA). P <0.05, * vs. baseline.# vs. sham,¥ vs. treatment 
group (PGI2). 
Correspondingly, HABF decreased significantly to 22% of baseline during the same time 
of maximum increase ofHA VR (Figs. 3 and 4). After an initial recovery ofHABF to 
baseline values 6 hours post-LPS, a marked elevation (148% ofbaseline) was noticed 
during the following 6 hours. 
Burned animals treated with iloprost maintained baseline level during the next 24 hours 
after the second insult (LPS). lloprost treatment attenuated significantly the hepatic 
arterial vasoconstriction caused by the administration ofLPS to burned animals, as 
HA VR did not increase but remained within baseline range to the end of the study (Figs. 
3 and4). 
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Fig 4. Bum and LPS yielded a significant increase (2.5- and IS-fold, respectively) in hepatic arterial 
vascular resistance (HA VR). lloprost treatment ameliorated these effects only during the late postbum 
endotoxic phase. P <0.05, * vs. baseline, # vs. sham.¥ vs. treatment group (PGI2). 
Hepatic portal circulation: 
During the first 4 hours postbwn, PVBF showed an increase, reaching 130% of 
baseline at 2 hours postbum (Fig. 5). The increased PVBF was associated with a 
moderate decrease in HPVR (68% of baseline) during the same time period (Fig. 6). 
PVP showed a 16% increase I hour postbum and declined thereafter to baseline level 
during the next 4 hours postbum (Fig. 7). In contrast, animals treated with iloprost 
showed a moderate decrease in their postburn PVBF of approximately 20% of baseline 
values (Fig. 5). HPVR in the treatment group increased to 161% of baseline values during 
the first 4 hours postburn (Fig. 6). PVP did not show any changes in iloprost- treated 
animals during the early postburn phase (Fig 7). 
Portal hemodynamic measurements showed a recovery to baseline values at !8 hours 
postburn in all animals (Figs. 5, 6 and 7). 
The second insult yielded significant alterations in the portal circulation, lasting 
for a prolonged time period. HPVR showed a 3.6-fold increase during the first 8 hours 
following LPS administration (Fig. 6). During this early septic phase, a significant portal 
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hypertension was noticed, whereas measured PVP was elevated to approximately !56% 
of baseline values (Fig. 7). 
0 , 2 4 3 16 
Fig 5. Bum and endotoxin resulted in significant alterations in portal venous blood flow (PVBF). lloprost-
treated animals showed steady PVBF values within baseline. P <0.05. * vs. baseline. # vs. sham. ¥ vs. 
treatment group (PGI2). 
-
Fig 6. Postbum endotoxemia yielded a significant increase (3.6-fold) in hepatic portal vascular resistance 
(HPVR). lloprost treatment ameliorated this effect. P <0.05. * vs. baseline,# vs. sham,¥ vs. treatment 
group (PGI2). 
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PVBF showed a biphasic response after LPS admioistration. During the first 8 hours 
post-LPS, PVBF decreased to approximately 45% of baseline (Fig. 5). 
After a transit recovery to baseline, a hyperdyoamic phase with an elevation ofPVBF to 
141% of baseline began at 30 hours (12 hours post-LPS) and remained till the end of the 
study period (Fig. 5). During this late septic period, HPVR was decreased to 61% of 
baseline and PVP was stable at baseline level (Figs. 6 and 7). lloprost treatment 
significantly attenuated the impact of the second insnlt (LPS) on portal hemodyoamics in 
burned animals. In contrast to nontreated animals, HPVR in the treated group showed for 
a short period of2 hours an increase of 1.8-fold, followed by a steady period of22 hours 
at baseline level (Fig. 6). lloprost treatment ameliorated the LPS-induced portal ischemia 
and reperfusion insult in burned animals, as PVBF showed after a moderate decrease of 
21% at 2 hours post-LPS, a steady increase within baseline range during the rest of the 
study period (Fig. 5). Portal hypertension did not occur after LPS administration to 
burned animals treated with iloprost. PVP remained within baseline range (Fig. 7). 
0124816 
Fig 7. Portal venous pressure (PVP) was significantly elevated after bum and endotoxin. but not in the 
treatment group. P <0.05, * vs. baseline.# vs. sham,¥ vs. treatment group (PGii). 
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Svstemic Oxygen Delivery and Consumption: 
After an initial reduction during the first 2 hours postburn, DO, and V02 showed a 
marked increase during the following 6 hours postbum (Fig. 8). Both DO, and V02 were 
elevated in the iloprost treatment group during the first 8 hours postburn. 
The second insult (LPS) yielded a significant drop in DO, during the first 2 hours. 
V02 remained unchanged at this time point. During the post-LPS hyperdynamic phase, 
both DO, and V02 were increased. Animals treated with iloprost remained baseline levels 
post-LPS (Fig. 8). 
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Fig 8. Effects ofbwn., endotoxin, and postburn administration ofiloprost on systemic oxygen delivery 
CD02) and systemic oxygen consumption (V02). P <0.05, * vs. baseline, # vs. sham. ¥ vs. treatment group 
(PG!,). 
Hevatic Oxvgen Delivery and Consumption: 
During the first 4 hours postburn, hD02 and h VO, showed a significant drop to 
approximately 63% of baseline (Fig. 9).1loprost treatment did not have any beneficial 
effects on hDO, and h V02 after thermal injury. As a matter of fact, both hD02 and h V02 
were reduced to approximately 61% during the entire postburn period (Fig. 9). 
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Administration ofLPS resulted in a significant reduction in bD02 to a level of 
12% ofbaseline during the first 2 hours post-LPS and remained as low as 56% of 
baseline at 4 hours post-LPS (Fig. 9). Postburn treatment with iloprost prevented this 
impact of LPS, as bD02 increased 40% above the postburn level for 2 hours and then 
remained within baseline range. h V02 showed a similar pattern, whereas a significant 
decrease of21% of baseline values was calculated during the first 2 hours post-LPS, 
followed by a 67% increase at 8 hours post-LPS. Animals receiving iloprost remained 
baseline levels post-LPS (Fig. 9). 
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Fig 9. Hepatic oxygen delivery (hDOz) and hepatic oxygen consumption (hVOz) showed a significant 
drop after burn and endotoxin. Iloprost treatment significantly attenuated the impact of only the second 
insult (LPS). P <0.05. * vs. baseline, # vs. sham, ¥ vs. treatment group (PGI2). 
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Discussion 
There is compelling experimental evidence that the amplified reaction of the 
primed inflammatory response system of burn patients to a subsequent insult, initiated by 
bacteria and their by-products ( endotoxins), is responsible for the typical 
pathophysiological alterations seen in post-injnry sepsis 12_ As the liver appears to have a 
gate function for endogenous bacteria and their endotoxins, it appears that impairment of 
this hepatic clearance function may potentiate systemic effects of gut barrier failure by 
allowing indigenous bacteria or endotoxin to reach the systemic circulation, where they 
potentiate systemic inflammatory responses 3. 
Thermal injnry appears to induce a selective vasoconstrictive effect on the hepatic 
arterial circulation, yielding hepatic ischemia and a reduction of hepatic oxygen delivery. 
The magnitude of the hepatic response to a second insult (endotoxemia) is magnified and 
manifested as a pronounced hepatic ischemia and reperfusion episode~ associated with an 
inadequate hepatic oxygen delivery and a pathologic supply-dependent hepatic oxygen 
consumption 5~ 6. 
A variety of autoregulatory mechanisms are involved in maintaining adequate 
splanchnic perfusion during periods oflow flow 13. The systemic inflammatory response 
to severe injuries and/or sepsis encompasses several cellular interactions~ leading to the 
generation of diverse proinflammatory cytokines and vasoactive peptides. The vasoactive 
metabolite of arachidonic acid, prostacyclin (PGI,), appears to play a pivotal role in the 
process of mesenteric ischemia following burn or sepsis. In a 25% TBSA burn model 
splanchnic vasodilator eicosanoid (PG!,) release was decreased by 50% postburn. Loss of 
this endogenous splanchnic vasodilator may contribute to ischemia of the splanchnic 
vascular bed at this critical time period following acute burn injnry 14_ We therefore 
tested whether prostacyclin treatment can improve hepatic perfusion after burn. 
Despite its well-known vasodilating effects, iloprost did not have any significant 
impact on systemic hemodynamic parameters during the postburn phase. This 
observation is in agreement with previous studies~ showing that the dose that was used in 
this study has no circulatory effects 15. Unexpectedly, no improvement was noticed in 
postburn hepatic perfusion in the iloprost treatment group. While the postburn ischemic 
phase was manifested for only 4 hours in the untreated animals, HABF was reduced 
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during the whole postburn period in the treated gtoup. The finding that postburn 
prostacyclin treatruent resulted in a 1.8-fold increase in HA VR shows that prostacyclin 
did not exert any vasodilating action at all on the hepatic arterial circulation. A possible 
explanation for this surprising finding is that the dose which we applied in our study was 
not sufficient enough to overcome the vasoconstrictive impact of thermal trauma on the 
hepatic arterial circulation. However~ similar schemes of administration and dose of 
iloprost have been used in previous studies. In those studies iloprost was found to 
effectively improve splanchnic circulation 15-17. On the other hand, in comparison with 
the design of our study, the previous experiments were different in three aspects. Iloprost 
was given in those studies as a pretreatment to examine its effect on intestinal perfusion 
in sepsis. As iloprost pretreatruent was also found to increase liver blood flow in a 
hyperdynamic model of sepsis 18, 19, one should conclude that iloprost can apparently 
enhance hepatic perfusion after certain insults such as endotoxemia, providing that the 
administration of which starts before the insult. For obvious reasons we have chosen in 
our study to investigate the efficiency of iloprost as a postburn treatruent. Little is known 
about the possible effects of exogenous prostacyclin in the early postburn phase. One 
study has reported that administration of a prostacyclin analogue did not improve 
survival after infection in burned mice 20. The mechanism by which splanchnic blood 
flow is reduced after thermal injuries involves altered release of arachidonic acid 
metabolites, resulting in a ratio of vasodilator prostacyclin (PG!z) and vasoconstrictor 
thromboxane A2, favoring the latter 21. Therefore, it could be argued for that 
administration of exogenous PGI2 according to our study protocol, failed in restoring the 
equilibrium between these vasomediators. Therefore, further studies investigating dose-
related effects ofPG!2 analogues and the impact of administration of exogenous PG]z on 
the feedback mechanisms in relation to endogenous prostacyclins and other mediators, 
such as tbromboxanes, are warranted in order to elucidate our results and possible 
therapeutic potentials of exogenous prostacyclin during the early phase postburn. 
Another important finding in our study was the observation of the positive impact 
of the administration ofPGiz on hepatic perfusion during the late postburn phase, e.g. 
after the second insult (LPS). The second insult (LPS) yielded a significant elevation in 
HA VR (15-fold vs. baseline), which was associated with a critical reduction ofHABF to 
178 
Hepatic Blood Flow and Oxygen Consumption: Effects of Prostacylin 
22% of baseline during the first 4 hours after endotoxin. After recovery to baseline, a 
reperfusion episode followed with an elevation ofHABF to 148% ofbaseline lasting for 
a period of 6 hours. On the contrary, HABF and HA VR remained their baseline valnes 
during the whole post-LPS phase (24 hours) in burned animals receiving PGI2 infusion. 
This beneficial effect ofPG!2 administration as documented in our study is completely in 
agreement with previous studies investigating the effect of PG}z in sepsis. Several 
experimental studies have reported that PG!z can increase splanchnic blood flow in septic 
animals 7. In animal studies, exogenous administration of PG!2 and analogues has been 
shown to exert beneficial effects on the redistribution of blood flow to the 
hepatosplancbnic area 16. Raper eta! found that PGI, increased liver blood flow in a 
hyperdynamic model of sepsis 18. More importantly, Trager eta! observed in a 
hyperdynamic endotoxic pig model that iloprost not only increased liver blood flow but 
also attenuated the endotoxin-induced metabolic alterations as reflected by a blunted 
decrease in liver lactate consumption and increase in hepatic venous lactate/pyruvate 
ratio 19. However, in contrast with our study, in all these previous studies the effect of 
PGh administration was solely studied in hyperdynamic endotoxic models. To date, no 
studies have been conducted to investigate the possible actions ofprostacylin treatroent 
on hepatic perfusion during the period of septic complications following thermal injuries. 
The findings of our study clearly show that postburn prostacylin treatroent is beneficial in 
marinating adequate hepatic perfusion during the late postburn endotoxic phase. The 
explanation of the paradoxical effects of iloprost during the endotoxic postburn phase in 
comparison with the early postburn period might be that different pathways or 
interactions with other mediators are involved in these different processes. Another 
explanation might be that the effect of prostacyclin on HABF is dose-related under 
different pathological events such as burn and sepsis. More studies on this area are 
certainly needed in order to clarify the ftmdaments of these conflicting data. 
Both burn and endotoxin had a striking impact on hepatic oxygenation. A 
pathologic flow-dependent hV02 response was observed, with a pronounced and 
prolonged hypoxic period. The first 4 hours postburn were marked by a significant 
decrease in hD02 and hV02• Administration ofLPS to burned animals led to a significant 
reduction in both hD02 and h V02 (12% and 21% of baseline, respectively). This early 
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decreased h V02 indicates the inability of the liver to compensate inadequate oxygen 
delivery by increasing oxygen extraction., resulting in tissue hypoxia. The development of 
flow-dependent liver hypoxia was shown before in a septic shock pig model and was 
reflected in a decrease in liver lactate twnover (increased liver lactate release) during late 
sepsis 22. In agreement with previous data. administration of prostacyclin in our 
bum/sepsis model was associated with enhanced hepatic oxygen delivery and 
consumption. In a porcine model of septic shock, iloprost tended to attenuate the 
reduction in liver oxygen delivery 16. In a hyperdynamic endotoxic pig model, iloprost 
was found to significantly attenuate the endotoxin-induced derangements of cellular 
energy metabolism as reflected by the diminished progressive decrease in hepatic lactate 
uptake rate 19. In a porcine model of septic shock, iloprost tended to attenuate the 
reduction in liver oxygen delivery 16. The experience with prostacyclin in patients with 
sepsis is more limited. Lehmann et a!. observed that prostacyclin increased the rate of 
disappearance of indocyanine green, a factor influenced by both liver blood flow and 
function, indicating improvement in liver function 23. Recently, in patients with septic 
shock iloprost was reported to increase splanchnic blood flow and shift oxygen utilization 
from the energy requiring de novo glucose production rate to other oxygen-demanding 
metabolic pathways 24. However, this beneficial effect of iloprost on hepatic 
oxygenation was only noticed during the late endotoxic postbum phase. In parallel to the 
effect ofprostacyclin on HABF, iloprost failed to improve hepatic oxygenation during 
the early postbum phase. The consistent effect of prostacyclin on DO, and V02 after both 
bum and endotoxin in comparison with its differential impact on hD02 and hV02 may 
argue for its selective range of action. 
Interestingly was the observation that administration of prostacyclin in this study 
not only altered HABF but also PVBF. The response of the HABF to burn was unrelated 
to changes in portal circulation. An early postbum hepatic arterial vasoconstriction was 
found to occur prior to changes in portal circulation (I hour vs. 2 hours postbum), 
demonstrating the relative independence of hepatic arterial response in relation with other 
splanchnic blood flow. Postbum treatment with iloprost was found to ameliorate to a 
certain extent the impact of bum on PVBF. The function ofPVBF as the major intrinsic 
regulator of hepatic arterial tone is known as the hepatic arterial buffer response 25. This 
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buffer function appears to depend on portal blood flow washing away local 
concentrations of adenosine from the area of arterial resistance. The similar biphasic 
pattern ofPVBF and HABF after the second insult (LPS) clearly indicates a loss of the 
hepatic arterial buffer response, as noticed in previous studies 6, 26. Despite the marked 
reduction in PVBF during the first 8 hours after endotoxin, HABF showed a significant 
decrease for a period of 6 hours. On the contrary, PVBF in iloprost-treated animals 
remained steady within baseline values during the whole period after endotoxin. This 
observation together with the finding that iloprost had exert the same effects on HABF 
during the same period demonstrates that iloprost was able to increase the total hepatic 
blood flow during the late postbum endotoxic phase. The exact pathways by which 
prostacyclin interferes with the different components of the hepatic circulation, and any 
possible interaction with other local mediators, remain to be delineated. 
The marked portal hypertension seen in the postbum endotoxemic period may 
account for the occurrence of bacterial translocation and contribute to the previously 
reported phenomenon of endotoxin-induced bacterial translocation 27. Portal 
hypertension initiated by endotoxin has also been shown to induce hepatic 
microcirculatory disturbance, which may cause liver injmy 28. Administration of 
prostacyclin to burned animals resulted in reducing PVP and subsequently attenuating 
portal hypertension during the late postburn endotoxemia. This specific effect of 
prostacyclin could be of clinical importance, as postbum administration of prostacyclin 
may reduce the incidence of hepatic injuries and bacterial translocation in the septic 
phase. 
In conclusion, postbum treatment with prostacyclin appears to have specific, but 
phase-dependent, effects on hepatic perfusion and oxygenation. The results presented in 
this study suggest that prostacyclin as applied in our model does not have any beneficial 
effects in preventing hepatic ischemia and reperfusion injmy in the early postbum phase. 
Quite the opposite, postbum prostacyclin treatment was found to significantly enhance 
hepatic blood flow and oxygen supply during the late postburn septic phase. In addition, 
postburn prostacyclin administration seems to attenuate burn- and endotoxin-induced 
portal hypertension. Because of the possible clinical significance of these data, further 
studies in this area are warranted. 
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Abstract 
Regional inflammation is normally a process that encompasses various host reactions in response 
to regional stimuli or in contribution to a systemic response, primarily with a host protective 
function. However, certain stimuli, such as ischemia, tissue necrosis or uncontrolled infection 
can alter the balance between the stimulatory and inhibitory mechanisms underlying this process, 
leading to a hyperactive status that is called the regional inflammatory response syndrome 
"RIRS". The defective regional cell immune response subsequent to severe injuries, together 
with the compensatory overgeneration of different immunomodulatory factors, have a 
detrimental impact on the host susceptibility to infections and cellular repair capacity. The 
consequent further progression of this response frequently leads to the point of the initiation of 
its systemic equivalent, the so-called systemic inflammatory response syndrome "SIRS". 
Therefore, it is proposed that an early and adequate regulation ofRIRS would be beneficial not 
only regionally but also systemically. 
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Introduction 
Our current understanding of sepsis and multiple organ dysfunction syndrome (MODS) needs to 
be revised, as the uniformly negative results of new therapies for these disorders suggest. 
Previous theories for the pathogenesis of these conditions are incomplete, as the surrogate 
models that have been used to study these disorders are not analogous to the clinical situation 
and patients who have less severe manifestations of these diseases are often overlooked I_ 
Most of the conducted experimental and clinical studies are focused on the systemic 
inflammatory response in the development of time-dependent outcomes that may contribute to 
sepsis and multiple organ failure (MOF) 2, 3. Although a considerable effort has been taken in 
an attempt to define the pathways and mechanisms by which a local injury or an infectious focus 
eventually transforms into SIRS, there is to date no conceivable mapping of this process. 
Localized inflammation is a physiological protective response, which is generally tightly 
controlled by the body at the site of injury. Loss of this local control or an overly activated 
response is thought to be the initiator of an exaggerated systemic response that is clinically 
identified as systemic inflammatory response syndrome (SIRS) 4. Spillover of pro inflammatory 
mediators from the site of injury into the systemic circulation is by now one of the most accepted 
theories describing the pathogenesis of SIRS 5, 6. Several studies have investigated these 
mediators with the result that a considerable number of the puzzle's pieces have been uncovered 
7. However, most of these studies were addressing the local injury as the first step in the cascade 
towards SIRS or as the precursor of the elements needed to fire up the systemic inflammatory 
response, all with less appreciation of the role of regional inflammatory response, a fundamental 
entity in this process. 
Therefore, the aim of this paper is to introduce a new concept regarding the post-injury 
inflammation sequel and to present RIRS as an identifiable stage between local injury and SIRS 
(Fig.!). ln this paper an atterupt is made to introduce a conceptual framework for the 
pathogenesis of MODS, in which local inflammatory response evolves to RlRS and eventually 
SIRS, which hopefully will contribute to better understanding of the inflammatory response and 
its sequelae and better approach to effective therapy. 
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Fig. 1: Conceptual model ofRIRS as an exclusive stage in the development of MODS. 
RIRS =regional inflammatory response syndrome., SIRS= systemic inflammatory response syndrome. MODS= 
multiple organ dysfunction syndrome. 
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Concept of staged inflammation 
SIRS is seen in three separate scenarios at present: (I) invasive infection; (2) dissemination of 
microbes secondary to failure of host defense mechanisms; and (3) severe activation of 
inflammation by injury, shock, severe soft tissue inflammatioll, and other noninfectious but 
proinflannnatory events 6. Obviously, the first two scenarios are more comprehensible and 
presumably less complicated to manage than the third one. The global hypothesis is that a local 
injury through various pathways triggers the host inflannnatory response, leading to a state of 
systemic hyperinflammation (i.e. SIRS). Mild to moderate SIRS is most likely beneficial (equal 
to the normal injury stress response), but severe SIRS can precipitate early MODS, whereas the 
intensity of SIRS is dependent upon the amount of tissue injury 8. Thus, in this conceptual 
construction the relation between the primary local focus and the resultant systemic response is 
defined in a causal one-step model. Alternatively, a less severe traumatic insult can create an 
inflannnatory enviromnent (i.e. primes the host) such that a later, otherwise innocuous, 
secondary inflannnatory insult precipitates severe SIRS. In this conceptual model, known as the 
two-hit theory, the interaction between the local and systemic inflammatory response is outlined 
in a more dynamic two-steps model 9. 
Marshall has recently postulated a three-stage development of SIRS, in which stage one is a local 
production of cytokines in response to an injury or infection. Stage tv.ro is the protective release 
of a small amount of cytokines into the body's circulation. Stage three is the massive systemic 
reaction where cytokines tum destructive by compromising the integrity of the capillary walls 
and flooding end organs IO.Jn this paper a four-phase concept (Fig. 2) ofhow local 
inflammation eventually becomes SIRS is proposed, in which phase one the local inflammatory 
response to a local stimulus, e.g. injury, infection or hypoxia, triggers an early systemic 
inflannnatory response. In the second phase, both local and systemic mediators initiate a late 
regional inflammatory response. As a result of an overstimulation of the regional inflammation 
through ongoing positive feedbacks or inadequate negative feedbacks, a state ofhyperactivation 
of the regional inflammatory response (RIRS) emerges during the third phase. Subsequently, 
through either insufficient regional host defense or spillover of regional mediators into the 
circulation and defective feedback pathways RIRS evolves to SIRS. 
The four phases of the host inflammatory response to a local stimulus, of which the first two 
stages are to be considered as the normal physiologic host defense and the following two as the 
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pathologic exaggerated host reaction, are further delineated. 
Fig2: Conceptual model of the spectrum from local inflammation through RIRS to SIRS. 
LIR = local inflammatory response.. SIR= systemic inflammatory response. RIR =regional inflammatory response. 
RIRS = regional inflammatory response syndrome. SIRS = systemic inflammatory response syndrome 
The first phase: local inflammation to systemic inflammation 
Although it is more conceivable that local inflammation is a process that is contained into the 
site of primary injury or infectious focus, this scenario is obviously valid in case of mild injuries 
or controlled infections. The host response to such injuries is usually appropriate in degree and is 
self-limited. In other situations, where severe injuries and/or infections are involved, the need of 
immediate systemic reinforcement becomes obvious. Under such circumstances~ in response to 
outside aggression, the organism tries to defend itself with two mechanisms: a nonspecific 
humoral and cellular response called inflammation, and a specific antigenic response that 
modifies the genetic codes of cells of the defense system and constitutes an immunologic 
response. Local release of potent inflammatory mediators ( cytokines, complement, arachidonic 
acid derivatives, reactive oxygen metabolites) primarily induces a repair process II. Through 
various messengers arriving from the local site of inflammation into the circulation a typical 
systemic stress response is initiated. These substances are mediated by a complex array of 
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neutrophil and macrophage products, afferent neural activity and vascular endothelial activation 
and are acting as triggers for a neuroendocrinologic, metabolic and immunologic host reaction 
12_ The resultant systemic inflammatory response in this phase acts primarily as a supportive 
mechanism enhancing the local host defense and secondarily as a protective agent, either 
protecting the host from systemic invasion or preparing the host for an eventual occurrence of 
such event. 
Tile second phase: local inflammation to regional inflammation 
There is evidence that the involvement of the regional immune system in the process of 
inflammatory response to a local injury or infection is a late event, occurring subsequent to its 
systemic equivalent. Clinically, severe local injuries or infections are associated with signs of 
activation of systemic inflammatory response that are normally present early in the course of the 
disease. During this period, no signs of regional inflammation are usually observed. For instance, 
an uncomplicated appendicitis or pneumonia is frequently associated with fever and 
leukocytosis, demonstrating the systemic reaction. However, early surgery on uncomplicated 
appendicitis or cholecystitis normally reveals only signs oflocal inflammation, but no signs 
indicating generalized inflammation of the abdominal region (i.e. peritoneum). Experimental 
stndies on the kinetics of macrophage recruitment to the peritoneum following the induction of 
acute inflammation bave shown an inflammatory influx of neutrophils from the circulation 
during the first 5 days after the onset of inflammation. Resident peritoneal macrophages were 
observed not until 7 days after inflammation 13. Thus, activation of the systemic inflammatory 
response seems to occur prior to the stimulation of the regional immune system. Both local and 
systemic inflammation seem to participate througb different pathways in the alarming of the 
regional inflammatory response, which in tnm acts as an enhancer of the local host defense and 
also as a natnral boundary for the initial insnlt, diminishing the systemic stress. The peritoneal 
response to intra-abdominal infection is an excellent illustrator of such regional response, as the 
peritoneum is known to execute this specific ftmction in 3 ways: direct absorption of bacteria 
into the lymphatic circulation, local destruction of bacteria througb phagocytosis by either 
resident macropbages or polymorphonuclear granulocytes attracted to the peritoneal cavity, and 
localization of the infection in the form of an abscess 14_ 
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The third phase: regional inflammatory response syndrome (RIRS) 
Under certain conditions, the regional host response may persist inappropriately, leading to a 
status ofhyperactivation of the regional inflammatory response. In general, after injwy if fluid 
resuscitation is adequate and necrotic tissue is debrided, a hypermetabolic state ensues, directed 
toward supporting repair of injured tissue. Inflammatory cells are recruited to the site of injwy 
and elaborate cytokines, which stimulate regional immune response and promote repair locally. 
However, if hypoxic or necrotic tissue and/or uncontrolled infection persist,. the ongoing 
activation of the regional inflammatory response 15, through local and systemic mediators and 
pathways, eventually results in a regional inflammatory response syndrome (RIRS). This 
syndrome is characterized by a pathologic status of a constantly unregulated regional 
inflammation. 
Research in recent years has examined the mechanisms underlying cellular host defence on 
regional leveL These studies have established that the resident cells, macrophages and 
mesothelial cells contribute to the initiation, amplification and resolution of regional 
inflammation 16-18. Once the inflammatory response is initiated, recent evidence suggests that 
mesothelial cells, upon activation by resident macrophages-derived IL-l~ and TNF-a, are 
capable of amplif'ying inflammation and generating signals (via the creation of a gradient of 
chemotactic cytokines, IL-8, MCP-1 and RANTES) for the recruitment ofleukocytes 19. This 
process is also facilitated via the cytokine-driven up-regulation of adhesion molecule expression 
(!CAM-I and VCAM- I) on the mesothelial cells 20_ Much less is understood about the 
mechanisms by which inflammation is resolved. The secretion of anti-inflammatory molecules 
(IL-6, !L-Ira and soluble TNF-p55/75) by receptors on resident cells, macrophages and 
mesothelial cells seems to play an important role in the process 19_ The regional inflammatory 
state appears also to regulate, through the production of regional substances, the production of 
eicosanoids in general, and leukotriene C4 (L TC4) and prostacyclin (PGJ,) in particular by the 
macrophage 21_ 
The persistence of local or systemic proinflammatory stimuli and/or defective negative feedback 
pathways may alter the balance between the regional pro- and anti-inflammatory mediators. 
Consequently, this chaos initiates sequelae of uncontrolled proinflammatory reaction, including 
microvascular coagulopathy, endothelial activation, increased permeability, transudation, and 
dysregulated apoptosis 22, all of which maintain the ongoing regional inflammation. An 
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unbalanced compensatory anti-inflammatory response can result in regional anergy and 
immunosuppression, resulting in dysfunction of regional organs, such as an ileus, which in turn 
sets the stage for progressive gut dysfunction with the result that the proximal gut becomes a 
reservoir for pathogens and toxins that contribute to late infections and amplify inflammatory 
response 23. Thus, the regional proinflammatory and anti-inflammatory forces may ultimately 
reinforce each other, creating a state of increasingly destructive immunologic dissonance 1. 
The fourth phase: regional (RIRS) to systemic inflammation (SIRS) 
As the regional inflammation continues in an uncontrolled fashion, more biochemical mediators 
of inflammation are released, with a subsequent spillover into the systemic circulation, triggering 
remote inflammation 7. The ongoing regional activation of various humoral (e.g. complement, 
coagulation) and cellular systems (neutrophils, endothelial cells, macrophages), and the 
subsequent excessive synthesis, expression and release of numerous mediators (toxic oxygen 
products, proteolytic enzymes, adherence molecules, cytokines) lead eventually directly, through 
spillover, or indirectly, through enhancing or suppressing certain systemic inflammatory 
pathways to a generalized inflammation 24. Thus, the regional inflammation becomes the 
precursor of its systemic equivalent. The transformation of acute pancreatitis from a local to 
regional and then into a systemic inflammation illustrates this phenomenon, as oxygen-derived 
free radicals, many cytokines (IL-l~. IL-6, !L-8), TNF-u, and platelet activating factor, released 
by peritoneal cells, have been reported to be principal mediators in this process 25. 
Moreover, failure of the regional clearance of the present bacterial load due to defective regional 
defense mechanisms or an aggressive infection may result in systemic invasion of bacteria and 
their toxic products, with a subsequent bacteremia and endotoxemia, which in turn potentiates 
the systemic inflammatory response 26. The accumulation of regional necrotic tissue, which 
might be either the cause or the resultant of the RIRS, may sustain a process of excessive 
presentation of antigens to the systemic immune system 27 through the migration of regional 
hyperactivated inflammatory macrophages into the lymphatic circulation 28, initiating an 
autodestructive inflammatory response 2. 
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Interactions between RIRS and SIRS 
Regional inflammation is a physiological protective response that is generally controlled by the 
body inside the involved region. Loss ofthis regional control or an excessively activated 
response (i.e. RIRS) may result in an exaggerated systemic response, which is clinically 
identified as systemic inflammatory response syndrome (SIRS) 4. Compensatory mechanisms 
are initiated in concert with regional and systemic responses and outcome (resolutio~ multiple 
organ dysfunction syndrome or death) is dependent on the balance ofRIRS and SIRS and such 
compensatory mechanisms. 
SIRS is paradoxically associated with an excessive inflammation 29, as shown by an exacerbated 
production of cytokines, and an acquired state of immunodeficiency 30, as assessed by a 
diminished ability of circulating leukocytes to produce cytokine upon in vitro activation. While 
cytokines are generally viewed as a destructive development in SIRS patients that generally 
leads to multiple organ dysfunction, cytokines also protect the body when localized 31. In a 
review of recent reports, Cavaillon 32 illustrated that the immune-depression reported in SIRS 
patients, often revealed by a dintinished capacity ofleukocytes to respond to lipopolysaccharide, 
is not a generalized phenomenon and that SIRS is associated with a compartmentalized 
responsiveness, which involves either anergic or primed cells. Also the responses of 
macrophages appear to vary from location to location and over time in the same organism in 
response to injury 33. Thus, it appears that once RIRS evolves to SIRS, a time- and most likely 
region-dependent hyper- or hypo-activated inflammatory response emerges into a dynamic 
network of inflammatory actions and reactions. 
Conclusion 
RIRS is an identifiable stage between tissue injury and the development of SIRS, associated with 
global inflammatory signs, but also with region specific symptoms. It arises in chaos of 
responses through the interactions of a network oflocal, regional and systemic inflammatory 
responses. The emerging clinical syndrome reflects the state of a regional hyperactivated 
inflammatory response to a local insult. As the four criteria that defme SIRS are nonspecific 
measures of physiologic severity, rather than distinctive manifestations of a disease process 10, 
and as SIRS and MODS appear to be considered as various stages of illness progressing to death, 
which cannot be treated specifically 34, it seems apparent that an early recognition of more 
195 
Chapter 10 
specific stages in these inflammatory cascades is of clinical importance. R!RS is not only a 
conceptual model, but also provides a clinical relevant description of an early specific event in 
the inflammatory process, which can be clinically distinguished during the course of an insult to 
SIRS and ultimately MODS. The understanding of the inflammatory fundamentals ofR!RS will 
most likely facilitate elucidating the more complex pathophysiology of critical illness. As the 
pathological scope ofR!RS seems to be narrower than SIRS and MODS, a target-oriented 
approach including early control of regional inflammation seems conceptually a more attractive 
therapeutic option,. either as a preventive measure for subjects at risk or as a potential adjuvant 
treatment for patients with MODS. 
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Introduction 
Multiple organ failure (MODS) is the cause of 50% to 80% of all deaths in surgical 
intensive care units 1. Although MODS was first described more than two decades ago, 
the cause of the condition is still poorly understood, the treatment is still largely 
supportive, and the mortality rate (30-70% in most series) is little improved 2. The 
clinical picture of MODS is indicative of generalized systemic inflanunatory response 
syndrome (SIRS), which typically occurs as a result of serious infection or severe trauma 
3. SIRS can proceed to MODS as organ systems fail. The response of the host to injury or 
infection is probably more important in the genesis of SIRS and MODS than the 
microbial agent or the initiating insult 4_ Thus, an appreciation of the host response in the 
pathogenesis of MODS is vital if physicians are to develop appropriate modalities for the 
prevention and treatment of this syndrome. 
Two-hit theory of MODS 
In many patients, MODS is ascribed to the summation of several insults rather than one 
event 5. Each of these insults may be clinically insignificant but may prime the host 
immune system so that the inflammatory response to subsequent secondary events 
becomes exaggerated, culminating in SIRS and MODS 4. This "two-hit" theory may 
explain how trauma can convert a nonlethal infectious or hypoxic challenge into a lethal 
insult (chapter I). In an attempt to mimic the clinical situation, which is commonly 
complicated by sepsis and endotoxin release, we utilized in the experimental studies of 
this thesis a combined bum and endotoxin porcine model. The second insult 
"endotoxemia" clearly amplified the host response and consequently resulted in 
augmenting the adverse impact of the initial insult "trauma". 
Splanchnic ischemia and reperfusion injury 
A consistent temporal association between shock and the later development ofMODS 
indicates that shock is an important etiologic factor in the pathogenesis ofMODS 6. 
Adequate resuscitation and oxygenation as global measures in restoring and maintaining 
optimal organ perfusion are considered to be life saving procedures in the early phase of 
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managing severely injured patients. However, clinical studies using aggressive volume 
resuscitation and supranormal oxygen delivery strategies have failed to show a reduction 
in the incidence of MODS or a survival benefit in patients developing SIRS and MODS 
7. 4_ Laboratory observations have shown that shock induces disproportionate splanchnic 
hypoperfusion 8. In the clinical setting, several investigatory groups have demonstrated 
that gut hypoperfusion, despite maximal resuscitative efforts, is predictive for MODS and 
death 9. 10. Thus, splanchnic ischemia has been implicated as an important inciting event 
in the pathogenesis of MODS. In our animal studies (chapters 4 and 6), severe trauma 
(40% TBSA third-degree bum) resulted in a significant decrease (approximately 58%) in 
mesenteric blood flow. This occurred despite a resuscitation format that resulted in 
normalization of cardiac output and systemic oxygen delivery. The importance of these 
findings is that maintenance of systemic hemodynamic parameters does not necessarily 
result in normal mesenteric blood flow. The second insult (endotoxemia) had a more 
pronounced and prolonged impact on mesenteric circulation and oxygenation, 
demonstrating the priming effect of the initial injury. 
The splanchnic ischemic period following trauma and in sepsis, as documented in our 
porcine model (chapters 4 and 6), was consistently followed by a mesenteric reperfusion 
phase. Reperfusion intestinal tissue damage appears to be due to the formation of oxygen 
radicals and the activation of phospholipase Az. The initial source of oxygen radicals 
seems to be the hypoxanthine-xanthine oxidase system. Oxygen radicals react directly 
with poly-unsaturated fatty acids, leading to lipid peroxidation within the cell 
membranes. Indirectly, the radicals trigger the accumulation of neutrophils within the 
affected tissue initiating inflammatory processes that lead to severe mucosal lesions 11. 
Lipid peroxidation, as indicated in our model by plasma conjugated dienes 
concentrations, showed a 68% and 210% increase after burn and in sepsis, respectively 
(chapter 5). 
Intestinal permeability 
The manifestation of mesenteric ischemia and reperfusion injury included a marked 
increase in intestinal permeability, measured using the lactulose/mannitol ratio (chapter 5 
and 6). The linear correlation, observed in our model, between both elevated plasma 
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conjugated dienes and increased permeability index suggests a causal relationship 
(chapter 5). Clinical implications of altered intestinal permeability were documented by 
Levoyer et al 12, who noted that patients with the most sustained and marked alterations 
in intestinal permeability were at increased risk for subsequent systemic infections. The 
hypothesis that dysfunction of the intestinal mucosal barrier contributes to the 
development of MODS is supported by clinical evidence that intestinal permeability is 
increased in patients developing sepsis 13 after major thermal injury 14. 
Bacterial translocation 
The hypothesis that gut-derived bacteria or their products contribute to the development 
of MODS has been introduced to explain why no identifiable focus of infection can be 
found in as many as 30% ofbacteremic patients who die from MODS 4. Several 
investigators have demonstrated that hemorrhagic shock causes bacterial translocation to 
mesenteric lymph nodes, liver, spleen and systemic circulation 15, 16. In our model, 
bacterial translocation to mesenteric lymph nodes and remote organs occurred in almost 
all animals receiving thermal injury and endotoxin (chapters 5 and 6). The clinical 
relevance of altered gut barrier function was challenged in a human study by Moore et al 
17, in which they evaluated bacterial translocation after trauma. In this prospective 
clinical study, the investigators failed to identify any significant concentration of 
endotoxin or bacteria in portal venous blood and therefore concluded that the occurrence 
of bacterial translocation in humans is uncertain. A possible explanation for this apparent 
controversy is that there are other conduits such as gut-derived mesenteric lymph through 
which gut-derived factors may reach the systemic circulation 18. These investigators 
have demonstrated that after hemorrhagic shock, mesenteric lymph induces endothelial 
injury and contributes to lung injury. Furthermore, mesenteric lymphatic division before 
thermal injury was found to prevent acute lung injury, supporting the hypothesis that gut-
derived factors carried in mesenteric lymph contribute to trauma-induced remote organ 
injury 19. Consequently, the gut hypothesis of MODS has been expanded to include gut-
derived inflammatory factors and bacteria. 
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Hepatic ischemia and reperfusion injury 
Acute hepatic dysfunction is a well-recognized component of MODS. Hepatic ischemia 
and reperfusion have been documented to activate Kupffer cells and increase cytokine 
levels, which may produce systemic inflammation and may be responsible for tissue 
injury locally and on remote sites 22. Although hepatic ischemia and reperfusion have 
been extensively investigated in transplantation studies, little is known about the impact 
of severe injuries and sepsis on hepatic circulation and oxygenation. The results of our 
experimental studies (chapters 7, 8 and 9) demonstrated that trauma induces a selective 
vasoconstrictive effect on the hepatic circulation, yielding hepatic ischemia and a 
reduction ofhepatic oxygen delivery. The magnitude of the hepatic response to a second 
insult (sepsis) is magnified and manifested as a pronounced hepatic ischemia and 
reperfusion episode, associated with an inadequate hepatic oxygen delivery and 
pathologic supply-dependent hepatic oxygen consumption. These alterations in hepatic 
hemodynamics and oxygenation were independent of the systemic parameters, indicating 
the involvment of specific pathways. 
There is a large body of evidence that the liver microcirculation has to be considered as a 
major target in hepatic ischemia and reperfusion injury. The nature of microvascular 
injury, which precedes manifestation of hepatic parenchymal tissue damage, includes 
both hypoxia due to lack of microvascular perfusion (i.e. no-reflow), and a reperfusion-
associated ioflammatory response, which includes the activation and dysfunction of 
leukocytes and Kupffer cells (the reflow paradox). No-reflow in sinusoids is thought to 
be caused by endothelial cell swelling and intravascular hemoconcentration, and involves 
also a deterioration of the balance between endothelins (ET) and nitric oxide (NO). The 
reflow paradox is associated with: the release and action of proinflammatory cytokines 
(TNF -alpha, IL-l) and oxygen radicals, the up-regulation of endothelial and leukocytic 
adhesion molecules (selectins, beta-integrins, !CAM-I), and the interaction ofleukocytes 
with the endothelial lining of the hepatic microvasculature 21. 
As the liver appears to have a gate function for gnt-derived bacteria and their products, it 
appears that impairment of this hepatic clearance function may potentiate systemic 
effects of gut barrier failure by allowing indigenous bacteria or their endotoxins to reach 
the systemic circulation (chapter 3), where they potentiate systemic ioflammatory 
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responses 5. Furthermore, when translocated bacteria and endotoxin reach the liver, 
activation ofKupffer cells occurs, resulting in the secretion ofproinflammatory 
mediators that enhance the stress response and alter various immune functions 23. These 
observations in conjunction with our previous data on intestinal permeability and 
bacterial translocation may support the hypothesis of the gut-liver axis in the 
pathogenesis of MODS. whereas the gut is the "starter" ofMODS and the liver is the 
"motor"' of MODS 24. The associated increased portal venous resistance and portal 
hypertension documented in our model (chapters 7, 8 and 9) may also contribute to the 
occurrence of intestinal mucosal damage and subsequent bacterial or endotoxin 
translocation (chapter 3). 
Splanchnic and hepatic ischemia and reperfusion injury as a regional inflammatory 
response syndrome "'RIRS" model 
Although the potential role of bacteria/endotoxin translocation and its clinical relevance 
remains controversial, many lines of evidence support the concept that early gut 
hypoperfusion sets the stage for progressive gut dysfunction, such that the gut becomes a 
reservoir for pathogens and toxins that contribute to SIRS and MODS 16. 
In this thesis a four-phase concept of how local inflanunation eventually becomes SIRS is 
introduced. As a result of an overstimulation of the regional inflammation through 
ongoing positive feedbacks or inadequate negative feedbacks, a state ofhyperactivation 
of the regional inflanunatory response (RIRS) emerges. This syndrome is characterized 
by a pathologic statns of a constantly uncontrolled proinflanunatory reaction and 
unbalanced compensatory anti-inflammatory response. Subsequently, through either 
insufficient regional host defense or spillover of regional mediators into the circulation 
and defective feedback pathways RIRS evolves to SIRS. 
In the four-phase concept of the pathogenesis of post-injury SIRS and ultimately MODS 
(chapter I 0), splanchnic and hepatic ischemia and reperfusion injury can be identified as 
a precursor ofRIRS. The initial regional hypoperfusion induced by the first insult can 
lead to gut batrier failure, microcirculatory injury and macrophage activation 4. The 
ongoing bacterial and endotoxin translocation together with the primed Kupffer cells and 
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diminished hepatic bacterial clearance capacity activate regional neutrophils 
sequestration, phospholipase A, release 16, synthesis and action ofproinflammatory 
cytokines 20 and oxygen radicals 21, setting up a vicious cycle of uncontrolled regional 
events (RIRS), leading to a subsequent spillover into the systemic circulation and 
ultimately cuhninating in MODS. 
Mediators and modulators 
The differentiated impact of trauma and sepsis on splanchnic and hepatic perfusion and 
oxygenation, independently of systemic parameters, together with the importance of the 
induced regional ischemia and reperfusion injury in the pathogenesis of SIRS and MODS 
necessitate a target-oriented approach including early augmentation of intestinal and 
hepatic perfusion and oxygenation. 
The systemic inflammatory response to severe injuries and/or sepsis encompasses several 
cellular interactions, leading to the generation of diverse proinflammatory cytokines and 
vasoactive peptides. Some of these substances appear to play a pivotal role in the process 
of mesenteric ischemia following bum or sepsis (chapter 2). 
The renin-angiotensin axis appears to play a critical role in the pathophysiology of post-
injury splanchnic and hepatic ischemia. Angiotensin II, a potent vasoconstrictor that 
exhibits important mesenteric selectivity, has been identified in our model as an 
important mediator in the process by which trauma and sepsis adversely affect splanchnic 
(chapter 4) and hepatic (chapter 8) perfusion and oxygenation. The results of our 
experiments clearly show that blocking the action of angiotensin II using a specific 
angiotensin II receptor antagonist can ameliorate trauma- and sepsis-induced mesenteric 
and hepatic ischemia by improving regional blood flow and oxygen supply (chapters 4 
and 8). The same treatment modality has also been shown to reduce intestinal 
permeability and to prevent bacterial translocation after severe trauma and in sepsis 
(chapter 5). 
As interleukin-1 o: (IL-l o:) has been reported to affect receptors for the peptide hormone 
angiotensin II25, we studied the effects of post-injury IL-Ia treatment in our model. Our 
data clearly show that administration of IL-l o: attenuates mesenteric ischemia and 
reperfusion injury induced by trauma and endotoxemia (chapter 6). This intervention 
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strategy also yielded a significant reduction in intestiual permeability and bacterial 
translocation (chapter 6). 
As IL-l has been documented to cause an increase in the vasodilator prostacyciin 
concentrations 26. we also studied the effects of prostacyclin in our model. According to 
the data collected in our studies (chapter 9), treatment with prostacyclin appears to have 
specific, but phase-dependent, effects on hepatic perfusion and oxygenation. Our findings 
suggest that prostacyclin, as applied in our model, does not have any beneficial effects in 
preventing hepatic ischemia and reperfusion injmy in the early post-injmy phase. Quite 
the opposite, administration of prostacyclin significantly enhances hepatic blood flow and 
oxygen supply during the late post-injmy septic phase. 
Thus~ the results of our studies clearly show that interventional strategies regionally 
directed towards an early enhancement of mesenteric and hepatic perfusion and 
oxygenation, through target-specific pathways, are effective in attenuating splanchnic and 
hepatic ischemia and reperfusion injmy induced by trauma and sepsis. The possible 
clinical significance of these findings and the potential benefits of these interventional 
modalities in preventing MODS and improving the outcomes of severely injured and 
septic patients warrant further research in this field. 
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Summary and Conclusions 
Chapter 1 
In the introduction of this thesis a brief overview is given of multiple organ dysfunction 
syndrome (MODS). It emphasizes the conceptual models describing the 
pathophysiological changes in the process of development of MODS in the surgical 
intensive care unit. lnterventional strategies to prevent or treat this process and their 
benefits and limitations are also discussed. The background of the experimental studies 
included in this thesis is expressed in a conceptual model emphasizing the importance of 
intestinal and hepatic ischemia and reperfusion injuries as early events in the process of 
post-injmy MODS. The studies are designed in an attempt to improve the understanding 
of the mechanisms through which sequential insults, e.g. injmy and sepsis, adversely 
influence the gut-liver axis and to examine interventional strategies targeting some of the 
mediators that play a pivotal role in these early events. 
Chapter 2 
The impact of major trauma, such as severe thermal injmy, on intestinal blood flow is 
delineated in this chapter, with emphasis on the subsequent intestinal ischemia that leads 
to the translocation of indigenous bacteria and endotoxin to remote body organs. The 
synergic impact of sepsis as a second insult on the primed host, in amplifYing trauma-
induced intestinal ischemia and reperfusion injmy is outlined. Possible mediators that 
initiate and maintain this process are reviewed. Interventional strategies interacting with 
these mediators are discussed. 
Chapter3 
The concept of the gnt acting as the primary motor of MODS has been getting a lot of 
scientific attention and most of the investigations were focused on describing, 
understanding, and eventually influencing this process. In this chapter another concept in 
the pathophysiology of MODS is introduced. The liver appears to be very susceptible to 
post-injmy ischemic insults. This global hepatic ischemia is implicated in priming the 
hepatic Kupffer cells yielding a release of several inflammatory mediators and a 
depression of the hepatic bacterial clearance function, with a subsequent systemic 
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bacterial and endotoxin spillover. Therefore, the description of the gut as the starter and 
the liver as the motor for MODS seems more conceivable. 
Chapter4 
In a combined bwn and sepsis chronic porcine model, a profound impact of both insults 
on intestinal perfusion and oxygenation is documented. The initial injmy causes a 
significant increase in mesenteric vascular resistance and a subsequent reduction in 
mesenteric blood flow and oxygen delivery. The impact of the second insult is more 
pronounced. The study examines the hypothesis that early blockade of angiotensin II 
receptors can be beneficial in this process. Postbum treatment with DnP753, a specific 
angiotensin II receptor antagonist, is shown to attenuate the adverse impact of thermal 
injmy and sepsis on intestinal perfusion and oxygenation. 
ChapterS 
Increased intestinal permeability after trauma and in sepsis is most likely the resultant of 
the induced intestinal ischemia and reperfusion injmy. Oxygen-derived free radicals have 
been implicated in the subsequent tissue damage that results in dysfunction of intestinal 
mucosal barrier. The data of this study clearly show that thermal injmy and endotoxemia 
significantly 1) increase intestinal permeability, as assessed by the lactulose/mannitol 
excretion ratio, 2) induce reperfusion injmy, yielding lipid peroxidation, as demonstrated 
by the elevation of plasma conjugated dienes, 3) enhance bacterial translocation to 
remote organs, as shown in increased rates of positive tissue cultures. The results of this 
study indicate that angiotensin II plays a pivotal role in this process. Blocking angiotensin 
II receptor by the administration ofDnP753 is found to attenuate these detrimental effects 
ofbwn and endotoxin on intestinal mucosal integrity, the result ofwbich is a decrease in 
intestinal permeability and bacterial translocation. 
Chapter6 
In this experimental study the effects of administration ofinterleukin Ia (IL-l a) as a 
post-bwn treatment modality are investigated in a bwn and sepsis chronic porcine model. 
The data of this study show that the cytokine IL-l a plays an important role in intestinal 
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perfusion and oxygenation after bum and in sepsis. Under such conditions, IL-l a 
significantly improves mesenteric blood flow and enhances mesenteric oxygen delivery. 
Subsequently, both intesrinal permeability and incidence of bacterial translocation are 
reduced after the treatment with IL-l a. 
Chapter 7 
This study is designed to define the hemodynamic response and the tissue perfusion of 
the liver to severe injuries and sepsis in a combined burn and endotoxin chronic porcine 
model. Thermal injury has a selective vasoconstrictive impact on hepatic arterial blood 
flow, yielding hepatic ischemia and a reduction of hepatic oxygen delivery. The response 
of the primed liver to a second insult, i.e. endotoxemia, is amplified and manifested as a 
pronounced hepatic ischemia and reperfusion episode~ associated with an inadequate 
hepatic oxygen delivery and a pathologic supply-dependent hepatic oxygen consumption. 
A loss of the hepatic arterial buffer response, as indicated by a profound decline in both 
portal venous and hepatic arterial blood flow, seems to be one of the mechanisms 
responsible for these phenomena. Post-injury sepsis appears to induce severe portal 
hypertension, which may contribute to gnt barrier dysfunction. 
ChapterS 
This study examines the hypothesis that angiotensin II, a potent vasoconstrictor, is 
involved in the occurrence of hepatic ischemia after trauma and in sepsis. Postbum 
administration of angiotensin II receptor blocker DuP753 significantly improves hepatic 
arterial hemodynamics. Endotoxemia is documented to cause a significant hepatic arterial 
vasoconstriction, with a significant increase in both hepatic arterial and portal venous 
vascular resistance. The administration of angiotensin II receptor antagonist DuP753 
significantly enhances hepatic blood flow and oxygen supply. The action ofDuP753 
appears to be selective. The enhancement in oxygen supply, seen after DuP753 treatment, 
to meet the increased oxygen demand is only observed in the hepatic circulation and no 
systemic changes are found. Another beneficial effect of angiotensin II receptor blocking 
treatment is the prevention of the sepsis-induced portal hypertension. Therefore, it is 
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concluded that angiotensin II plays a pivotal role in the process of hepatic ischemia and 
reperfusion injury induced by trauma and endotoxemia. 
Chapter 9 
The hypothesis that the stable prostacyclin analogue iloprost beneficially influences post-
injury hepatic hemodynamics and thereby improves tissue perfusion and oxygenation is 
investigated in a burn and sepsis porcine modeL Postburn treatment with prostacyclin 
appears to have specific, but phase-dependent, effects on hepatic perfusion and 
oxygenation. During the early post-injury phase, prostacyclin seems to have no beneficial 
effects on hepatic perfusion. However, during the late post-injury septic period, 
prostacyclin seems to significantly improve hepatic total blood flow and oxygen supply. 
Portal hypertension, induced by thermal injury and sepsis, can be attenuated by 
prostacyclin treatment. 
Chapter 10 
The aim of this paper is to introduce a new concept regarding the post-traumatic 
inflammation sequeL The regional inflammatory response syndrome "RJRS" is presented 
as an identifiable stage between local injury and the systemic inflammatory response 
syndrome or "SIRS". The pathophysiology of the process during which RIRS emerges is 
extensively delineated. Various cellular interactions, biochemical pathways, 
immunomodulators, and proinflam.matory agents that are involved in this process are 
discussed. Examples of clinical situations that may initiate the manifestation ofRJRS are 
reviewed. The paper also emphasizes the importance of understanding RIRS in providing 
new insights into the complex process of sequelae of systemic inflammation (SIRS), 
embodied in the concept of the multiple organ dysfunction syndrome (MODS). 
Chapter 11 
A general discussion of the thesis is presented in this chapter. The outcomes of our 
studies are reviewed in one unifying concept. Furthermore, the validity of the conclusions 
included in this thesis and their clinical implications are debated. 
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Conclusions 
1- Ischemia of the hepato-splanchnic region appears to be an early specific event in 
the cascade following major trauma and in sepsis. 
2- A post-injury septic challenge acts synergistically with the initial injury. 
amplifYing the selective vasconstrictive impact of trauma on hepato-splanchnic 
blood flow with a subsequent critical tissue hypoxia followed by a profound 
reperfusion injury. 
3- Neither adequate resuscitation nor maintenance of normal cardiac output and 
systemic oxygen delivery necessarily results in normal hepato-splanchnic 
perfusion and oxygenatioD,- under such conditions. 
4- Manifestations ofhepato-splanchnic ischemia and reperfusion injury include lipid 
peroxidation of cell membranes~ mucosal damage, increased permeability and an 
altered hepatic bacterial clearance function. 
5- Alterations in hepato-splanchnic blood flow and oxygenation have potential 
clinical implications in that hepato-splanchnic barrier function (gut-hepatic axis) 
is altered, promoting systemic spillover of regional bacteria, endotoxin, and 
inflanunatory mediators. 
6- These events are at least partially regulated by angiotensin II, IL-l a and 
prostacyclin. 
7- Administration of a specific angiotensin II inhibitor, IL-l a or prostacyclin 
attenuates trauma- and sepsis-induced hepato-splanchnic ischemia and reperfusion 
injury and reduces the subsequent adverse events. 
8- RIRS is an identifiable stage between tissue injury and the development of SIRS, 
associated with global inflammatory signs~ but also with region specific 
symptoms. 
9- In the four-phase concept of the pathogenesis of post-injury SIRS and ultimately 
MODS, hepato-splanchnic ischemia and reperfusion injury can be identified as a 
precursor ofRIRS. 
217 
Chapter 12 
I 0- The selective impact of trauma and sepsis on hepato-splancbnic perfusion, 
together with the importance of the induced regional ischemia and reperfusion 
injwy in the pathogenesis of SIRS and MODS, necessitate a target-oriented 
approach, including early augmentation ofhepato-splancbnic perfusion and 
control of regional inflammation. 
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